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1.1 The stress response
Stress is broadly defined as a disruption of homeostasis, be it real or anticipated.
The response to stress has two faces. On the one hand, it is a highly adaptive re-
sponse to disturbances in homeostasis. On the other hand, if the stress response is
dysregulated it is a potential risk factor for a large number of diseases, ranging from
peripheral illnesses such as obesity and heart and cardiovascular problems to psy-
chiatric disorders including major depression, schizophrenia, drug addiction and
posttraumatic stress disorder (de Kloet et al., 2005; McEwen, 2008; Yehuda, 2009).
Stress-related disorders can occur when the balance between the multiple players,
phases and responsive tissues in the stress system is disturbed, so the adaptive stress
response converts into a maladapted, detrimental chain of events (de Kloet et al.,
1998; McEwen, 2001). Individual variations in this balance, due to genetic or en-
vironmental factors, determine whether an individual is resistant or sensitive to
stress-related disorders (Kaffman and Meaney, 2007; Oitzl et al., 2010). Key to un-
derstanding what causes the balance to shift from adaptive towards detrimental ef-
fects of stress is a comprehensive understanding of the different players and phases
involved in the stress response and their interactions with each other.
Two stress systems: the ANS- and HPA-axis
The body rapidly responds to a stressor by a combined activation of two stress sys-
tems in order to deal with the stressor and reinstate homeostasis as rapidly as pos-
sible. These two stress systems are the autonomic nervous system (ANS) and the
hypothalamic-pituitary-adrenal (HPA) axis. The autonomous nervous system re-
sponds within seconds via sympathetic and parasympathetic innervations through-
out the body. This system results in a rapid release of adrenaline and noradrenaline
and a number of peripheral effects, such as an increase in blood pressure and heart
rate, combined with a number of rapid effects in the brain. Together this results in
an increased state of alertness, vigilance, fear or aggression also called the “fight-or-
flight” response (de Kloet et al., 2005; Ulrich-Lai and Herman, 2009).
On a slightly slower time scale (minutes to hours) the HPA-axis is activated
(see Box I). This hormonal response system culminates in the release of corticoste-
roid hormones in the blood stream. Cortisol is the main corticosteroid in humans,
while rodents producemainly corticosterone. Corticosteroids enable a long-term re-
sponse to the stressor and affect tissues throughout the periphery as well as major
response sites within the brain. Their most pronounced actions include the regula-
tion of glucose, fat and protein metabolism, anti-inflammatory actions and effects
on mood, memory and cognition (de Kloet et al., 2005; McEwen, 2008; Ulrich-Lai
and Herman, 2009; Silverman and Sternberg, 2012; McGaugh, 2013). Throughout
this thesis I will use the term corticosteroids in reference to the naturally occur-
ring glucocorticoids: cortisol and corticosterone and their endogenous metabolites.



















Figure 1.1: The HPA-axis
Schematic overview of the HPA-axis.
Secreted cortisol or corticosterone ex-
erts a negative feedback on all levels
to prevent overstimulation of the axis.
Through limbic areas, corticosteroids
exercise an additional level of feedfor-
ward and feedback regulation.
Box I The HPA-axis
The release of corticosteroids is regulated by the
HPA-axis (Figure 1.1). Perception of a potentially
threatening situation activates the paraventricu-
lar nucleus (PVN) of the hypothalamus. In the
PVN, corticotrophin releasing hormone (CRH)
and vasopressin-containing neurons are activated
and stimulate the pituitary to release adrenocor-
ticotropin hormone (ACTH). In turn, this hor-
mone induces the release of corticosteroids from
the adrenal glands. Corticosteroids circulate in the
blood stream and thus reach every organ in the
body, including the brain. Corticosteroids signal
back to the HPA-axis at all levels to inhibit fur-
ther release, thus giving a negative feedback and
preventing overexposure (Figure 1.1). Activation of
the HPA-axis is also affected by higher brain ar-
eas, most notably by the limbic system. Corticoste-
roids are released in hourly pulses that are high-
est in amplitude during the active period, thereby
causing an overall circadian release pattern (Young
et al., 2004). This pattern of pulsatility is essential
to keep tissues responsive to stress-induced peaks
in corticosteroid release (Lightman and Conway-
Campbell, 2010; Sarabdjitsingh et al., 2012). Super-
imposed on this ultradian and circadian rhythm is the response to a stressor, which
(depending on the severity of the perceived stressor) results in high circulating cor-
ticosteroid levels for several hours.
ticosteroids, but are different in both their function and release regulation. I will
always name these separately when including them in my discussions. (see Box II)
Two corticosteroid receptors: MR and GR
The actions of corticosteroids are mediated by two receptor types, the glucocor-
ticoid receptor (GR) and the mineralocorticoid receptor (MR) (Reul and de Kloet,
1985). Both belong to the family of nuclear receptors, a family of hormone-activated
transcription factors. The dual receptor system gives corticosteroids a versatile re-
sponse pattern. The MR has a ∼10-fold higher affinity for the naturally occurring
corticosteroids (corticosterone and cortisol) than the GR (MR: Kd of 0.5n and
GR of 5n ). This implies that both receptors are activated at different time points
during a stress response: the MR is already activated to a large extent by basal cor-
ticosteroid levels, while the GR becomes gradually activated when corticosteroid
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levels rise, for example after a stressful event, during the circadian rise in cortico-
steroids (Reul and de Kloet, 1985; Kitchener et al., 2004) or during the peak of ul-
tradian pulses (Conway-Campbell et al., 2007). Of note, the membrane-associated
subpopulation of the MR (to be discussed later in this introduction) has reduced
corticosteroid affinity and requires higher hormone levels. The GR is expressed in
virtually every cell of the body. Within the brain, the GR is expressed ubiquitously
as well, both in glia cells and neurons, with highest levels in the PVN and in the hip-
pocampus (Reul and de Kloet, 1985). The expression of the MR, on the other hand,
is more restricted. High levels of MR are found in limbic areas, with moderate lev-
els in the (prefrontal) cortex and the amygdala and high levels in the hippocampus
(Reul and de Kloet, 1985). In addition, MR expression is found in circumventricular
organs and the nucleus of the solitary tract (Geerling et al., 2006) and peripherally
within the kidneys and throughout the cardiovascular system. But, in these latter
tissues the MR acts as aldosterone receptor as corticosterone is metabolized into an
inactive form in these tissues (see Box II).
The differences in affinity and expression pattern between the MR and GR are
also reflected in their respective functions within the stress response. Due to its
high affinity for corticosteroids, the MR plays a proactive role in maintaining home-
ostasis. Within the brain, low levels of corticosteroids, activating the MR, are re-
quired to maintain basal firing frequency and stability of limbic circuits (Joëls et
al., 2008). Probably through input of higher brain regions to the PVN, the MR mod-
ulates HPA-axis activation (Reul et al., 2000). In cognition, the MR is involved in
appraisal of novel situations, learning strategies, response selection and emotional
reactivity (Oitzl and de Kloet, 1992; Schwabe et al., 2010; Zhou et al., 2010, 2011; Kruk
et al., 2013; Souza et al., 2014). Part of these MR-mediated actions are likely due to
non-genomic signaling (to be discussed further in Chapter 2). Conversely, the GR,
which is only activated when corticosteroid levels rise, plays a reactive role in the
stress response. For one, through the GR, corticosteroids inhibit their own release in
order to prevent corticosteroid overexposure (de Kloet and Reul, 1987). Within the
brain, GR activation generally suppresses transiently raised excitatory transmission
for instance by enhancement of calciumdependent K+ afterhyperpolarization (Joëls
and de Kloet, 1989) and by increasing serotonin dependent K+hyperpolarization
(Joëls and de Kloet, 1990; Joëls et al., 1991). GR activation can also stimulate recruit-
ment and mobility of AMPA receptors into the post-synaptic membrane (Groc et
al., 2008; Popoli et al., 2011). As a result LTP, the cellular form of memory, is oc-
cluded by these GR-mediated effects (Alfarez et al., 2002; Kim and Diamond, 2002).
One of the main function of the GR within cognition is to promote consolidation
of stress-related information and to facilitate behavioral adaptation (Oitzl and de
Kloet, 1992; de Kloet et al., 1999; de Quervain et al., 2009; Zhou et al., 2010). In
addition, the GR exerts important functions within the periphery, for example re-
garding glucose metabolism and suppression of immune activation during stress




Box II The promiscuity of the mineralocorticoid receptor
TheMR is an odd receptor in the sense that it bindsmultiple families of functionally
different hormones. Thus, both the naturally occurring glucocorticoids (corticos-
terone or cortisol) and mineralocorticoids (aldosterone and deoxycorticosterone)
bind the MR with similar affinity, and also progesterone is bound with high affinity
(Joëls et al., 2008; Funder, 2010; Gomez-Sanchez, 2010). In the epithelial cells of the
kidneys and distal colon, the MR acts as the prime receptor for aldosterone and is
essential for the regulation of the body’s salt and fluid balance (Gomez-Sanchez,
2011). However, the circulating plasma level of corticosterone/cortisol is 100 to 1000-
fold higher than that of aldosterone, so how does the MR in the kidney retain its
mineralocorticoid sensitivity? This enigma was solved with the discovery of the key
enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) (Edwards et al., 1988;
Funder et al., 1988). This enzyme converts cortisol and corticosterone into inactive
metabolites (see Figure 1.2) and thus strongly reduces the excess of these gluco-
corticoids in aldosterone-sensitive tissues. Indeed, 11β-HSD2 is highly expressed in
aldosterone-sensitive tissues, such as the kidneys, skin and colon and is absent from
classical glucocorticoid target tissues as the liver, brain and immune system (Wyr-
woll et al., 2011). In the brain its expression is limited to somenuclei in the brainstem,
most notably the nucleus of the solitary tract, an important nucleus in salt home-
ostasis regulation (Geerling et al., 2006). In addition to regulating the hormone ac-
cessibility of the MR, 11β-HSD2 also acts to protect tissues against glucocorticoids.
For example, there is widespread expression of 11β-HSD2 throughout the placenta
during gestation and the developing fetus shows 10–100 fold lover glucocorticoid
levels as the mother (Wyrwoll et al., 2011). Deficiencies in 11β-HSD2 expression dur-
ing late pregnancy generally decrease the birth weight and may be associated with
cognitive and affective deficits later in life (most notably increased anxiety and a
dysregulation of the HPA-axis) (Cottrell et al., 2014). In classical glucocorticoid tar-
get tissues such as the liver and the brain, another type of enzyme is expressed:
11β-HSD type 1 (Agarwal et al., 1989). The enzyme 11β-HSD1 has predominant re-
ductase activity. It converts inactive cortisone and 11β-dehydrocorticosterone into
the active 11β-hydroxy form (see Figure 1.2) and thus potentiates glucocorticoid ef-












Figure 1.2: 11β-HSD1 and 2
The active corticosteroids, cortisol and corticosterone are metabolized into their inactive counterparts,
cortisone and 11-dehydrogenated corticosterone by 11β-HSD2 and vice versa regenerated by 11β-HSD1.
5
G
Two modes of actions: genomic and non-genomic
Both MR and GR are ligand-driven transcription factors. They predominantly re-
side in the cytoplasm in their unbound state. Upon hormone binding, the receptor-
ligand complex translocates to the nucleus and affects gene transcription (Beato
and Sanchez-Pacheco, 1996). Although theMR and GR share almost identical DNA-
binding domains, they do not regulate the same sets of genes. For example, the set
of genes that are over- or under-expressed after MR versus GR activation show only
limited (less than 30%) overlap (Datson et al., 2001).
However, over the last decades an alternative mode of action was found for both
receptors that does not involve gene transcription. Genomic effects are slow in on-
set and the first physiological responses are expected after a delay of at least 15 min-
utes, and often in the order of hours (Haller et al., 2008). This is in sharp contrast
to the reality of some of the corticosteroid effects, of which the fastest have been
observed within seconds to minutes. Thus, there must be an alternative mode of
action of corticosteroids that does not involve the genomic MR and GR mediated
pathways. Indeed, a small portion of the population of theMR andGR is localized at
the plasma membrane where they interact with multiple kinase signaling pathways
and exert rapid, non-genomic effects (Di et al., 2003, 2009; Johnson et al., 2005;
Karst et al., 2005, 2010; Prager et al., 2009). As such, both the MR and GR affect
neuronal excitability and behavior over a wide time range: from a few minutes after
corticosteroid exposure until many hours thereafter (Joëls et al., 2012).
To understand the response of a tissue or an organism to stress it is important to
understand what happens at the lower levels; i.e. at the cellular level. These cellular
actions are the result of a complex interplay between the effects of corticosteroids
and other stress hormones, and effectsmediated by the two corticosteroid receptors
(MR and GR). The existence of two corticosteroid responsive pathways (genomic
and non-genomic) adds to the complexity. For the cellular basis of both modes of
action much has already been discovered but more remains unknown. In the next
two sections, I will introduce the state of knowledge for both the genomic and the
non-genomic mode of action of corticosteroids.
1.2 Non-genomic corticosteroid signaling
For many years rapid actions of corticosteroids on neurotransmission and behavior
were noted but their cellular basis remained ill understood. For one, corticosteroid
application can inhibit neuroendocrine output of the brain within a few minutes
(Evanson et al., 2010b). On the level of behavior, depending on the context, corti-
costerone application results rapidly in increased locomotion (Sandi et al., 1996a),
aggression (Mikics et al., 2004; Kruk et al., 2013) or risk assessment (Mikics et al.,
2005). Also in humans corticosteroids affect learning and emotional processing in
a non-genomic manner (Henckens et al., 2012; van Ast et al., 2013).
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The Tasker group (Di et al., 2003, 2005, 2009; Malcher-Lopes et al., 2006) per-
formed a set of pioneering experiments that opened the field to understanding the
cellular basis of these rapid effects. They demonstrated that a high dose of corti-
costerone (from 100n ) irreversibly reduces the frequency of miniature excitatory
postsynaptic currents (mEPSCs) within 5 minutes within the PVN of the hypotha-
lamus. This effect did not require gene transcription or protein synthesis. The fre-
quency of mEPSCs is a measure of the excitability of neurons, reflecting either the
release probability of glutamate vesicles or the number of synaptic contacts. In sub-
sequent years, the Joëls group (Karst et al., 2005, 2010; Pasricha et al., 2011) found
rapid effects of corticosterone on mEPSC frequency in the hippocampus (both CA1
and DG) and the basolateral amygdala. They observed a rapid reduction of mEPSC
frequency in the hippocampus, which is opposite to what was found in the PVN.
Moreover, within the hippocampus, the rapid reduction was reversible and induced
by lower doses of corticosterone (from 10n ). Over recent years many more effects
have been identified in stress responsive areas in the brain, I will summarize these
in Chapter 2.
Membrane-associated MR and GR
A large part of the non-genomic actions of corticosteroids require the presence of
the MR or GR. For instance, the enhanced mEPSC frequency in the hippocampus is
absent in MR-/- mice and prevented by pretreatment with MR antagonists (Karst
et al., 2005). Similarly, in the amygdala rapid GR-dependent effects were observed
(Karst et al., 2010). Rapid behavioral effects have been shown to depend on the GR
(Barsegyan et al., 2010) and MR (Khaksari et al., 2007) as well. Thus, the MR and
GR appear to have an alternative function as mediators of non-genomic cortico-
steroid signaling. Intriguingly, in this role the MR and GR seem to be accessible
at the outside of the plasma membrane. Rapid effects can still be induced with a
membrane-impermeable conjugate of corticosterone (cort-BSA) (Karst et al., 2005,
2010; Groc et al., 2008; Roozendaal et al., 2010) and cannot be induced by intracel-
lularly infused corticosterone (Liu et al., 2007; Olijslagers et al., 2008). Additionally,
the presence of the MR and GR at the (synaptic) membrane was demonstrated in
membrane extracts and synaptosomes (Komatsuzaki et al., 2005; Wang and Wang,
2009; Qiu et al., 2010) and with electron microscopy imaging (Johnson et al., 2005;
Prager et al., 2009). Part of the downstream signaling cascades has also been unrav-
eled. One of the most common signaling partners are the G-proteins, which bind
to the receptors at the membrane. Inhibition of G-protein activation abolishes the
rapid effects of corticosterone on a variety of neuronal functions (Zhu et al., 1998;
Di et al., 2003, 2009; Olijslagers et al., 2008; Hu et al., 2010). More downstream, the
cAMP-PKA and ERK1/2 pathways have been implicated in non-genomic corticoste-




The regulation of membrane translocation for the MR and GR remains incom-
pletely understood. For the related estrogen receptor α (ERα), presence within cave-
olae, association with caveolin-1 and palmitoylation have been established as vi-
tal steps in its membrane targeting (Levin, 2009). However, only association with
caveolin-1 has been shown for the MR and GR (Matthews et al., 2008; Pojoga et al.,
2010b). Moreover, the fraction of the receptors associated with the membrane, their
local binding partners and the effect of ligand treatment on membrane trafficking
and internalization have not yet been addressed.
1.3 Genomic corticosteroid signaling
As discussed, a small fraction of the MR and GR are anchored at the cell membrane,
but the bulk of the receptor population is present within the cytoplasm. In the ab-
sence of ligand, these cytoplasmic receptors are kept in an inactive conformation
by association with a large chaperone complex. Most chaperones are shared by all
steroid receptors, these include heat shock proteins (HSP) 90, 40 and 70, p23, p70,
and cochaperone proteins, such as the immunophilins FKBP51, FKBP52, and pro-
tein phosphatase 5 (PP5) (Picard, 2006). Association with chaperones also serves
to keep the nuclear localization sequence hidden and prevents protein degradation
(Faresse et al., 2010). Corticosteroids are lipophilic and as such easily pass the cell
membrane and reach their receptors within the cytoplasm. Ligand binding to the
ligand-binding pocket (LBP) results in a massive conformational shift that exposes
the nuclear localization signal. Next, the ligand-receptor complex is actively trans-
ported into the nucleus by importins (primarily importin α (Tanaka et al., 2003)).
DNA binding
Through the two zinc fingers in their DBD (see Box III), theMR andGR bind directly
to GREs on the DNA. Direct DNA-binding of the MR and GR to GREs is mostly as-
sociated with enhanced gene transcription or transactivation. The receptor binds
the DNA as a dimer, forms a complex with coactivators and attracts the general
transcription machinery to induce increased transcription of the related gene (Dat-
son et al., 2008). A cofactor is defined as a protein that affects the interaction of a
transcription factor with the DNA, but that does not act as a transcription factor
itself. Cofactors have diverse functions and affect the stability of the transcriptional
machinery, (de)acytelate histones or recruit other cofactors or transcription factors
(Zalachoras et al., 2013). Cofactors are divided into coactivators and corepressors de-
pending on their role in gene transcription. The GR also induces transrepression of
genes. This can occur through direct binding to negative GREs, but it is mostly as-
sociated with indirect DNA-binding. For example, the GR has been well described




Box III Functional domains of the GR andMR
All steroid receptors share a modular structure encompassing four functional do-
mains. TheN-terminal domain is least conserved between steroid receptors (around
15% overlap) and contains the activating factor-1 (AF-1) domain. Adjacent is the
highly conserved (90% homology among steroid receptors) DNA-binding domain
(DBD), which recognizes the hormone response elements in the DNA by its two
zinc finger structures. Due to the almost perfect sequence homology between this
region in theMR andGR they recognize and bind the sameDNA sequences, dubbed
glucocorticoid response elements (GREs) (Datson et al., 2008). C-terminally located
is the ligand-binding domain (LBD). The sequence homology of the LBD is also gen-
erally quite high between steroid receptors (∼60% between the MR and GR), but
the structures lining the ligand-binding pocket show less overlap and determine
ligand specificity (Bledsoe et al., 2002; Huyet et al., 2012). The conformation of the
LBD is highly affected by ligand binding, it exposes chaperone binding sites in its
unbound conformation, while ligand binding leads to exposure of the nuclear lo-
calization signal and AF-2 domain (Pascual-Le Tallec and Lombès, 2005). For most
steroid receptors, helix-12 which contains the AF-2 domain refolds into an open
conformation only when agonists are bound and not upon binding of antagonists
(Fagart et al., 1998; Bledsoe et al., 2004). Both the AF-1 and AF-2 mediate cofactor
binding and are affected by ligand-induced conformation changes. While the AF-2
domain is highly conserved, the AF-1 is very variable and determines receptor spe-
cific and cellular context-dependent cofactor binding patterns (Fuse et al., 2000;
Simons and Kumar, 2013). In between the DBD and LBD is a small hinge region







< 15% ~ 60%> 90%overlap MR-GR
Figure 1.3: Functional domains of the GR and MR
Schematic overview of the modular structure of the GR and MR. Below the average sequence homology
between the two receptors is given. Image adapted from Pippal and Fuller (2008).
target genes (Nixon et al., 2013). This is functionally important for GR’s immunosup-
pressant actions. Indirect binding does not necessarily have to entail transrepres-
sion though. Co-binding of the GR and other transcription factors can also induce
gene transcription (Kassel and Herrlich, 2007; Ratman et al., 2013).
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The MR and GR show a large overlap in their DBD and activating function
domains (see Figure 1.3) and as result their genomic actions overlap. In tissues
where the MR and GR are coexpressed they also form heterodimers (Nishi et al.,
2004) and DNA transactivation will thus occur through a mixture of GR-GR ho-
modimers, MR-MR homodimers and GR-MR heterodimers. The extent of overlap
betweenMR and GR regulated genes is still debated. Early gene expression profiling
studies found only limited overlap in MR- and GR- responsive genes (Datson et al.,
2001, 2008), while a recent study investigating direct DNA binding using chroma-
tine immuno precipitation (ChiP) did find MR binding for all examined GR-target
sequences (Polman et al., 2013). The MR and GR are known to share many cofac-
tors (also with other steroid receptors), but each receptor uses a distinctive set as
well (Yang and Young, 2009; Zalachoras et al., 2013). In regards to transrepression
though indirect binding to the DNA, this has classically been associated with only
the GR and not the MR. Indeed, the MR lacks immunosuppressant efficacy (Pippal
and Fuller, 2008). However, in vitro transrepression of AP-1 activity by the MR have
been shown by some (Africander et al., 2013), albeit with much reduced potency
compared to the GR (Pearce and Yamamoto, 1993). This has not yet been validated
in vivo. An overview of MRs and GRs cellular actions is represented in Figure 1.4.
Corticosteroids reach a multitude of tissues where they execute very variable
functions, on a cellular level this means they require the capacity for tissue specific
patterns of gene transcription. Indeed, Chip-Seq studies and microarray studies
have both shown that there is only amoderate overlap in GR target genes and bound
sequences between different cell types (Datson et al., 2008; Reddy et al., 2009; Yu et
al., 2010; John et al., 2011; Polman et al., 2012, 2013). For example, the set of sequences
bound by GR in a neuronal-like cell line overlapped for only 7% with those found
in an alveolar-derived cell line and for 11% with an adipose-derived line (Polman
et al., 2012). Differences in chromatin structure and cofactor availability are impor-
tant determinants of this tissue specificity. The DNA sequence of the GR binding
site (GBS) represents another level of complexity and regulation of GR’s (and MR’s)
genomic output. Identified GR binding sites show a certain level of sequence ho-
mology and thus a consensus GBS (Strähle et al., 1987). However, there are also
quite some variations to the consensus sequence possible. In an elegant study, the
Yamamoto group showed that single nucleotide mutations to identified GBS’s af-
fected the conformation of the GR when bound and resulted in severe shifts in (in
vitro) transactivation capacity (Meijsing et al., 2009). This effect was found to de-
pend on cofactor recruitment. Within the brain an in silico search for preserved GR
binding sequences resulted in the identification of a brain-specific consensus GBS
(Datson et al., 2011) and also found considerable variation within this sequence and
its flanking regions between different GR-regulated genes. The exact correlation be-
tween binding sequences and GR’s conformation and capacity to induce gene tran-
scription is still only partly understood but it is clear that this represents another

















Figure 1.4: Cellular MR- and GR-mediated corticosteroid actions
A small fraction ofMR andGR translocate (through unknown pathways) to the plasmamembrane, where
they associate with caveolin-1 and other binding partners and induce non-genomic corticosteroid effects.
The largest fraction of both MR and GR resides within the cytoplasm while unbound and is bound here
by chaperones. Hormone binding releases the chaperones and enables nuclear translocation. Within
the nucleus both receptors bind the DNA in a dynamic fashion (see insert). The GR can bind its target
genes through direct receptor-DNA interactions as dimer and indirectly through binding to / with other
transcription factors as monomer. The first is predominantly associated with transactivation and the
latter with transrepression, but both modes of DNA binding can lead to both stimulation and inhibition
of gene transcription. Indirect DNA binding by the MR is less established and its genomic actions are
thus mostly restricted to direct binding as dimer and transactivation. When coexpressed, the MR and
GR also form heterodimers on the DNA.
Steroid receptors show highly dynamic DNA-binding
For many years the binding of steroid receptors (and other transcription factors)
to their DNA-target sites was envisioned as a static event: the transcription factor
binds, recruits cofactors and RNA polymerases and gene transcription is initiated
(Perlmann et al., 1990). However, since the start of the new millennium all compo-
nents of the transcriptional machinery have been found to be highly dynamic. In
this new era many advanced (functional) imaging techniques have been developed,
improved and used that enable the observation of protein dynamics on a seconds to
even milliseconds timescale. I will discuss some of the most important advances in
microscopy in the next section of the introduction. First the current view on steroid
receptor DNA-binding dynamics will be discussed.
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The first to study the dynamics of the GR at the DNA was the Hager group. They
developed a tandem repeat of a naturalistic GR binding site, the mouse mammary
tumor virus (MMTV) promoter, incorporated into the native DNA. This repeat con-
sists of 800–1200 GR binding sites and as such binding of GFP-GR to this site can
be visualized directly (Walker et al., 1999; McNally et al., 2000). With this model
system, the Hager group used fluorescence recovery after photobleaching (FRAP)
to show very rapid exchange of the GR at its binding site. The half maximum of
recovery was obtained within 5 seconds at the site (McNally et al., 2000; Stavreva et
al., 2004). A multitude of follow up studies on the GR and related steroid receptors
(Stenoien et al., 2000; Schaaf and Cidlowski, 2003; Farla et al., 2004; Stavreva et al.,
2004; Mueller et al., 2008; Stasevich et al., 2010b), irrevocably showed that activated
steroid receptors remain verymobile within the nucleus. Similarly, a rapid exchange
at the DNA was found for all transcription factors and also for cofactors and RNA
polymerases (Dundr et al., 2002; Gorski et al., 2008; Johnson et al., 2008). Only a few
structural chromatin components (core histone proteins) were found to be stably
associated with the DNA (Kimura and Cook, 2001). An important observation was
that mobility of steroid receptors is negatively correlated to their transcriptional ac-
tivity (Schaaf and Cidlowski, 2003; Stavreva et al., 2004, 2009). This suggests that
DNA-binding is either less frequent or shorter in duration for less potently acti-
vated receptors. In addition, a large fraction of the observed immobilizations are
presumed to be due to nonspecific DNA binding (Mueller et al., 2013). Nonspecific
DNA-binding likely aids a transcription factor in its search for specific binding sites,
but the exact mechanisms remain debated. In vitro transcription factors show 1D
sliding across the DNA (i.e. remains associated with the DNA), in addition to 3D
hopping (rapid association and dissociation to the DNA), but whether this also oc-
curs on nascent chromatin remains unclear (Gowers et al., 2005; Hager et al., 2009).
The highly dynamic behavior of steroid receptors at the second and millisecond
level must further be integrated with additional levels of dynamics at longer time
frames. For both the GR and the ERα spontaneous oscillations of receptor binding
to responsive genes are observed within single cells in 20–40 minute cycles (Becker,
2002;Métivier et al., 2003). Id est: a responsive genewill cycle through 20–40minute
periods of high occupancy (by dynamically interchanging receptors) and similar pe-
riods with very low occupancy. These types of asynchronous oscillations are likely
caused by local chromatin remodeling. Chromatin remodeling precedes recruit-
ment of the GR to a DNA sequence and displacement of the chromatin remodeling
complex is soon followed by GR displacement from the sequence (Nagaich et al.,
2004). In addition to these oscillations, in the organism also the hormone secretion
oscillates and also this induces oscillations in gene expression (Stavreva et al., 2009).
Thus, oscillating pulses of corticosterone also result in oscillations of GR-DNA bind-
ing, RNA polymerase binding and mRNA transcript levels of endogenous GR-target




Taken together, these findings paint a picture of a highly dynamic transcrip-
tional complex at gene promoters (and enhancers) with multiple components dy-
namically exchanging. This process has been dubbed the “hit-and-run” mode of
transcription (Rigaud et al., 1991). This is a field still in development and theories
about what types of DNA interactions occur and what their relevance to transcrip-
tion is are still being developed (recent reviews on this topic include (Mueller et
al., 2008; Biddie and Hager, 2009; Hager et al., 2009; Voss and Hager, 2014). More
recently, the relevance of transcription factor dynamics for local chromatin remod-
eling and complex formation has received more attention and added another level
of complexity to the view on transcription factor-DNA interplay (Voss and Hager,
2014). One of the largest challenges remains to accurately quantify the dynamics at
sufficient spatial and temporal resolution and therefore the field is very dependent
on the development of novel sophisticated imaging methods.
1.4 The analysis of protein dynamics using advanced
fluorescence microscopy techniques
The use of fluorescently tagged receptors has revealed much about the dynamics of
the MR and GR within the cell and within the nucleus. Over the last fifteen years a
number of live imaging and advanced microscopy techniques have been developed
to enable the tracking of fluorescent proteins within living cells. In the next sections
I will introduce the three mostly used techniques and discuss their advantages and
disadvantages. I will also briefly discuss some imaging approaches directed towards
specific subcellular regions.
Fluorescence Recovery After Photobleaching
All fluorescent proteins experience photobleaching, i.e. the irreversible loss of flu-
orescent capacity due to (prolonged) excitation. This phenomenon can be utilized
to measure protein dynamics with FRAP (van Royen et al., 2009a). In FRAP a target
area is exposed to a high intensity laser pulse to effectively bleach all fluorescent
molecules within that area. Subsequently, the recovery of fluorescence within that
area is monitored. As photobleaching is a permanent state, any recovery of fluores-
cence is due to fluorescent proteins moving from unbleached areas into the target
area and replacing the bleached molecules that are moving out of this area. Thus,
the faster the recovery, the more mobile the fluorescent protein (Figure 1.5 ). Ad-
vantages of FRAP are that it is relatively simple to implement and that it records
protein dynamics over a large time range (from a few 100 milliseconds to several
minutes; Table 1.1). Its main disadvantages are that it is not accurate in tracking fast
diffusion (< 100 milliseconds) and that there is no consensus on how to quantify




Spatial resolution (in XY ) diffraction limited diffraction limited 20nm
Time domain ∼100ms – 102 sec µs – 101 sec ∼5ms – 100 sec
Population modeling yes yes yes/no
Tracking of fast diffusing
proteins poor good good
Assessment DNA-binding
times yes no yes/no*
Table 1.1: Comparison of advanced imaging techniques
* attenuations to the illumination schedule enable a quantification of DNA-binding times for SMM
(Gebhardt et al., 2013).
differences in modeling parameters and a failure to correct for laser irregularities
severely affected the acquired parameters (Mueller et al., 2008).
Fluorescence Correlation Spectroscopy
Fluorescence Correlation Spectroscopy (FCS) is a fluorescence imaging technique
that can be used for accurate assessment of the mobility of fast diffusing proteins
(Chen et al., 1999; Ries and Schwille, 2012). In FCS, the fluorescent signal in a rel-
atively small (∼200nm diameter) area is monitored over time (Figure 1.5 ). This
measured fluorescence fluctuates as fluorescent proteins move in and out of the
volume. The faster a protein diffuses, the shorter it will reside within this measur-
ing volume. Therefore, the correlation of fluorescence over increasing time frames
is recorded and the rate of change of the correlation curve over time is a measure
of the diffusion rate of the protein. The main advantage of FCS is that it can re-
liably quantify relatively rapid diffusion. Its main disadvantages are that FCS can
only be applied for a limited time domain (microseconds to several seconds) and
that the size of the imaging volume is restricted by diffraction of light and can thus
not become smaller than ∼200nm in XY (depending on the objective and laser
wavelength) (Table 1.1).
Single-Molecule Microscopy
In single-Molecule Microscopy (SMM), a wide-field fluorescence microscopy setup
is used. Fast, ultra-sensitive imaging of samples with very low levels of fluorescence
enables the visualization of single fluorescent molecules (Figure 1.5 ). The fluores-
cent signal can be fitted with a Gaussian curve, of which the center represents the
location of the fluorescent molecule. This approach results in a positional accu-
racy of 20–40 nanometer. The positional accuracy depends only on the signal-to-
noise ratio and can therefore be a lot smaller than the diffraction-limited resolution
of conventional fluorescence microscopy. A further advantage of SMM is its high
temporal resolution (several milliseconds). Quantification of SMM data has been



















































Figure 1.5: Functional imaging approaches
A schematic overview of the threemain functional fluorescence imagingmethods. (A) FRAP. In FRAP a >
1000nm diameter area is bleached by a high-energy laser pulse and subsequently the recovery of fluores-
cence within this area is observed. Quantification of protein dynamics is obtained from modeling of the
recovery curve. (B) FCS. In FCS a > 200nm diameter area is observed and fluorescence within this area
is observed. Quantification of protein dynamics is obtained by autocorrelation of the fluorescence over
time. (C) SMM. In SMM a region of interest (ROI) is chosen within a lightly fluorescent cell. Within this
ROI, single fluorescent molecules are observed and as their fluorescence is fitted with a Gaussian curve
a positional accuracy of ∼40nm is obtained. Quantification of protein dynamics occurs either through
tracking of single molecules or by PICS where for each time lag all distances of molecules between the
two images is fitted. FRAP: Fluorescence Recovery After Photobleaching, FCS: Fluorescence Correlation
Spectroscopy, SMM: Single-Molecule Microscopy.
lation Spectroscopy (PICS). In SMT, a very low density of fluorescent molecules is
required and the trajectories of singlemolecules are constructed over several frames
(Persson et al., 2013). The length of these trajectories is restricted by blinking and
15
G
photo-inactivation (bleaching) of the used fluorophore. Population data can be ex-
tracted by population modeling or non-averaged data can be analyzed (Elf et al.,
2007). In PICS, higher densities of fluorophores are allowed and blinking is less of
a problem (Semrau and Schmidt, 2007). PICS measures the correlation of distances
of each single fluorescent molecule to all existing fluorescent molecules in a subse-
quent time frame. From the overall data the uncorrelated distances are subtracted
and the remaining correlated distances are fitted with populationmodels. Themain
disadvantage of SMM is that it is not easily applied to long time ranges (Table 1.1).
SMT is hampered by the stability of fluorophores over longer time delays and both
SMT and PICS become less accurate over long time delays due to escaping of the
faster diffusing molecules from the imaging volume (van Royen et al., 2014). La-
belling of proteins with gold particles or quantum dots enables long-term imaging
and is very promising, but has so far been applied in only a few occasions due to
labeling issues (Cognet et al., 2014).
Total internal reflection fluorescence (TIRF) microscopy
Total internal reflection fluorescence (TIRF) microscopy provides a means to selec-
tively excite fluorophores in a thin layer close to the glass-medium interface (Ax-
elrod et al., 1983; Axelrod, 2008; Toomre, 2012; Martin-Fernandez et al., 2013). In
short, in TIRF the excitation laser is redirected so that it exits the objective at a
large angle relative to the optical axis. Once a critically large angle is achieved, the
excitation light is totally internally reflected at the glass-medium interface. As a re-
sult a low energy electromagnetic field is generated from this interface, which is
dubbed the evanescent wave field. The evanescent wave field is capable of exciting
fluorophores, but its energy decreases exponentially, which results in an excitation
field of 60–100nm in depth. The biggest advantage of TIRFmicroscopy is that it pro-
duces wide-field images with very low background fluorescence from out-of-focus
planes and thus a very high signal-to-noise ratio. TIRFmicroscopy can be combined
with advanced imaging techniques as FCS, FRAP and SMM. Especially, the combina-
tion of SMMandTIRF has been used in awide variety of studies to study the kinetics
of membrane-bound proteins, near membrane structures and docking vesicles (Ax-
elrod, 2008). In a variation of TIRF, entitled highly inclined and laminated optical
sheet (HILO) microscopy, a thin sheet of excitation light penetrates the sample at
an angle, thus exciting a thin section, but within the cell. HILO can thus be used to
image within the cytoplasm or nucleus, with improved signal-to-noise ratio (Toku-
naga et al., 2008). Similarly, reflected light sheet microscopy (RLSM) also enables
imaging of a thin section within the cell and thus reducing out of focus light. RLSM
has been successfully combined with single-molecule tracking (Ritter et al., 2010;




1.5 Objective and outline
As the stress system is such a tightly regulated system, it is of vital importance to
understand the finesses of the underlying molecular pathways, which ultimately
determine the responses on the tissue and organism levels. Within a target cell
corticosteroids can bind both the MR and GR and through these receptors it will ac-
tivate both non-genomic and genomic pathways. Although much has been learned
regarding the mode of action of both receptors, many questions still remain. In this
thesis I will explore further finesses of the cellular actions of corticosteroids medi-
ated byMR andGR in both theirmembrane-associated and nuclear subpopulations.
I have three specific aims:
1. To investigate the multitude of non-genomic effects of corticosteroids in dif-
ferent brain areas and explore how these fit within the coordinated (rapid
phase of the) stress response (Chapter 2).
2. To set up in vitro models to show the presence of a distinct membrane-
associated population of the MR and further characterize its function,
structure-function relationship and dynamics (Chapter 3 and 4).
3. To quantify the chromatin binding dynamics of the MR and GR within the
nucleus and explore the effect of mutations within the receptors and different
ligands on their DNA-binding dynamics (Chapter 5 and 6).
Thesis outline and approach
To investigate these three aims I will use a number of different experimental ap-
proaches.
In Chapter 2 we will investigate available knowledge concerning the multitude
of rapid non-genomic corticosteroid actions within different brain areas. We focus
on the timing of the effects in each brain area, their interaction with delayed ge-
nomic effects and explore what this implies for the known behavioral and hormonal
effects known to be associated with these brain areas.
Corticosteroids inhibit potassium A-type currents in a rapid, non-genomic and
membrane-MR dependent fashion in hippocampal neurons. In Chapter 3, we will
explore the potential of using neuronal-like cell lines, NS-1 and N1E-115 cells, as an
in vitro setting to study a similar rapid potentiation of potassium currents by corti-
costerone in cells with or without MR protein expression. We show that the potas-
sium A-type currents in NS-1 cells are inhibited by corticosterone in a membrane-
initiated and MR-dependent fashion. The slow-inactivating potassium currents in
N1E-115 cells are not affected by corticosterone. We further describe an instability
of MR protein in in vitro settings.
Next, in Chapter 4 we describe a novel approach to deduce whether a subpop-
ulation of the MR is associated with the cell membrane. In these experiments we
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use TIRF microscopy to specifically image fluorescently tagged MR at the cell mem-
brane. Furthermore, we analyze the dynamics of thismembrane-associatedMR sub-
populationwith single-molecule analysis. Using these approaches, we find that near
the membrane a distinct MR subpopulation is present, with dynamics substantially
different from the cytoplasmic MR population.
In Chapter 5 we use SMM and combine this with FRAP to derive a compre-
hensive characterization of the dynamics of nuclear GR. With this combined ap-
proach we obtain a reproducible quantification of the DNA-binding behavior of
activated GR. When bound to potent agonists, GR molecules undergo frequent but
transient immobilization due to DNA binding. Both the frequency and duration of
DNA-binding are reduced when GR is bound by antagonists or, more surprisingly,
by less potent agonists. We find evidence for specific ligand-receptor interactions
to underlie differences in the GR’s affinity for DNA. Furthermore, we study the ef-
fect of deletions of functional domains of the GR to show that receptors devoid of
(direct) DNA-binding capacity indeed show reduced DNA binding.
In Chapter 6 we build upon the approach and findings from Chapter 5 and
study the dynamics of nuclear MR with the same combination of SMM and FRAP.
As for the GR, we find that also the MR shows more and longer DNA-binding when
activated by its most potent agonists and reduced frequency and duration of these
interactions when bound by antagonists or less potent agonists.
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C affect brain functioning through both delayed,
genomic and rapid, non-genomic mechanisms. The latter mode of ac-
tion was long known but only in recent years the physiological basis
in the brain is beginning to be unravelled. We now know that cortico-
steroids exert rapid, non-genomic effects on the excitability and acti-
vation of neurons in (amongst others) the hypothalamus, hippocam-
pus, amygdala and prefrontal cortex. In addition, corticosteroids af-
fect cognition, adaptive behaviour and neuroendocrine output within
minutes. Knowledge on the identity of the receptors and secondary
pathways mediating the non-genomic effects of corticosteroids on a
cellular level is accumulating. Interestingly, in many cases an essen-
tial role for the ‘classical’ MR and GR in a novel membrane-associated
mechanism is found.
Here, we systematically review the recent literature on non-
genomic actions of corticosteroids on neuronal activity and function-
ing in selected limbic brain targets. We will discuss the relevance of
these permissive effects for cognition and neuroendocrine control,
and the integration of this novel mode of action into the complex
balanced pattern of stress effects in the brain. Subsequently, we will
review the knowledge regarding the underlying molecular pathways
addressing the following questions: How do the MR and GR translo-





Corticosteroids play a major role in the response of the brain to stress. For many
years, they were believed to be only responsible for the delayed and prolonged ef-
fects of stress, as opposed tomonoamines and neuropeptideswhichwere thought to
establish rapid effects (de Kloet et al., 2005).While this is generally true, the picture
is actually more complex. For instance, corticosteroids influence a wide range of be-
haviors and endocrine outputs within minutes, a timeframe that is too rapid to be
explained by genomic effects (de Kloet et al., 1999; Haller et al., 2008). In agreement,
we and others recently established that corticosteroids rapidly alter neuronal activ-
ity and excitability in a number of brain areas, providing a physiological basis for
the rapid effects on behavior (Tasker et al., 2006; de Kloet et al., 2008). Many rapid
effects are still mediated by the classical corticosteroid receptors, the MR and the
GR, but by a subpopulation of these receptors, anchored at the membrane (Karst
et al., 2005, 2010). The existence of such a rapid mode of action raises many new
questions. Where in the brain do these rapid effects take place? Which receptors
and pathways are involved in these effects? What are the functional consequences
for cognition and neuroendocrine control? How are these rapid corticosteroid ac-
tions integrated with other components of the stress response? Equally important
are the remainingmolecular questions. How strong is the evidence for amembrane-
localization of the MR and GR and for other types of (novel) membrane receptors.
Also, as steroid receptors do not have a transmembrane domain, how doMR andGR
associate with the plasma membrane? And finally, are there common downstream
pathways. In this chapter we discuss our current understanding of rapid actions of
corticosterone, with emphasis on their function within the brain.
2.1 Rapid effects of corticosterone in the brain
The rapid effects of corticosterone on brain and cognition have been subject of sev-
eral recent reviews (Dallman, 2005; Tasker et al., 2006; de Kloet et al., 2008; Haller
et al., 2008; Prager and Johnson, 2009; Evanson et al., 2010a). However, over the
last two years a number of new studies have emerged that extend and challenge
the existing views on the function and nature of these rapid effects. Here, we focus
on the integration of these new findings in the existing theories on rapid cortico-
steroid signalling. The findings are discussed per brain area; i.e. the hypothalamus,
pituitary, hippocampus, amygdala and frontal cortical areas. In the following sec-
tions, the major findings in these four different brain areas are summarized (see for
overview Table 2.1). In this review we restrict ourselves to the non-genomic roles of
theMR and GRwithin neurons. Both receptors have vital functions in the periphery
and also here many non-genomic actions have been observed. However, these are
beyond the scope of this review and have been described elsewhere (Boldyreff and




The PVN is one of the core structures in theHPA-axis. PVNneurons express high lev-
els of GR, but virtually noMR. Indeed, throughGR activation in the PVN corticoster-
one negatively feeds back on theHPA-axis in a delayed, genomic fashion (de Kloet et
al., 1998). However, corticosterone also regulates HPA-axis activity in a more rapid
time frame, through non-genomic actions (Jones et al., 1972; Dallman, 2005). Im-
portantly, a recent study showed that this rapid inhibition can be induced by local
infusion of dexamethasone or a membrane-impermeable conjugate of dexametha-
sone with bovine serum albumine (dex-BSA) into the PVN (Evanson et al., 2010b).
This effect can be prevented by co-administration of an antagonist of the cannabi-
noid receptor type 1 (CB1) (Evanson et al., 2010b). Thus, at the level of the PVN,
corticosterone rapidly reduces HPA-axis activation in a non-genomic, membrane-
associated manner, involving endocannabinoid signalling.
Insight in the neurobiological substrate of these fast effects was provided by
Tasker and colleagues. This group was the first to carry out detailed studies on the
frequency of miniature excitatory postsynaptic currents (mEPSCs) in the PVN and
the nearby supraoptic nucleus (SON) (Di et al., 2003). An mEPSC reflects the post-
synaptic current resulting from the spontaneous release of a single glutamatergic
vesicle from a presynaptic terminal (Bekkers and Stevens, 1989). Importantly, the
frequency of these events (particularly in the absence of changes in mEPSC ampli-
tude) is considered to be determined by presynaptic properties, reflecting changes
in either release probability of the vesicles or changes in the number of synaptic con-
tacts. Tasker and colleagues established that a high dose of corticosterone (between
100n and 1 µ ) or its synthetic analogue dexamethasone reduces the frequency of
mEPSCs in PVNneurons (Di et al., 2003;Malcher-Lopes et al., 2006). This effect was
detectable within 5 minutes and did not reverse when corticosterone was washed
out. Effectively, the excitability of PVN neurons was reduced by application of cor-
ticosteroids in a rapid but prolonged manner. Rapid changes in mEPSC frequency
induced by corticosterone could not be blocked by MR or GR antagonists (Di et al.,
2003, 2009). In contrast, preliminary data shows that they are prevented by condi-
tional knockout of the GR gene within the hypothalamus and thus will involve the
(membrane-associated) GR (Haam et al., 2010; Tasker and Herman, 2011). How this
new finding should be integrated with the lack of effect of antagonists remains un-
clear and awaits further clarification in a full study. The effects within the PVNwere
further shown to be non-genomic, membrane-initiated and to involve G-protein
coupled signalling. Interestingly, rapid corticosteroid actions required retrograde
endocannabinoid signalling and the CB1 receptor. The presumed cellular signalling
pathway is visualized in Figure 2.1 . Since the CB1 receptor is also required for rapid
inhibition of theHPA-axis (Evanson et al., 2010b), the rapid inhibition ofmEPSC fre-






2-AG / AEA 
















Figure 2.1: Schematic representation of the synaptic pathways of corticosterone-induced rapid
effects on glutamatergic transmission
(A) Inhibition of glutamatergic transmission is initiated by postsynaptically located receptors; this can be
either G-protein coupled receptors (hypothalamus) or membrane-localized GRs (amygdala). Activation
of these receptors by corticosterone induces activation of G-proteins and the cAMP-protein kinase A
(PKA) pathway, which eventually induces synthesis of the retrograde messengers anandamide (AEA)
and 2-arachidonoylglycerol (2-AG). In a retrograde mode of action at the presynaptic terminal 2-AG and
AEA activate the cannabinoid receptor type 1 (CB1), which in turn inhibits the release probability of
glutamatergic vesicles. (B) Facilitation of glutamatergic transmission is initiated by both pre- and post-
synaptically located membrane-MRs. Presynaptically, activation of the MR by corticosterone activates
an extracellular signal-regulated kinase (ERK) pathway resulting in stimulation of the release probability
of glutamate vesicles. At the same time, postsynaptic activation of a membrane-associated MR inhibits
potassium IA-currents, and stimulates membrane diffusion of AMPA receptors. All three effects together
result in a facilitation of glutamatergic transmission.
However, rapid inhibitory effects of corticosterone in the PVN are not restricted
to vasopressin- and CRH-containing parvocellular neurons, but they are seen in all
neuronal populations (parvocellular and magnocellular) in the PVN (Di et al., 2003,
2005; Tasker et al., 2006). In the magnocellular neurons in the PVN and SON, a sec-
ond effect was observed on the spontaneous release of gamma-aminobutyric acid
(GABA), the main inhibitory neurotransmitter. The frequency of mIPSCs (minia-
ture inhibitory postsynaptic currents) was rapidly increased by dexamethasone, but
this required even higher concentrations (1 µ ormore) (Di et al., 2005, 2009). Func-
tionally, this suggests a more general coordinative role for the non-genomic effects
of corticosterone in the hypothalamus, which requires further specification (Tasker
et al., 2006).
Pituitary
Fast and delayed effects of corticosteroids have also been observed at the level of the
anterior pituitary gland, where GR is abundantly expressed and MR levels are quite
low (Reul et al., 1990). Already in the 1970’s and 80’s both rapid and delayed actions
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of corticosteroids on pituitary ACTH release were reported (Jones et al., 1972; Wid-
maier and Dallman, 1984). Inhibition of ACTH release was seen as early as 1 minute
and as late as 2 hours after corticosteroid administration. The latter is a genomic
action mediated by GR-driven gene transcription, while the former action was in-
sensitive to protein synthesis inhibitors and thus mediated by non-genomic path-
ways (Keller-Wood and Dallman, 1984). Interestingly, the rapid inhibition of ACTH
release was only seen when corticosterone levels were rapidly rising and not when
they were already high, suggesting that this feedback is rate-sensitive (Jones et al.,
1972; Kaneko and Hiroshige, 1978).
The cellular basis of the rapid effects is not well established and controversy
remains about the receptor mediating the effects. On the one hand, pretreatment
with a GR antagonist did not prevent the rapid effects of corticosterone on CRH-
inducedACTH secretion in vivo (Hinz andHirschelmann, 2000). Also, in a pituitary-
derived cell line a membrane binding place for dexamethasone and corticosterone
was identified that did not have any affinity for the GR-antagonist RU486 (Maier et
al., 2005). However, another line of evidence does suggest a role for the classical GR
inmediating rapid feedback at the pituitary. Thus, a rapid and non-genomic translo-
cation of annexin-I by dexamethasone was prevented by GR-antagonist treatment
in a pituitary derived cell line (Solito et al., 2003). This translocation of annexin-I
was required for rapid inhibition of ACTH release (Buckingham et al., 2003; Tierney
et al., 2003). Thus, corticosterone rapidly inhibits ACTH release from the pituitary,
but whether this is due to a novel receptor or to the classical GR is still controver-
sial. This rapid inhibition is also seen in control human subjects, while it is absent
in depressed patients, suggesting that the rapid negative feedback is somehow as-
sociated with disease (Young et al., 1991).
Hippocampus
Adaptation to a stressful situation is a coordinated effort mediated by the limbic
system —the hippocampus and amygdala— in coordination with the prefrontal
cortex (see Figure 2.2). This, among other things, involves projections of these ar-
eas to and hence control over the PVN (Ulrich-Lai and Herman, 2009). Collectively,
these areas also facilitate the formation of a memory trace of a stressful emotional
event. Processing of contextual information depends predominantly on hippocam-
pal function. The hippocampus expresses high levels of both MR and GR in all sub-
fields (except its cornu ammonus-3 (CA3) region that mainly expresses MR) (Reul
and de Kloet, 1985). Corticosterone exerts strong genomic effects on the activity
and plasticity of all hippocampal subfields as well as on hippocampus-dependent
memory (McEwen, 2001; Kim and Diamond, 2002; Mirescu and Gould, 2006; Joëls,
2008). Low levels of corticosterone, through MR activation, facilitate plasticity and
hippocampus-dependent memory (Diamond et al., 1992). By contrast, absence or
very high levels of corticosterone inhibit plasticity; the latter is mediated through
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Figure 2.2: Brain circuitry of stress
The limbic system is implicated in adapta-
tion, learning & memory processes, mood,
and control of the HPA-axis. The hormones
of theHPA-axis coordinate information pro-
cessing and promote connectivity between
amygdala, prefrontal cortex and hippocam-
pus to facilitate behavioral adaptation. Pro-
jections from the limbic structures inner-
vate the PVN network and regulate trans-
synaptically the activity of the HPA-axis.
Similar to neurons in the hypothalamus, hippocampal neurons spontaneously
show mEPSCs. In a first study (Karst et al., 2005), the effect of corticosterone was
examined on mEPSC frequency in the CA1 region of the hippocampus. It appeared
that within 5 minutes of corticosterone administration, the frequency of mEPSCs is
significantly enhanced, i.e. changed in a direction opposite to that observed in the
PVN. The amplitude was unaffected (Karst et al., 2005; Olijslagers et al., 2008) (see
Figure 2.3 , ). This effect was recently reproduced by other investigators (Qiu et al.,
2010) and granule neurons in the dentate gyrus respond similarly to corticosterone
as CA1 neurons (Pasricha et al., 2011). Similar to the corticosteroid effect in the hy-
pothalamus, the rapid effect in the hippocampus does not depend on gene transcrip-
tion and involves a membrane-located receptor (Karst et al., 2005). However, fur-
ther studies established profound differences between rapid responses to corticos-
terone in the hippocampus compared to the PVN. The increased mEPSC frequency
in hippocampus rapidly reversed when corticosterone was washed out. Also, in the
CA1 the effect occurred at a 10-fold lower dose of corticosterone (10n or higher)
than in the hypothalamus. Importantly, corticosterone efficiently enhancedmEPSC
frequency in the hippocampus of wild type and GR knockout mice, but the effects
were completely abolished in MR knockout mice, supporting that rapid effects in
the hippocampus aremediated byMRs (Karst et al., 2005). This was confirmed with
specific MR and GR antagonists. Importantly, the membrane-located MR appears
to have a lower affinity than the cytosolic form (Karst et al., 2005), so that it po-
tentially could play an important role when corticosteroid levels rise, shortly after
stress (Joëls et al., 2008). Follow-up studies suggested that rapid corticosteroid ef-
fects involve MRs inserted into the presynaptic membrane (Olijslagers et al., 2008)
(see Figure 2.1 ). This is backed up by preliminary evidence that shows localization
of the MR in the plasma membrane of hippocampal neurons, co-localized with the
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Figure 2.3: Effect of two pulses of corticosterone onmEPSC frequency in the CA1 region and the
basolateral amygdala (BLA)
(A) Typical traces of mEPSC pulses recorded from hippocampal neurons before (white bars) and after
(black bars) treatment with 100n corticosterone. (B) In hippocampal CA1 neurons exposure to two
consecutive pulses of 100n corticosterone (1hour apart) both induce a reversible increase in mEPSC
frequency. (C) In amygdalar BLA neurons, the first pulse of corticosterone induces an increase in mEPSC
frequency, this increase is not reversible. For the second pulse of corticosterone the basal mEPSC fre-
quency is already elevated and the second pulse induces an irreversible decrease instead. mEPSC, minia-
ture excitatory postsynaptic current. ∗ p < 0.05 compared with baseline (paired t test). Figure reprinted
with permission from Karst et al. (2010).
Corticosterone also affects two postsynaptic features of CA1 neurons through the
MR. Firstly, corticosterone was found to inhibit postsynaptic IA-currents, an effect
that could be blocked with an MR-antagonist (Olijslagers et al., 2008). IA-currents
are potassium currents that are negative regulators of neuronal excitability and plas-
ticity (Hoffman et al., 1997; Yuan et al., 2002). Consequently, the inhibition of these
currents by corticosterone is expected to stimulate excitability and plasticity of hip-
pocampal neurons. Secondly, corticosterone stimulated, within 5 minutes, lateral
diffusion of α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid (AMPA) recep-
tors in cultured hippocampal neurons (Groc et al., 2008). This effect also turned
out to depend on membrane-localized MRs (Groc et al., 2008). Potentially, a more
mobile pool of AMPA receptors facilitates the induction of synaptic plasticity. All
of these studies support a membrane-localised form of the MR as main mediator of
rapid corticosteroid signalling in the hippocampus. Overall, corticosterone seems
to rapidly potentiate the excitability of hippocampal neurons via membrane-MRs
located on both pre- and postsynaptic sites, thus priming the hippocampal circuit
for subsequent stimulation by context-dependent factors.
However, not all rapid effects in the hippocampus involve the MR. First, a non-
genomic increase in spine density of hippocampal neurons was found to depend
on GRs rather than MRs (Komatsuzaki et al., 2005). Yet other rapid corticoster-
one effects occur independent of MR or GR and therefore could be mediated by
a novel (so far not identified) membrane-localized receptor. This applies to rapid
stimulatory corticosterone effects on inhibitory transmission (Hu et al., 2010), on
levels of extracellular excitatory amino acid (Venero and Borrell, 1999), long-term
potentiation (LTP) induction (Wiegert et al., 2006) and N-methyl-D-aspartatic acid
(NMDA)-dependent neurotoxicity (Xiao et al., 2010). Some studies also reported in-
hibitory actions of corticosterone on NMDA signalling (Sato et al., 2004; Liu et al.,
2007). Apparently, corticosterone affects hippocampal signalling in multiple ways,






Stressful events invariably activate the amygdala, the brain’s principal emotional
centre (Roozendaal et al., 2009). The amygdala expresses bothMR and GR in its var-
ious subnuclei (Reul and de Kloet, 1985) and amygdala-dependent memory, such
as cued learning and emotional memory is very sensitive to stress and corticoste-
roids (Roozendaal et al., 2009). Interestingly, genomic effects of corticosterone on
the amygdala are generally opposite to those seen in the hippocampus, with en-
hanced activity in the former (Duvarci and Pare, 2007; Mitra and Sapolsky, 2008)
and reduced activity and plasticity in the latter (Alfarez et al., 2002, 2009; Kim et
al., 2004). In addition, the amygdala is one of the main targets of the adrenergic sys-
tem.Many corticosteroid effects on amygdala functioning in fact require adrenergic
signalling (Roozendaal et al., 2009). This interaction might in part be mediated by
non-genomic effects of corticosteroids. For instance, a systemic injection of corti-
costerone directly after a learning task rapidly (within 15 minutes) increased the
levels of noradrenaline in the basolateral amygdala (BLA) and this was correlated
to the later facilitation of fear memory by corticosterone (McReynolds et al., 2010).
An important finding that raised interest in non-genomic actions of corticoster-
one in the amygdala was the demonstration ofMR and GR at the plasmamembrane
in amygdalar neurons. Johnson et al. used detailed electron microscopic analyses to
study the subcellular distribution of the GR (Johnson et al., 2005) and MR (Prager
et al., 2010) in the lateral amygdala. The GR was identified at the plasma membrane
as well as in the nucleus and cytoplasm. GRs turned out to be present at both post-
synaptic dendrites and presynaptic sites (Johnson et al., 2005). More recently the
same was shown for the MR (Prager et al., 2010).
The functional consequences of corticosterone on mEPSC frequency in the BLA
and the central nucleus of the amygdala (CeA) were recently revealed (Karst et al.,
2010). In the CeA, corticosterone had no effect on either frequency or amplitude of
the mEPSCs. However, in the BLA, corticosterone induced a significant increase in
mEPSC frequency, comparable to the effects found in hippocampus albeit slightly
slower in onset (Karst et al., 2010) (Figure 2.3 ). Comparable to the hippocampus,
this enhancedmEPSC frequency after corticosterone treatment wasMR-dependent
and non-genomic in nature (Karst et al., 2010). However, in contrast to the hip-
pocampus, the effect in the amygdala was not only slower in onset, but also persis-
tent after washout of the hormone. One hour after a pulse of corticosterone mEPSC
frequency was still high. This lasting phase of the response was found to depend on
protein synthesis and required the presence of both MR and GR (Karst et al., 2010).
The long-lasting effects of corticosterone were shown to also determine the re-
sponses of BLA neurons to subsequent pulses of the hormone. When BLA cells
were exposed to a second pulse of corticosterone, mEPSC frequency was reduced
(Karst et al., 2010) (see Figure 2.3 ). Reduction inmEPSC frequency also occurred in
tissue prepared from animals exposed to restraint stress prior to slice preparation.
Interestingly, this rapid and non-genomic effect to renewed corticosteroid expo-
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sure depended on the GR rather than the MR. Similar to the hypothalamus (but in
contrast to the hippocampus), it was shown to involve a postsynaptically localized
GR and subsequent retrograde endocannabinoid signalling (see Figure 2.1 ). Thus,
in a non-stressed animal corticosterone seems to have a stimulatory effect in the
(basolateral) amygdala. However, due to the long-lasting nature of these effects, a
second exposure to corticosterone induces opposite effects, suggesting metaplastic-
ity of corticosteroid responses. These data suggests that the amygdala will respond
differently to a stressor depending on the recent stress history of the organism.
Prefrontal cortex
The prefrontal cortex (PFC) is critically involved in complex behavioural control,
such as behavioural inhibition, decision-making and working memory. It is exten-
sively connected to the amygdala and receives afferents originating in the hippocam-
pus (Arnsten, 2009). Despite its important function, the PFC is underrepresented
concerning studies on the effects of corticosteroids and stress. A number of stud-
ies have examined the effect of chronic stress or corticosterone exposure on the
PFC. Under these conditions, LTP, dendritic complexity and PFC-dependent work-
ing memory were reduced in a genomic fashion (Arnsten, 2009; Holmes and Well-
man, 2009). On the contrary, exposure to acute stress or corticosterone increased
glutamatergic transmission and improved working memory performance (Yuen et
al., 2009, 2010). These effects occurred with a delay of several hours and were shown
to require gene transcription (Yuen et al., 2010). Thus acute and chronic stress affect
PFC plasticity and functionality in an opposite manner.
The only studies so far in the PFC that focused on rapid, non-genomic effects
were performed in synaptosomes. In this preparation, corticosterone induced a
rapid enhancement of glutamate uptake and of calcium-dependent calmodulin sta-
bilization (Sze and Iqbal, 1994; Zhu et al., 1998). Unfortunately, the receptors or
pathways involved were not examined. In a recent study, Roozendaal and colleagues
reported a putative membrane-GR mediated effect of corticosterone in the insular
cortex that is involved in memory acquisition. In this elegant study, administra-
tion of either corticosterone or cort-BSA directly into the insular cortex facilitated
the acquisition of object recognition memory (Roozendaal et al., 2010). Although
there are some concerns about the stability of cort-BSA in vivo, this is still indica-
tive of a membrane-initiated effect. The effect was prevented by co-administration
of a GR antagonist. The authors further proved that the facilitation of memory by
membrane-GR activationwas established through protein kinase A (PKA), cAMP re-
sponse element-binding (CREB) and histone acetylation (Roozendaal et al., 2010).
Taken together, rapid non-genomic actions of corticosterone are found in (some)
prefrontal areas; so far they seem to be mostly excitatory (as are the sub-acute ge-
nomic effects) and could have implications for higher-order learning in complex





2.2 Functional implications of rapid corticosteroid effects in
the brain
Taking all results into account, we can distinguish some interesting general features
of the rapid effects of corticosteroids in the brain.
i) It is important to notice that all non-genomic effects are permissive or condi-
tional effects. In none of the studies corticosteroids induced any activity on their
own, instead they facilitate or inhibit signalling of ion channels, receptors and neu-
rotransmitters. In short, they increase or decrease the threshold for activation of
these neurons by context-dependent factors. Therefore, it will depend on the con-
text which effects (in which brain areas) will be most pronounced during a stressful
encounter.
ii) We see a distinctive pattern with a general increase in excitability for some
areas (hippocampus, amygdala and potentially the prefrontal cortex) and a decrease
in others (the hypothalamus).
iii) While some responses are transient (mostly in the hippocampus), other ef-
fects are prolonged (hypothalamus, pituitary and amygdala). The brain circuitry
activated by stress will thus be different depending on the delay after the stressor.
iv) In general, the inhibitory effects on hypothalamic functioning seem to require
a higher dose of corticosterone than most effects in other brain areas. If so, the set
of responses seen after a mild stressor may be different from that of a more severe
stressor, the latter having an additional negative effect on PVN-related responses
(Prager and Johnson, 2009).
v) Finally, a number of rapid corticosteroid effects require the presence of classical
MR and GR inserted in or attached to the plasma membrane, while other effects
are mediated through yet unknown (G-protein coupled) receptors. In general, MR-
mediated effects tend to stimulate excitation, while GR-mediated effects can also
be inhibitory (see Figure 2.1).
We will refer to these five general points when we next consider the potential
functional consequences of rapid corticosteroid actions in the brain for HPA-axis
regulation and cognition, also taking the ultradian release pattern into considera-
tion. Finally we will address the integration of these rapid effects with the rest of
the brain’s response to stress.
Regulation of the HPA-axis
Corticosteroids exert rapid, as well as delayed, inhibitory feedback at the core struc-
tures of the HPA-axis; the PVN of the hypothalamus (Evanson et al., 2010b) and the
pituitary gland (Jones et al., 1972; Hinz and Hirschelmann, 2000). In the pituitary
this seems to be caused by both GR-dependent (Buckingham et al., 2003) and GR-
independent (Hinz andHirschelmann, 2000) rapid signalling pathways. In the PVN,
the rapid suppression of glutamatergic transmission by corticosterone could well
underlie (amongst others) fast suppression of the HPA-axis in a GR-independent
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manner (Tasker, 2006). As mentioned earlier, this hypothesis is backed up by the
effectiveness of intra-PVN infusions of dexamethasone or dex-BSA on HPA-axis ac-
tivity in a rapid time frame (Evanson et al., 2010b).
In addition, extra-hypothalamic structures also control the activity of the HPA-
axis. For instance, the hippocampus and prefrontal cortex exert negative feedback
on the HPA-axis through (indirect) projections to the PVN, while the amygdala has
a stimulatory influence on the PVN and thus HPA-axis (Ulrich-Lai and Herman,
2009). Rapid non-genomic corticosteroid actions in these areas may affect this lim-
bic control over the HPA-axis. This also enables a role for the MR, absent from the
hypothalamus, in the regulation of HPA-axis activation. Indeed, MRs in the hip-
pocampus are important to determine the threshold of the stress response (Reul
et al., 2000; Joëls et al., 2008). In agreement, treatment of rats with MR agonists
induced a rapid suppression of both ACTH and corticosterone release (Atkinson
et al., 2008). Thus, not only can corticosterone inhibit HPA-axis activation directly
through its genomic and non-genomic effects at core structures of the axis, it also
provides a second layer of control at limbic areas that enables a subtler and context-
dependent rapid trans-synaptic regulation of the HPA-axis.
Adaptation of behaviour and cognition
In addition to regulation of the HPA-axis through (trans-synaptic) connections to
the PVN, the limbic circuitry is vital for adaptation to stressful events and the for-
mation of memory of these events (Figure 2.2). Many actions of corticosteroids, for
example facilitation of memory consolidation, are dependent on gene transcrip-
tion, through activation of the genomic GR (and MR) (Oitzl et al., 2001). However,
corticosteroids also affect behaviour and memory in a rapid and presumably non-
genomic manner. Thus, rapid effects of corticosteroids have been described for a
number of adaptive behaviours, including rapid facilitation of novelty-induced lo-
comotion (Sandi et al., 1996a,b), context-dependent aggression (Mikics et al., 2004)
and risk assessment behaviour (Mikics et al., 2005). These effects were all observed
within 7 minutes and the latter two were proven to be independent of gene tran-
scription, see also Table 2.1. In all cases, an injection with corticosterone rapidly
increased a specific type of behaviour that is seen as adaptive in that context (i.e.
aggression towards an intruder, or locomotion and risk assessment in a novel en-
vironment). Interestingly, the MR has been repeatedly reported to be involved in
these types of behaviour, involving novelty reactivity, coping strategies and aggres-
sion (Oitzl and de Kloet, 1992; Sandi and Rose, 1994; Berger et al., 2006; Joëls et al.,
2008; Brinks et al., 2009; Kruk et al., 2013). As these behavioural effects are rapidly
induced and by stress-doses of corticosterone, they always seemed incompatible
with the constitutively active genomic MR. The lower affinity membrane-MR could
prove to be the logical substrate for these effects. Unfortunately, this role of the
membrane-MR has not been studied directly yet. There is circumstantial evidence





out mice for the limbic system-associated membrane protein (LSAMP). These mice
showed increased novelty reactivity and impaired learning (Catania et al., 2008; Qiu
et al., 2010), and associated with this, a reduction in non-genomic MR function in
the hippocampus (Qiu et al., 2010).
In behavioural studies on the regulation of memory, the GR is reported to have
a predominant function in memory consolidation, while the MR is mostly involved
in memory retrieval and learning strategies (Oitzl and de Kloet, 1992; de Kloet et
al., 1999). A similar convergence of functions is seen in the rapid domain. Firstly,
a rapid facilitation of memory consolidation by corticosterone was shown to de-
pend on the (presumably membrane localized) GR in the cortex (Roozendaal et al.,
2010). Secondly, application of antagonists for endocannabinoid signalling in the
amygdala was reported to block corticosterone-induced effects on memory consol-
idation (Campolongo et al., 2009). Together, this suggests that the membrane-GR
mediated and endocannabinoid-dependent inhibition of neuronal excitability (see
Figure 2.1 and Karst et al. (2010)) might be implicated in memory consolidation.
In contrast, corticosterone effects on memory retrieval seem to be MR-mediated.
Administration of corticosterone 30 minutes before a memory retrieval task im-
paired retrieval of information in a non-genomic, hippocampal-dependent andMR-
mediated manner (Khaksari et al., 2007; Sajadi et al., 2007). Finally, acute stress or
cort-BSA infusion into the hippocampus induced a shift in memory retrieval tested
5 or 15 minutes later, although this study did not investigate the receptor involved
(Chauveau et al., 2010). Rapid —in addition to delayed— corticosteroid effects thus
seem to be involved in all phases of the memory process, i.e. acquisition, consoli-
dation and retrieval. In general, the GR seems to potentiate consolidation via both
rapid and delayed (genomic) pathways. Conversely, the MR seems to have a specific
(non-genomic) role during memory retrieval, possibly as a mechanism to focus at-
tention to a new stressor. Taken together, in its role as rapid corticosteroid sensor,
the MR facilitates adaptive behaviour in the context of the stressor while inhibiting
behaviours that are no longer relevant.
Implication of ultradian pulses
Corticosteroids do not only reach the brain in high amounts during a stressful sit-
uation, but also during ultradian peaks (Droste et al., 2008). Rapid non-genomic
corticosteroid actions might have an additional function in translating these pulses
into ultradian alterations in brain function. Indeed, both rapid feedback on theHPA-
axis (Windle et al., 1998), aggressive behaviour (Haller et al., 2000) and novelty re-
activity (Sarabdjitsingh et al., 2010) depend on the phase of an ultradian pulse the
animal is in. In a recent study by Sarabdjitsingh et al., ultradian pulses weremanipu-
lated experimentally. Exposure to noise stress induced a stronger ACTH release and
higher behavioural reactivity when animals were stressed during the rising phase of
an ultradian corticosterone pulse compared to animals exposed to the same stressor


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































These responses were seen within minutes, so that non-genomic mechanisms
must have been involved. In the brain, these effects were associated with increased
activity of the amygdala and decreased activity of the PVN (recorded by c-fos ex-
pression) during the rising compared to the falling phase (Sarabdjitsingh et al.,
2010), reminiscent of the corticosteroid effects seen for mEPSC frequency in PVN
and amygdala. Hypothetically, during the rising phase of an ultradian pulse, non-
genomic pathways are activated in limbic areas, which in turn could affect stress-
related behaviour.
Integration of non-genomic and genomic effects
In several cases, rapid non-genomic corticosteroid actions were shown to transgress
into more lasting effects, integrating two temporal domains (rapid and delayed)
which up till recently were each linked to different classes of stress hormones, i.e.
monoamines (and to some extent neuropeptides) on the one hand and corticoste-
roids on the other hand. For example, rapid effects in the hypothalamus are long
lasting (Di et al., 2003) and thus HPA-axis feedback will be inhibited over a long pe-
riod of time. Indeed, dexamethasone infusions in the PVN exert both rapid and de-
layed negative feedback actions on the HPA-axis activity (Dallman et al., 1994; Dall-
man, 2005). Similarly, the increased excitability in the BLA starts as a non-genomic
MR-dependent phenomenon and eventually evolves into a genomic phenomenon
that also requires the GR (Karst et al., 2010). At a cognitive level, the facilitation of
memory consolidation by cort-BSA injections in the insular cortex is evoked by a
membrane-associated effect that evolves into a genomic effect through activation of
the transcription factor CREB (Roozendaal et al., 2010). Finally, rapid corticosterone
effects on aggressive and risk assessment behaviour are independent of gene tran-
scription immediately after corticosterone injection but develop into transcription-
dependent effects later on (Mikics et al., 2004, 2005). Thus, many non-genomic
effects of corticosterone are tightly linked to later genomic actions. At least in one
case (Karst et al., 2010), the initial non-genomic action is required for the subse-
quent genomic phase, suggesting that both phases work in coordination.
However, non-genomic and genomic actions can also be integrated if they occur
independent from each other. In the hippocampus, the initial enhancedmEPSC fre-
quency is quickly reversed: when corticosteroid levels drop, the effects are imme-
diately lost (Karst et al., 2005). Supposedly, a brief period of enhanced excitability
is followed by a refractory period with an increased threshold for the induction of
new signals, the latter depends on genomic GR signalling (Alfarez et al., 2002, 2009;
Krugers et al., 2010). A similar dichotomy was seen with respect to LTP induction
in the hippocampus. Corticosterone given immediately before LTP induction stim-
ulated LTP induction (Wiegert et al., 2006), while corticosterone applied hours ear-
lier inhibited the induction of the same type of LTP (Diamond et al., 1992; Pavlides





appraise the novel situation; gradually the genomic phase will take over and restore
the activity of the circuits to regain homeostasis (Joëls et al., 2006).
Overall, this implies that the temporal pattern of activation by corticosterone is
different for the various areas. As summarized in Figure 2.2, both the hippocampus
and amygdala, are more sensitive for incoming signals during stress or corticoster-
one exposure, while activity in the PVN is rapidly inhibited. In a delayed fashion,
the hippocampus will switch to a state where the threshold for activation is ele-
vated, while activation thresholds in the amygdala and hypothalamus do not differ
between the two time-domains. Hypothetically, this can have consequences for the
cognitive functions associated with these brain areas. For example, as the amygdala
is involved in emotional memory formation, the prolonged activation in this area
might support efficient encoding of emotional aspects of a stressful event, which
could explain the preferential memory of emotional over neutral, hippocampal-
dependent information (Buchanan and Lovallo, 2001; Karst et al., 2010). Finally, it
seems that a second exposure of corticosterone switches amygdalar excitability back
to its pre-stress state (Karst et al., 2010). This mechanism could protect the amyg-
dala from inappropriately prolonged activation (McEwen, 2001; Karst et al., 2010).
For the PFC, the limited data so far, suggest that its sensitivity is elevated by corti-
costerone in both an acute and more prolonged manner. However, as the data for
the PFC is still sparse, we have not included it in Figure 2.2.
2.3 Molecular aspects of non-genomic corticosterone actions
The quest for a better understanding of the role of non-genomic corticosteroid sig-
nalling is paralleled by another quest: that for a better understanding of the cellular
basis of these non-genomic effects. Here we will summarize the current state of un-
derstanding of the membrane localization, and translocation, of the MR and GR as
well as that of their downstream signalling partners. We will, again, focus mostly
on corticosteroid signalling in neural tissues but we will also use knowledge from
the periphery and of related steroids and their receptors where necessary.
Presence of MR and GR at the plasma membrane, critical evaluation
of the evidence
Formany years themembrane localization of theMR andGRhas been controversial,
however, over the last years evidence of their membrane presence has culminated.
(i) Intracellular applied corticosterone cannot induce rapid non-genomic effects;
therefore it is unlikely that the receptors are located inside the cells. (ii) Membrane
impermeable corticosterone-BSA (cort-BSA) and dex-BSA conjugates induce the
same rapid effects as free corticosterone or dexamethasone. Moreover, they do so
















































Hippocampus Amygdala (BLA) 
Hypothalamus Figure 2.4: A putative model of the temporal
dynamics of excitability in the hippocampus,
amygdala and hypothalamus
A stressor or corticosterone injection induces a
temporal diverse set of responses in the three dif-
ferent brain areas. Denoted are the receptors that
are (mainly) responsible for the effects in the dif-
ferent areas. Importantly, the temporal pattern
of excitability in hippocampus, amygdala and hy-
pothalamus determines the actions of stress and
corticosterone on neuroendocrine regulation, be-
haviour and cognition. mMR/mGR (membrane-
associated MR/GR), gGR (genomic GR), ?? (recep-
tor unclear).
efficacy. (iii) Most convincingly, the presence of MR and GR has been shown in
synaptosome extracts (Komatsuzaki et al., 2005; Wang and Wang, 2009; Qiu et al.,
2010) and at neuronal membranes using electron microscopy (Johnson et al., 2005;
Prager et al., 2010). (iv) Finally, the MR and GR are by no means unique in their as-
sociation with the plasma membrane. Membrane localization has been shown for
most, if not all, steroid receptors including the ER α and β, AR and PR (Hammes
and Levin, 2007).
Not all rapid corticosteroid effects can be attributed to the MR or GR though.
Multiple non-genomic actions of corticosteroids on neurotransmission (Wiegert
et al., 2006; Di et al., 2009), HPA-axis regulation (Evanson et al., 2010b) and be-
haviour (Sandi et al., 1996b) remain in the presence of MR and GR antagonists
and are thus postulated to require a novel membrane-associated receptor. However,
the identity of this receptor has proved very difficult to resolve; as yet, none have
been cloned. The most likely candidates are G-protein coupled receptors (GPCR),
because inhibitors of G-proteins can preventmany—though not all (Orchinik et al.,
1997)— MR/GR independent corticosteroid effects (Di et al., 2003, 2005). Multiple





neuronal substrates in a number of species (Orchinik et al., 1991, 1992, 1997, 2000;
Guo et al., 1995; Maier et al., 2005; Breuner andOrchinik, 2009; Schmidt et al., 2010).
However, the affinity and selectivity of these binding sites is very variable, making
it unlikely that they all stem from a single type of evolutionary conserved receptor.
The association of steroid receptors at the plasma membrane
How is the membrane association of receptors mediating rapid corticosteroid ac-
tions accomplished and how is this process regulated? Unfortunately, there is little
known about this subject regarding MR and GR. However, much more results have
been obtained on themembrane translocation of ERα. Since ERα and corticosteroid
receptors may share some of the pathways involved in membrane localization, we
will first evaluate the available insights in the ERα and next compare this with what
is presently known about corticosteroid receptors.
The estrogen receptors ERα and ERβ can both be targeted to the cell membrane
(Gorosito et al., 2008;Micevych andDominguez, 2009)where they primarily exist in
caveolae (Razandi et al., 2002). Caveolae are invaginations of the plasmamembrane
formed by caveolins, scaffolding proteins that bind and bring together a large num-
ber of signalling molecules including GPCRs, G-proteins, c-Src and other kinases;
this facilitates rapid signal transduction (Anderson, 1998; Cohen et al., 2004). The
most ubiquitously expressed caveolin is caveolin-1. Ablation of caveolin-1 severely
diminished ERα membrane localization (Sud et al., 2010). Moreover, mutation of
a single amino acid (S522A) in the ligand binding domain of the ERα resulted in a
60% reduction of caveolin-1 binding, membrane localization and rapid signalling
of ERα (Razandi et al., 2003). Caveolin-1 binding is also required for membrane
translocation of the ERβ, AR and PR (Lu et al., 2001; Salatino et al., 2006; Gilad and
Schwartz, 2007). Mutation of another amino acid, cysteine477 (C477A), resulted
in an almost complete reduction of ERα membrane localization, while its genomic
functions were left undisturbed (Acconcia et al., 2005). This mutation was shown to
be essential for palmitoylation of the receptor. Palmitoylation is a post-translational
modification where a lipid tail is attached to the receptor, thus enabling insertion
into the plasma membrane. ERα palmitoylation is essential for caveolin-1 binding,
membrane translocation and rapid signalling (Acconcia et al., 2005; Pedram et al.,
2007). A final component of the ERα membrane translocation pathway was identi-
fied recently: disruption of heat shock protein (HSP) 27 prevented palmitoylation,
caveolin-1 binding, membrane localization and rapid signalling of ERα (Razandi et
al., 2010). Together this leads to a model where ERα associates with HSP27, this
interaction enables ERα to get palmitoylated, and due to the palmitoylation the re-
ceptor can bind caveolin-1 which facilitates transport to the plasma membrane (see
Figure 2.5 ).
Importantly, this membrane translocation process seems to be a common path-
way for all steroid receptors. The group of Levin (Pedram et al., 2007) identified






























Figure 2.5: Steroid receptor membrane association and downstream signalling
(A) The putative common pathway for membrane translocation of steroid receptors is shown with the
ERα as example. Translocation of the ERα requires the association of heat shock protein 27 (HSP27)
(step 1), subsequently the receptor is palmitoylated at cysteine 477 (step 2), this facilitates association of
the adaptor protein caveolin-1 (CAV1) (step 3). Finally, the ERα is transported to the plasma membrane,
where it is localized in caveolae (step 4). (B) Model of the downstream signalling pathways implied in
non-genomic corticosteroid signalling in neurons.
sequence was identified in the AR, PR, ERβ and other receptors. Mutation of key
amino acids in this sequence abolished membrane localization and rapid signalling
for all steroid receptors tested (Pedram et al., 2007). Similarly, association of HSP27
is required for membrane translocation of ERα, PR and AR (Razandi et al., 2010).
Thus, so far the data suggest that there is a common membrane translocation
pathway for all (or most) steroid receptors involving caveolin-1, palmitoylation and
HSP27.
Membrane translocation of MR and GR
Now the question remains whether the MR and GR are transported to the mem-
brane in a similar way. For these receptors only a few studies have been reported
and none in brain cells. In peripheral models an association between both MR
and GR to caveolin-1 has been demonstrated. In epithelial cells, dexamethasone in-
duced rapid binding of GR to c-Src and subsequent activation of the PI3K-Akt path-
way (Matthews et al., 2008). Transfection of a double-negative form of caveolin-1
disrupted all aspects of this signalling cascade, as did disruption of caveolae. In
addition, a direct interaction between the GR and caveolin-1 was seen with co-
immunoprecipitation (Matthews et al., 2008). In contrast, in hepatic cells no colo-
calization of membrane-associated GR and caveolin-1 could be found with conven-





For MR, a similar association was studied in caveolin-1 knockout (cav1-/-) mice
(Pojoga et al., 2010a,b). First of all, a direct association between the MR and
caveolin-1 (but not caveolin-2) was shown with co-immunoprecipitation in heart
homogenates from both rat and mouse as well as in cultured human endothelial
cells (Pojoga et al., 2010a). As expected, this association was lost in cav1-/- mice.
Secondly, these mice showed heightened vascular responses to treatment with the
MR antagonist eplerenone (as compared to wild type mice) and a reduced sensitiv-
ity to aldosterone treatment on myocardial damage (Pojoga et al., 2010b). Thus, not
only is the MR associated with caveolin-1 in vascular tissues, but a loss of caveolin-1
also alters the vascular responses to MR agonists and antagonists. The precise con-
sequences of the loss of caveolin-1 for MR-associated functioning seem to depend
strongly on the context of the response.
Additional supporting evidence for themembrane localization of theMR comes
from the group of Grossmann and Gekle (2008, 2010). In an initial study, they
showed that transfection of only the ligand binding domain of the MR was suffi-
cient for aldosterone to rapidly activate the ERK1/2 pathway in Chinese hamster
ovary cells (Grossmann et al., 2008). This is similar to the ERα, where the ligand
binding domain suffices for membrane translocation and signalling (Razandi et al.,
2002). More recently, they studied the colocalization between the MR and the EGF
receptor. This colocalization was lost when lipid rafts (including caveolae) were dis-
rupted (Grossmann et al., 2010). This strongly suggests that the MR is localized in
caveolae, since the EGF receptor is known to be associated with caveolae.
Finally, regarding the conserved palmitoylation motif, an interesting picture
emerges. The palmitoylationmotif of theGR contains all essential groups andwould
be predicted to be a palmitoylation site (although the GR was not tested in the
original study) (Pedram et al., 2007). The MR, by contrast, lacks the essential cys-
teine residue. As this cysteine provides the thiol group to which the palmitate tail
is transferred, the MR cannot be palmitoylated at this sequence. The MR could be
palmitoylated at another motif or could translocate to the membrane through an
alternative pathway.
Regulation of membrane translocation and place in the membrane
Why does only part of the receptor population translocate to the membrane while
the bulk remains in the cytoplasmandnucleus, andwhat determines the proportion
of these pools? For the ERα, most studies estimate that approximately 5–10% of
the receptor population is localized at or in the membrane, which leaves 90–95%
of the population in the cytoplasm and nucleus (Chambliss et al., 2000). Caveolin-1
overexpression was found to elevate the proportion of membrane ERα (Sud et al.,
2010), suggesting that this protein has a regulatory effect.
It is known that ligand binding affects membrane translocation. Most studies
show that treatment with (high concentration of) ligands reduces palmitoylation,
association with caveolin-1 and membrane expression (Razandi et al., 2002; Ac-
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concia et al., 2005; Micevych and Dominguez, 2009). In contrast, other studies re-
port an increased membrane translocation with steroid treatment (Razandi et al.,
2002; Gorosito et al., 2008; Bondar et al., 2009). Clearly, the timing, concentration
and duration of ligand exposure will influence these effects. GR expression in hip-
pocampal synaptosomes was slightly decreased after 3 weeks of daily corticosterone
injections and increased by adrenalectomy (which abolishes endogenous corticos-
terone) (Wang and Wang, 2009), suggesting that the GR also traffics from the mem-
brane by ligand treatment. Interestingly though, in amygdalar neurons acute stress
or corticosterone treatment abolishedMR-mediated non-genomic signalling, while
it actually allowed GR-mediated actions to take place (Karst et al., 2010).
It is still unclear how steroid receptors are integrated into the plasmamembrane.
The effectiveness of impermeable hormone conjugates (such as estradiol-BSA or
cort-BSA) suggests that the receptors are accessible from the outside of the plasma
membrane. In addition, biotinylation studies (for ERα) provide evidence for an ex-
tracellular recognition site of the receptors (Bondar et al., 2009). This would sug-
gest that the receptors are integrated in the outer sheet of the membrane with their
palmitate tail. However, this seems in contradiction with studies showing a direct
interaction of steroid receptors with caveolin-1 (Razandi et al., 2002; Sud et al., 2010)
and secondmessenger molecules such as c-Src and G-proteins (Sanchez et al., 2011),
which suggest that receptors are inserted into the inner sheet of the membrane,
where they are able to interact with the cytoplasmic molecules. Possibly the steroid
receptor shuttles to the inside of the membrane upon activation, but at present this
is mere speculation.
A general model of steroid downstream signalling
As a final point we will evaluate the secondary pathways of steroid receptors. Sur-
prisingly, although the physiological functions of steroids are very diverse (ranging
from sexual differentiation to electrolyte balance) the non-genomic signal pathways
show a large overlap.We will discuss the very basics of steroid receptor downstream
signalling in order to come to general characteristics.
As steroids are lipophilic and easily penetrate the plasma membrane, their re-
ceptors do not need to be located at the plasma membrane. More likely, membrane-
association of steroid receptors is required for binding to signalling partners that
are present only at the membrane. In fact, caveolae are well known signalosomes
that bring receptors, adaptor molecules and kinases together (Anderson, 1998). In-
deed, the ERα was shown to assemble a multi-protein complex consisting of other
membrane-spanning receptors (most often growth factor receptors) and multiple
small adaptor molecules like G-proteins (both Gα and Gβγ subtypes) (Kumar et al.,
2007), c-Src (Sanchez et al., 2011) and PI3K (Simoncini et al., 2000). Through this
signalosome a variety of kinase pathways are activated (Hammes and Levin, 2007;
Vasudevan and Pfaff, 2007; Micevych and Dominguez, 2009). Most commonly, ac-





kinase A), PI3K-Akt and Ras-ERK pathways have been found (Figure 2.1). Impor-
tantly, activation of components of these three general pathways has been reported
for the ERα, ERβ, AR, PR, MR and GR. For example, ERK1/2 phosphorylation can be
seen within minutes of stimulation with aldosterone, corticosterone, estradiol, an-
drogens or vitamin D (Qiu et al., 2001; Pedram et al., 2007; Grossmann et al., 2008)
and reviewed in Hammes and Levin (2007) and Grossmann et al. (2010).
The initial event, i.e. the composition of the signalosome, seems to determine
which downstream pathway is recruited. For example, in hippocampal neurons
estradiol can activate two distinctive pathways in a single cell; on the one hand acti-
vation of ERK1/2 leads to subsequent genomic effects through activation of the tran-
scription factor cAMP response element binding (CREB), on the other hand inhibi-
tion of PKA induces a decrease in Ca²⁺-currents (Boulware et al., 2005). These two
effects originate from two separate pathways; one involves ERα bound to caveolin-1
and attracts the metabotrophic glutamate receptor GluR1A and Gq resulting in the
activation of ERK1/2 and CREB, while the other effect originates from an ERα/β het-
erodimer bound to caveolin-3, GluR2/3 and Gio, this pathway results in the inhibi-
tion of PKA and Ca²⁺-currents (Boulware et al., 2007). Also interesting in this regard
is the role of the coreceptors in the signalosomes; multiple studies showed that inhi-
bition of growth factor signalling prevented the non-genomic effects of steroids. For
example, phosphorylation of ERK1/2 by either aldosterone (Grossmann et al., 2005)
or estrogen (Razandi et al., 2003) could be prevented by inhibitors of the EGF recep-
tor. Direct interactions between the MR (Grossmann et al., 2010) and ERα (Song et
al., 2010) with growth factor receptors were also shown. In fact, some people opt for
a GPCR hypothesis for rapid steroid signalling; the activation of amembrane steroid
receptor activates a growth factor receptor and this enables further signalling (see
Micevych and Dominguez, 2009). Whether this is just one mechanism of action or
the mechanism of action remains to be determined.
Ultimately, activation of the cellular pathways affects the physiology of cells and
tissues. Depending on the precise composition of the signalosome and the cellular
context a wide variety of effects are obtained. These are too diverse to discuss in
full here, but we will give a few examples for rapid aldosterone signalling in the pe-
riphery. In kidney cells, aldosterone rapidly enhances sodium transport through an
ERK pathway, this results in a rapid effect on sodium absorption in these cells which
eventually also regulates blood pressure (Gekle et al., 2001). In the vascular system,
activation of the enzyme nitric oxide (NO) synthase by aldosterone (through a PI3K-
Akt pathway) results in an increased release of NO which attracts immune cells and
affects constriction of vascular smooth muscle cells (Hafezi-Moghadam et al., 2002;
Mutoh et al., 2008).
The signal partners of central non-genomic corticosteroid signalling
The cellular pathways involved in neuronal non-genomic corticosteroid actions
have not been studied in detail yet, however, many studies did examine the involve-
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ment of some signal partners (see Table 2.1) and we can fit these within the general
model of non-genomic steroid signalling. As for ERα and other steroid receptors, the
most obvious effectors of the rapid effects are G-proteins. Inhibition of G-protein
activation abolished the rapid effects of corticosterone on (i) inhibition of mEPSCs
in the hypothalamus (Di et al., 2003), (ii) facilitation of mIPSCs in the hypothala-
mus (Di et al., 2005), (iii) facilitation of mEPSC’s in the hippocampus (Olijslagers et
al., 2008) (iv) inhibition of potassium currents in the hippocampus (Olijslagers et
al., 2008), (v) inhibition of calcium currents in the hippocampus (Ffrench-Mullen,
1995) and (vi) activation of glutamate uptake in frontal neurons (Zhu et al., 1998)
(see also Table 2.1). Interestingly, as for the estradiol effects in the hypothalamus,
corticosterone can activate two different signalling pathways in single neurons in
the hypothalamus. Through activation of Gαs, corticosterone induces the release
of endocannabinoids and an inhibition of glutamate release, while Gβγ activation
leads to the release of NO and the facilitation of GABA release in the same neuron
(Di et al., 2009). It remains to be investigated whether different GPCRs or caveolin
subtypes are also involved.
More downstream, corticosterone rapidly activates both the cAMP-PKA path-
ways and the ERK1/2 pathway in neurons. cAMP-PKA signalling is required in the
hypothalamus (Malcher-Lopes et al., 2006) and for one effect in the hippocampus
(Liu et al., 2007). Activation of the ERK1/2 pathway is seen after corticosteroid ex-
posure in some cases (Xiao et al., 2005, 2010; Roozendaal et al., 2010) and is re-
quired for other effects (Olijslagers et al., 2008). Evidence for the involvement of the
PI3K pathway has not yet been studied in the brain. Thus, although still very lim-
ited, non-genomic corticosteroid signalling in neurons follows similar kinase path-
ways as their peripheral counterparts and as that of other steroid receptors. Likely,
the regional variation in the precise signalling cascades activated will prove to be
crucial for understanding the more subtle difference between the actions in differ-
ent neurons and under changing conditions. As examples from related fields show,
this variation could well arise from the recruitment of different proximal adaptor
molecules and interactions with signalling of other (neurotransmitter) receptors.
In Figure 2.5 we show a very general model of the downstream signalling partners
in central non-genomic corticosteroid signalling.
2.4 Concluding remarks
The existence of rapid effects of corticosterone has been known for over 50 years;
however, it is only in the last 10 years that these effects have been studied in more
detail. Yet, there are still many unanswered questions.
First, we cannot appreciate the consequences of non-genomic effects of cortico-
steroids when they are studied in isolation, instead we must view these effects in





genomic actions are integrated to collectively accomplish the behavioural response
to stress awaits further investigation, as discussed in the previous section.
Secondly, through its non-genomic effects corticosterone acts in the same
time-domain as other transmitters and hormones released after stress, e.g. cate-
cholamines or CRH. This gives ample opportunities for cross-talk between the vari-
ous stress hormones (Alfarez et al., 2009). For example, activation of the noradren-
ergic system in the amygdala is required for effects of corticosterone to take place
(Roozendaal et al., 2002, 2006). However, at this time relatively little is known about
the mechanism by which corticosteroids alter responsiveness to other stress factors
and if non-genomic corticosteroid signalling is involved.
Thirdly, only a few signalling partners for rapid effects have been discovered. A
comparison of the available data (see Table 2.1) suggests that many pathways are
shared across brain areas. For example, multiple studies have proven involvement
of G-proteins and the ERK-CREB pathway. Importantly, these same pathways are
also activated by rapid signalling of other steroid receptors (Hammes and Levin,
2007; Vasudevan and Pfaff, 2007; Levin, 2008). Information gathered in these re-
lated fields could serve as an important guideline for investigation of the signalling
partners of corticosteroids in the brain. For instance, both rapid corticosterone (Di
et al., 2009) and estradiol signalling (Boulware et al., 2007) in neurons suggests
that the specific type of G-protein that is engaged in the hormonal actions is an
important determinant of the subsequent signalling cascade and the physiological
outcome.
Fourthly, regulation of membrane translocation of the MR and GR in neurons is
still undiscovered. Caveolin-1 is required for membrane translocation of all steroid
receptors including the MR and GR (Matthews et al., 2008; Pojoga et al., 2010b).
However, this has yet to be shown for the MR and GR in neurons. All three types of
caveolins are expressed in the brain and they are known to be required for ERα and
ERβ non-genomic signalling (Boulware et al., 2007). Interestingly, neurons do not
have caveolae (Head and Insel, 2007), instead caveolins seem to be associated with
synaptic markers and interact with multiple types of glutamate receptors. Thus, it
is likely that caveolin association enables the enrichment of MR and GR at synap-
tic sites in the membrane (Johnson et al., 2005; Prager et al., 2010) and places the
receptors well in reach to regulation of synaptic transmission.
Finally, the conserved palmitoylation motif found in many steroid receptors, in-
cluding the ERα and the GR, is presumably ineffective in the MR. This motif is ab-
solutely required for palmitoylation and membrane expression of ERα, ERβ, PR and
AR (Pedram et al., 2007) and it thus remains unclear if and how the MR could be
palmitoylated, possibly at another sequence. Consensus palmitoylation sequences
were identified in the MR with the online CSS-Palm tool (Ren et al., 2008), how-
ever, this still needs conformation in vivo. Alternatively, the MR could use another
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M rapid non-genomic actions of corticosterone in the brain act
through the membrane-associated subpopulation of the MR, includ-
ing a rapid reduction in fast-inactivated A-type potassium currents
by corticosterone. Here we present two attempts to reproduce this
membrane-associated role of the MR in neuronal-like cell lines. In
differentiated NS-1 cells we obtain A-type potassium currents. Corti-
costerone did not affect these currents in empty-vector transfected
cells. Importantly, upon transfection with the MR both corticoster-
one and cort-BSA did lead to a rapid reduction of A-type current am-
plitude (> 25%). In contrast, the slowly-inactivated potassium cur-
rents in N1E-115 cells were not affected by corticosterone in the pres-
ence of the MR. The MR is thus sufficient for a rapid inhibition of
fast-inactivated potassium channels by corticosterone and this effect
is specific for certain subtypes of potassium channels.We further find
that the MR is very instable in an in vitro setting and that successful
DNA transfection and MR mRNA transcription does not necessarily






Corticosteroids play a major role in the response of the brain to stress. Within the
brain, corticosteroids exert their actions through two receptors: the GR and MR.
For many years, the MR and GR were purely associated with a genomic role as they
act as transcription factors within the nucleus (de Kloet et al., 2005; Datson et al.,
2008). While this is generally true, corticosteroids can also influence a wide range
of behaviors and endocrine outputs within minutes, a time frame that is too rapid
to be explained by genomic effects (Groeneweg et al., 2011). In agreement, we and
others recently established that corticosteroids rapidly alter neuronal activity and
excitability in a number of brain areas (Di et al., 2003; Karst et al., 2005, 2010; Tasker
et al., 2006). Several of these rapid actions require the MR (and some also the GR)
and seem to occur by corticosteroids binding to a molecule that is accessible from
the outside of the cell membrane. In agreement, a subpopulation of the MR and GR
have been shown to be present at the plasmamembrane (Johnson et al., 2005; Prager
et al., 2010). Despite considerable knowledge regarding the functional significance
of membrane-initiated corticosteroid signaling, themolecular pathways underlying
these actions are just beginning to be unraveled in neurons (see also Chapter 2).
In vitro cell lines have been very valuable to examine the effects of aldosterone
or corticosterone through the MR on cell signaling. The identification of many sig-
naling partners of membrane-associated MR signaling has been accomplished in
cell lines, including cAMP, ERK1/2, G-proteins, caveolin-1, PKC and PI3K (Gross-
mann and Gekle, 2009; Dooley et al., 2012). Additionally, structure-function rela-
tionships can be delineated. Thus far, it has been established that transfection of
the ligand binding domain of the MR is sufficient for aldosterone to rapidly activate
the ERK1/2 pathway (Grossmann et al., 2008). For other steroid receptorsmutations
of single amino acids have aided the understanding of the membrane translocation
pathways of these receptors (Levin, 2009). However, the genomic actions of cor-
ticosteroids are greatly affected by cell-context (John et al., 2011) and remarkably
low overlap in corticosteroid regulated gene patterns were found between neuronal
and non-neuronal cells types (Polman et al., 2012, 2013). Whether non-genomic cor-
ticosteroid actions are also different between neuronal and non-neuronal settings
remains to be addressed. In addition, numerous single nucleotide polymorphisms
(SNPs) in the MR gene, including the promoter region, have found to be associated
with variability in neuroendocrine and autonomic activity (Martinez et al., 2009;
DeRijk et al., 2011; van Leeuwen et al., 2010a,b) and the occurrence of psychiatric
symptoms (Kuningas et al., 2007; Klok et al., 2011). Functional in vitromodels would
be valuable to investigate whether altered brain function associated with MR SNPs
is purely explained by MRs genomic actions and expression levels or whether they
also depend on the non-genomic membrane-associated functions of the MR.
Earlier, potassium currents of hippocampal cells were reported to be rapidly
affected by MRs. The amplitude of fast-inactivating (A-type) potassium currents
in CA1 neurons reduced rapidly after corticosterone application (Olijslagers et al.,
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2008). This effect was prevented by pretreatment with an MR antagonist. A-type
channels are important for determining firing frequencies and to reduce the am-
plitude of back-propagating action potentials in dendrites (Hoffman et al., 1997).
As such they are important for plasticity and excitability. For example, deletion of
A-type channels potentiates the induction of LTP (Chen et al., 2006). A decrease
in A-type current amplitude after corticosterone application would thus enhance
plasticity and excitability in neurons.
Potassium currents can be induced in multiple neuronal-like cell lines. The
widely used PC12 cell line expresses multiple types of voltage-dependent potassium
channels (Hoshi and Aldrich, 1988; Castillo et al., 2001), including fast-inactivating
A-type currents. In addition, a number of neuroblastoma cell lines show expression
of multiple subtypes of potassium and other ion channels. Of these, the mouse neu-
roblastoma cell line N1E-115 shows induction of large amplitude potassium currents
with both inactivating and non-inactivating components (Hirsh and Quandt, 1996;
Lima et al., 2008).
Here, we tested the feasibility of using in vitro neuronal-like cell lines to mimic
non-genomic effects of corticosterone on potassium currents, with the ultimate aim
of unraveling the underlying mechanism. As both these cell lines are devoid of en-
dogenous MR, we can further test whether MR expression is sufficient for rapid
corticosterone actions to occur.
3.2 Methods
Compounds
Corticosterone was obtained from Sigma and first diluted in EtOH to a concentration of
15m and next to the final concentration in PBS or recording medium. The same concentra-
tion of EtOH was used as vehicle. Corticosterone-BSA (cort-BSA) was dissolved to a concen-
tration of 12.5 µ in 0.9% NaCl, 0.25% carboxymethyl cellulose and 0.2% Tween (solvent
A). There are 23 molecules of corticosterone bound to one BSA-molecule, therefore 4.4n
cort-BSA matches 100n of free corticosterone.
Cell culturing procedures and plasmids
In addition to PC12-Neurocreen-1 (NS-1) and N1E-115 cells, in some experiments COS-1 or
CHO cells were used. COS-1 cells are maintained in high glucose DMEM and CHO cells in
F-12 medium (both GIBCO), both supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin and streptomycin. The pRSV-MR plasmid that was used contains the human MR
gene under a Lac promotor (kind gift of R. Evans (The Salk Institute for Biological Studies, La
Jolla, CA)). pEYFP-hMR was generated by cloning the MR gene from the pRSV plasmid into
the pEYFP-C1 plasmid (described in more detail in Chapter 6), generating an N-terminally
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Figure 3.1: Patch protocols for NS-1 cells
(A) 3 days of NGF application leads to a neuronal-like phenotype inNS-1 cells. (B) The general experimen-
tal outline of single-cell patch clamp experiments in NS-1 cells. (C) Voltage dependency of the potassium
currents are obtained with the activation (left) and inactivation protocols (right). Example currents are
shown next to the corresponding protocols.
NS-1 cells
NS-1 cells weremaintained in RMPI 1640, supplementedwith 10%horse serum (HS), 5%FBS
and 1% penicillin and streptomycin. Throughout culturing, all plates and coverslips were
pre-coated with collagen (60 µg / 10 cm2, overnight at RT) to enable better cell attachment.
DNA transfection was performed with an electroporation method, using the Amaxa Nucleo-
fection apparatus (Lonza). In short, NS-1 cells were trypsinated and divided in 1 mln aliquots
and spun down. Cell pellets were dissolved in 100 µl prewarmed nucleofector-solution, care-
fully mixed with 5 µg DNA and transferred to a certified cuvette for electroporation (pro-
gram U29). Immediately after, cells were remixed with growth medium and plated onto col-
lagen coated ø 13mm coverslips, allowing differentiation 24h later. For NS-1 cells, differen-
tiation into a neuronal-like phenotype is acquired with a combination of serum starvation
and nerve growth factor (NGF) treatment. At 24h after transfection, culture medium was
replaced for low serum medium (RMPI 1640 supplemented with 3.4% HS and 1.6% FBS).
After 24h this was replaced for fresh low serum medium with 0.05% NGF. Cells were kept
in NGF-containing low serum medium for 3–5 days and medium was replaced every 2 days.
NS-1 cells can differentiate into an adrenocortical-like phenotype with glucocorticoids, there-
fore all sera used in the low serum medium were 2× charcoal-stripped to bind and wash away
all reminiscent endogenous hormones. Cells were used for electrophysiology after 3–5 days
of NGF treatment (the timeline of all procedures is summarized in Figure 3.1 ).
N1E-115 cells
N1E-115 cells were maintained in low glucose DMEM, supplemented with 10% FBS and 1%
penicillin and streptomycin. N1E-115 cells differentiate into a neuronal-like cell type with
serum starvation and 2% DMSO. Thus, cells were plated onto ø 13mm coverslips coated
with poly-l-lysin (100 µg/10 cm2, 2h at RT). 24h after plating, normal growth medium was
replaced for differentiation medium (low glucose DMEM, supplemented with 2% FBS and
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2% sterile DMSO; medium replaced every 2 days). N1E-115 cells were transfected with lipo-
fectamine (Life Technologies) during differentiation. In short, cells were washed with PBS
and transfected in empty DMEM according to normal protocol (lipofectamine:DNA = 3:1,
1 µg DNA / 100 000 cells). Cells were incubated with the lipofectamine-DNA mixture for 4h
and thereafter replenished with differentiation medium. Cells were used for electrophysiol-
ogy 2–3days after transfection, thus after 6–7days of differentiation (for the time line see
Figure 3.6 ). 24h before patch clamping, normal differentiation medium was replaced for
media containing charcoal-stripped sera to prevent effects of endogenous hormones.
Western blot
ForWestern blot analysis ofMR and control proteins, cells were transfectedwith the required
plasmids, harvested 48h after transfection and prepared for western blot. Protein lysates,
SDS-polyacrylamide gel electrophoresis and Western blotting were performed as described
previously (Vreugdenhil et al., 2007). For each experiment, equivalent amount of samples
(10–15 µg) were used. The blots were incubated with 1:500–2500 MR 1D5 or 2B7 antibodies
(both are generous gifts of Gomez-Sanchez (Gomez-Sanchez et al., 2006)) and co-assessed
for α-tubulin (1:5000; Sigma-Aldrich) in combination with 1:5000 goat-anti-mouse IgG HRP.
All antibodies were diluted in TBST with 0.5% milk powder. Primary antibody incubation
was done for 1hour at RT or for 16hours at 4 °C. Detection was performed with the ECL
detection system (GE Healthcare).
Immonufluorescence staining
For immunofluorescence stainings cells were plated on collagen-coated coverslips (diameter
12mm) and used for experiments 48h after transfection. If required, cells were treated with
hormones or vehicle for 2h before fixation. Fixation was performed with 4% paraformalde-
hyde (PFA) for 30min at RT. Subsequently, cells were permeabilized with 0.5% Triton-100
in PBS, incubated with primary antibody (1:1000 MR 1D5 antibody (Gomez-Sanchez et al.,
2006)) in PBST (0.1% Triton-100 in PBS), supplemented with 1% BSA for 60min. Next, cells
were incubated for 60min with 1:1000 goat-anti-mouse AlaxaFluor488 (or 594) in PBST with
1%BSA and finally for 10minwith 1:5000 withHoechst 33342 (Life Technologies) for nuclear
counterstaining (all in the dark). Between all steps, cells were washed for 3×5 minwith PBST.
Cells were mounted with Aqua Poly/Mount (Polysciences) and imaged on a conventional flu-
orescencemicroscope (Leica DM6000). For YFP-MR, fixation, permeabilization andHoechst
staining and mounting were performed according to the same protocol, but no antibodies
were applied.
qPCR
For RT-qPCR, NS-1, N1E-115 and COS-1 cells were either left untransfected or transfected with
5 µg EV, 1, 5, or 10 µg MR / mln cells (with their respective transfection methods) and har-
vested by TRIZol method 48h later. Reminiscent DNA was removed by DNAse treatment
(Life Technologies, 1 µl DNAse for 1 µg DNA). Subsequently, cDNA was synthesized using
the iScript kit (Bio-Rad). A set of 20bp primers was designed to span a 220bp region in exon
2–3 of the MR. RT-qPCR was conducted using the capillary-based LightCycler® thermocycler





instructions and described in more detail in (Polman et al., 2012). All samples were run twice
and relative expression levels were calculated with a generated standard curve.
Luciferase essay
For the luciferase essay, cells were transfected with a combination of 500ng/10 cm2 YFP,
YFP-MR or MR together with 100ng/10 cm2 TAT3-Luciferase (tyrosine amino transferase
triple hormone response element) and 2ng/10 cm2 pCMV-Renilla (Promega). 24h after
transfection cells were treatedwith 10n corticosterone, 10n aldosterone or 0.001%EtOH
in culturemedium supplementedwith charcoal stripped FBS. After 20h, cells were lysedwith
passive lysis buffer and firefly and renilla luciferase luminescence was determined accord-
ing to the general prescription of the dual label reporter essay (Promega) on a luminometer
(CENTRO XS3 LB960, Berthold). For analysis, the ratio of the two luminescent signals were
used to control for differences in transfection efficiency and cell density.
Electrophysiology
Differentiated NS-1 or N1E-115 cells plated on ø 13mm coverslips were submerged in record-
ing solution in a custom made recording chamber. For NS-1, recording medium contained
130m NaCl, 5m KCl, 2m CaCl₂, 1m MgCl₂, 10m HEPES and 5m glucose, sup-
plemented with 10m tetraethylammonium (TEA) to block sustained potassium currents,
pH 7.3 adjusted with NaOH (all from Sigma-Aldrich). For N1E-115 cells, no TEA was
added and molarity was compensated by using 15m glucose. Throughout the recordings
the recording solution was continuously refreshed and kept at 32 °C. For both cell lines,
the recording pipette contained: 140m KCl, 10m HEPES, 5m EGTA, 2m MgCl₂,
0.1m CaCl₂, 2m MgATP and 0.4m Na₂GTP (pH 7.3 adjusted with KOH; all from Sigma-
Aldrich). Cells were imagedwith an uprightmicroscope (Axioskop 2 FS plus, Zeiss), equipped
with differential interference contrast and wide field fluorescence. Healthy and well differ-
entiated cells were identified manually and patched using 4–6MΩ borosilicate glass elec-
trodes (0.86/1.5mm inner/outer diameter, Harvard Apparatus). For some experiments, GFP
or YFP-MR fluorescence was checked with wide field fluorescence and moderately fluores-
cent cells were chosen for patch clamping. To prevent phototoxicity, fluorescence exposure
duration was kept at a minimum and low intensity fluorescence was used. Whole cell voltage
clamp recordings were made with an Axopath 200B amplifier (Axon instruments) interfaced
to a computer via a Digidata (type 1322A; Axon Instruments). After reaching a gigaseal, the
membrane patch was ruptured and the cell was kept at a holding potential of −60mV (NS-1)
or −70mV (N1E-115). Series resistance was compensated for 60%. To test voltage dependency
of A-type current activation and inactivation, two types of protocols were used. Protocol
1 tested activation properties by changing the activation step from −60mV to +60mV in
10mV steps. Protocol 2 tested voltage dependency of inactivation by changing a prepulse
from 0mV to −130mV in 10mV steps. Duration of the voltage steps differed for NS-1 and
N1E-115 cells, all protocols are shows in Figure 3.1 and 3.6 .
Data analysis was performed with ClampFit (Molecular Devices). Data was corrected
for leak current and baseline and maximum current amplitudes were recorded and plotted
against voltage steps. Half maximal values were calculated as the first voltage step where the
half maximum amplitude was achieved.
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Statistics and data representation
Rapid effects of compounds on potassium currents were tested with two-tailed paired sam-
ples t-tests on the original, uncorrected data. Due to large differences in basal amplitudes
between cells, the A-type current data is represented as % of maximum amplitude during
baseline recordings in all figures. All between-subject comparisons were performedwith two-
tailed independent sample T -tests for comparisons of 2 groups or one-way ANOVAs for < 2
groups.
3.3 Results
A-type currents in Neuroscreen-1 cells
PC12 cells are a well-known neuronal-like cell line that shows large potassium
currents upon differentiation (Hoshi and Aldrich, 1988; Castillo et al., 2001).
Neuroscreen-1 (NS-1 cells are a subclone of PC12 cells with a higher responsiveness
to NGF (Dijkmans et al., 2008). Upon stimulation with NGF, NS-1 cells show neu-
ritogenesis within a day and develop a network of extensive neurites within 2–5
days upon NGF-induced differentiation (Dijkmans et al., 2008). We recorded single
well-differentiatedNS-1 cells in the voltage-clampmode after 3–5 days of differentia-
tion. Comparable to their parent strain, differentiated NS-1 cells showed large potas-
sium currents with a large non-inactivating (delayed rectifier) and a smaller fast-
inactivating (A-type) component. The delayed rectifying component was effectively
blocked by 10m TEA, thus revealing clear rapidly inactivating A-type currents
(Figure 3.1 ). The maximum A-type current amplitude (at +60mV) showed large
cell-to-cell variation, ranging from 145 to 5600pA, with an average of 1491 ± 155pA
(n = 59). A-type currents are most efficiently activated with a hyperpolarizing pre-
pulse preceding the depolarizing step, relieving the voltage-dependent inactivation
of the channels. Indeed, we found that a prepulse of −130mV increases the potas-
sium current to a subsequent depolarization by 2.5 ± 0.4 fold (compared to stepping
directly from a holding potential of −60mV). NS-1 A-type currents were half max-
imally activated with a depolarization to 20.2 ± 1.3mV and the half maximal value
for inactivation was −71.6 ± 2.8mV. Further characterization of the currents is pre-
sented in Figures 3.1 and 3.2.
Corticosterone and cort-BSA reduce A-current amplitude only after
MR transfection
In the mouse hippocampus, corticosterone application led to a reduction in A-type
current amplitude and a shift in activation properties so that larger depolarizations
were required for the induction of similar A-type currents (Olijslagers et al., 2008).
These effects were shown to require the MR. PC12 cells do not express endogenous





First, we tested whether corticosterone could similarly affect A-type current am-
plitudes in NS-1 cells transfected with an empty vector (EV). In EV-transfected NS-1
cells, we observed a small, but statistically significant, decrease in maximal A-type
current amplitudes (−12.4 ± 0.5%compared to baseline; Figure 3.2 , ), presumably
due to run down of cells during the patch procedure.
Next, we electroporated NS-1 cells with a plasmid containing human MR and in-
duced differentiation the next day. The transfection efficiency of this method was
assessed with transfection with (untagged) GFP. We found that the transfection ef-
ficiency was very high: 24h and 48h after transfection 89.4 ± 1.1% and 90.1 ± 1.4%
of cells respectively was GFP positive (n = 12 wells). Due to differentiation cells
do not divide and transfection efficiency is thus not expected to drop significantly
over time, although this was not verified directly. We observed a rapid action of
corticosterone on A-type currents in MR transfected cells. Within 5 to 10 minutes
after application of 100n corticosterone, A-type current amplitudes were strongly
reduced (Figure 3.2 and , top panel). This effect was most apparent with high de-
polarization steps. No effect was seen on activation or inactivation properties. Thus,
the maximum A-type current amplitude was reduced to 64.7 ± 0.1% of baseline
levels, but the voltage dependency of the channels was unaffected (Figure 3.2 – ,
½ max of 15.7 ± 2.2mV). This reduction of maximal A-type current amplitudes was
significantly greater than in EV-transfected cells. In its non-genomic role, corti-
costerone has been reliably show to act at the cell membrane (Groeneweg et al.,
2012). We therefore tested the effect of BSA-conjugated corticosterone (cort-BSA),
a membrane-impermeable conjugate of corticosterone. Comparable to corticoster-
one, also cort-BSA application led to a reduction of the maximal A-type current
amplitude (to 72.6 ± 6.2% of baseline levels), but did not affect voltage dependen-
cies of the channels (Figure 3.2 , middle panel). Finally, vehicle treatment led to
a much smaller reduction of A-type amplitudes in MR-transfected NS-1 cells (to
84.6 ± 4.4% of baseline levels, Figure 3.2 , bottom panel).
To conclude, we show that we can reproduce —in cell lines in vitro— the rapid,
membrane-initiated reduction of A-type current amplitudes earlier observed in hip-
pocampus slices. Moreover, here we show that expression of the MR is not only
required for these effects, but MR expression is sufficient to obtain non-genomic
corticosterone-induced effects.
Instability of MR protein in NS-1 cells leads to failure to reproduce
results
We transfected NS-1 cells with a method known to give high transfection efficiency
and with an MR plasmid (pRSV-MR) known to induce robust MR protein expres-
sion in other cell lines (Klok et al., 2011). However, when we assessed MR expres-
sion by Western blot 48h after electroporation we failed to find any MR protein
(Figure 3.3 ). As a control we also transfected COS-1 cells with the same pRSV-MR




































































































































































in transfected cells. Similarly, prolonged exposure, different transfection procedures
or a different MR antibody (N2B7 (Gomez-Sanchez et al., 2006)) all failed to show
MR expression in transfected NS-1 cells (data not shown). The MR is known to be
a very unstable protein and can be lysed during lysate preparations leading to frag-
ments of incorrect size (Gomez-Sanchez et al., 2011). However, even though we did
observe fragments of incorrect size on the Western blot (Figure 3.3 ), these were
seen in both transfected and untransfected NS-1 cells and are likely to be due to
aspecific interactions of the antibody.
Next we initiated a number of different biochemical approaches to test for pres-
ence ofMR protein. First, we showed thatMR immunofluorescence is indistinguish-
able betweenNS-1 cells transfected (according to normal procedure) with theMR or
EV with immunofluorescence staining (Figure 3.3 ). Again, COS-1 cells transfected
with MR showed clear MR immunofluorescence and in the expected pattern of en-
hanced nuclear localization. Secondly, we obtained YFP-tagged MR and assessed
YFP fluorescence in YFP-MR transfected NS-1 cells after treatment with vehicle or
100n corticosterone for 2h. Also here, we failed to find a higher fluorescence in
transfected cells compared to untransfected cells (Figure 3.3 ); neither was there
an indication of nuclear translocation of the YFP signal to the nucleus (data not
shown). Transfection of YFP or GFP alone did lead to clear fluorescence throughout
the cell (Figure 3.3 ). As a final attempt, we assessedMR function with a transactiva-
tion essay.We cotransfectedNS-1 or COS-1 cells withMR, EV or YFP-MRwith Firefly
luciferase under an MR-dependent TAT3 promotor (van Leeuwen et al., 2010a; Klok
et al., 2011), and Renilla luciferase under a control (CMV) promotor. In COS-1 cells,
we observed an increase in Firefly-to-Renilla luminescence ratio after transfection
with either the MR or YFP-MR (Figure 3.3 ). As expected, treatment with either
corticosterone or aldosterone (10n for 16h) resulted in a 6 and 7 fold increased
Firefly luciferase production respectively. In contrast, in NS-1 cells there was no in-
crease in Firefly-luciferase induction in MR or YFP-MR transfected cells. We did
Figure 3.2 (preceding page): A-type currents are reduced by corticosterone only in
MR-expressing NS-1 cells
(A) Example of A-type currents from NS-1 cells transfected with an empty vector (EV) (left panel) or the
MR (right panel). Corticosterone induces a reduction in A-type current amplitude for MR-transfected,
but not for EV-transfected NS-1 cells. Currents elicited with −100mVpriming and 60mVdepolarization
step, scale bars: 500pA (vertical) and 50ms (horizontal). (B-C) A-type currents are measured before and
10 to 15 minutes after hormone treatment with the activation (left) and inactivation (right) protocols.
(B) In NS-1 cells transfected with an empty vector (EV), corticosterone only marginally affects the ampli-
tude of A-type currents. (C) NS-1 cells transfected with pRSV-MR. In MR-expressing cells, both 100n
corticosterone (top) and 100n cort-BSA (middle) treatment results in decreased A-type current am-
plitudes. Vehicle treatment has little effect (bottom). (D) The effect of corticosterone on A-type current
amplitude is rapid in onset, as a significantly reduced current amplitude is already observed after 6
minutes. No significant reduction is observed for EV-transfected cells. (E) The decrease in maximum
A-type current amplitude (+60mV step) is significantly larger in the MR-cort versus the EV-cort group.
Statistics. (A-C) Paired samples t-test. Significant effects with p < 0.01 are shown. (D) Repeatedmeasures
(against baseline). (E) One-way ANOVA with post hoc multiple comparison (Tukey). Group sizes: EV+cort
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Figure 3.3: MRmRNA is present, but MR protein absent fromMR-transfected NS-1 cells
NS-1 cells do not show detectable MR protein expression after pRSV-MR transfection in NS-1 cells. (A-D)
(A) Representative western blot of MR expression after MR transfection in COS-1 and NS-1 cells. There
is no appreciable MR protein expression 48h after transfection in NS-1 cells, while MR protein is clearly
seen in transfected COS-1 cells. Expected size of MR: 107 kDa. α-tubulin is coassessed as loading con-
trol. (B) Representative IF images for MR do not show quantitative difference in fluorescence between
MR and EV-transfected NS-1 cells. In COS-1 cells, clear MR IF signal is seen with, as expected a high nu-
clear localization. (C) Transfection with YFP-MR does not lead to detectable YFP fluorescence 48h after
transfection, nor is there an accumulation of fluorescence in the nucleus after corticosterone treatment.
Transfection of YFP alone does show clear YFP fluorescence in NS-1 cells. Quantification of average IF
levels is shown on the right. (D) Transactivation essay. COS-1 and NS-1 cells are transfected with MR,
YFP-MR or EV and the ratio between MR-driven Firefly and control-driven Renilla luminescence is as-
sessed 48h after transfections. In COS-1 cells, both aldosterone and corticosterone (10n , 16h) induce
an increased Firefly/Renilla ratio. In NS-1 cells, however, corticosterone does not affect the Firefly/Renilla
ratio and aldosterone does so onlymarginally. (E)MRmRNA levels assessedwith RT-qPCR. In contrast to
the lack of detectable MR protein and function, there is clear MR mRNA expression 48h after pRSV-MR
transfection in NS-1 cells, albeit in a > 100 fold lower amount as in COS-1 cells. (F) The corticosterone-
induced decrease in A-type current amplitude is not reproduced in a new set ofMR-transfectedNS-1 cells.
Both 100n and 1 µ corticosterone fail to induce a decrease of maximum A-type current amplitude
(n = 13/2). Statistics. Independent-samples t-test against untransfected condition in C and E and against

















Figure 3.4: Stable MR cell lines show selection against
MR expression
(A) Clones of CHO cells stably transfected with YFP-YFP
(52 kDa; left panel) or YFP-MR (137 kDa; right panel) and
stained for YFP (1:1000). For YFP-YFP clones, 3 out of 4 show
a primary band at the expected size. However, none of the
4 putative YFP-MR clones show a band at the correct size
(indicated by triangle), but instead a selection of low weight
protein bands suggestive of YFP with a small portion of the
MR attached. (B) Western blot for an assortment of CHO
cells. Band to the right is of clone A09 previously described
to be stably expressing the MR (Grossmann et al., 2005). No
MR band is seen for this sample, while clear bands are seen
in cells transiently transfected with YFP-MR (left). MR: 1D5
antibody 1:1000.
observe a small, but statistically significant, increase in Firefly-to-Renilla ratio af-
ter aldosterone treatment, i.e. 1.4 to 2.4 fold in MR and YFP-MR transfected cells
respectively which was not seen in EV-transfected cells (Figure 3.3 ). Possibly, this
indicates a very low expression of the MR.
A failure to induce MR protein expression after transfection could be due to a
low transfection efficiency or due to autolysis of the expressed protein within the
cells. We showed clear expression of GFP and YFP (both under a CMV promotor)
after electroporation in NS-1 cells, but failed to find expression of pRSV-MR (Lac
promotor) or YFP-MR (CMV promotor), thus it is unlikely that the lack of protein
expression was due to problems with transfection efficiency or transcription of the
transfected plasmids. Still, to verify that MR DNA was expressed and transcribed
in transfected NS-1 cells, we measured MR mRNA levels. As shown in Figure 3.3 ,
we found clear expression of MR mRNA in both COS-1 and NS-1 cells after trans-
fection with increasing levels of the MR plasmid. Thus, transfection with 1 µg, 5 µg
and 10 µg (/mln cells) MR resulted in 4-, 8- and 15-fold higher mRNA levels respec-
tively. MR mRNA levels in NS-1 cells were > 100 fold lower than what is seen in
COS-1 cells after transfection with similar doses of MR plasmid (Figure 3.3 ). Also
in differentiated cells, 7 days after transfection, there was still clear MR mRNA ex-
pression, although this was approximately 4-fold lower compared to that found 48h
after transfection (data not shown).
In an additional set of experiments, we attempted to create stable expression of
YFP-tagged MR in CHO cells. However, while the procedure led to successful ex-
pression of another YFP construct (YFP-YFP) in 3 out of 4 clones, for YFP-MR all
YFP positive clones only had fragments of the MR attached (Figure 3.4 ). Similarly,
the group of Claudia Grossmann and Michael Gekle had successfully created stable
expression of the MR plasmid in CHO cells (Krug et al., 2002; Grossmann et al.,
2005). However, they observed decreasing levels of MR within these cells even un-
der antibiotic selection and correspondingly, we found no indication of MR protein




In the first set of electrophysiological experiments we observed a reduction
in potassium A-type currents specifically after MR transfection (Figure 3.2). This
seems irreconcilable with the lack of MR protein expression observed. However,
there was large variation between cells and no decrease in amplitudes was observed
in about 25% of cells (Figure 3.2 ). Moreover, a new experiment where we electro-
physiologically measured the effect of either vehicle, 100n corticosterone or 1 µ
corticosterone in a new group ofMR-transfected NS-1 cells failed to reproduce these
earlier obtained results (Figure 3.3 ).
Taken together, the MR protein seems to be highly instable in NS-1 cells. MR
mRNA was observed after transfection of NS-1 cells with an MR plasmid. But,
whereas the same plasmids resulted in clear and reproducible MR protein expres-
sion in COS-1 cells, we found no indications forMR protein expression after success-
ful transfection in NS-1 cells. The MR is thus either not translated or immediately
degraded in NS-1 cells, for reasons unknown to us. We have noted problems with
MR expression on other occasions as well. Consequently, these expression issues
make the NS-1 cell line unsuitable for reliable and reproducible electrophysiologi-
cal experiments.
Potent MR protein expression in a second neuronal-like cell line:
N1E-115 cells
A number of neuroblastoma-generated cell lines also show large potassium cur-
rents. Of these, the N1E-115 cells, a mouse neuroblastoma cell line, is known to ex-
press large amplitude potassium currents, consisting of a (slow-) inactivating and
a non-inactivating component (Hirsh and Quandt, 1996; Lima et al., 2008; Vicente
et al., 2010). It is unclear whether the inhibitory effect of corticosterone on fast-
inactivating potassium currents seen in CA1 hippocampal cells (Olijslagers et al.,
2008) is specific for a subtype of potassium channels or a more broad effect on
(inactivating) potassium channels. Thus, we tested the effect of corticosterone on
potassium currents in N1E-115 cells after transfection with MR.
We first employed a number of biochemical approaches to verify that MR pro-
tein was expressed and functional after transfection in N1E-115 cells. Indeed, on
Western blots we found proteins of the correct size 48h after transfection (Fig-
ure 3.5 ). In addition, YFP-MR transfection showed clear YFP fluorescence in
N1E-115 cells and nuclear translocation of YFP-MR after corticosterone treatment
as expected (Figure 3.5 ). Moreover, all MR plasmids (pRSV-MR, pcDNA3-MR and
YFP-MR) led to the expression of a functional MR protein as shown by robust trans-
activational capacity (Figure 3.5 ). Without additional hormone treatment, TAT3-
Firefly luciferase was already produced at higher levels as compared to EV trans-
fected cells. Treatment with 10n corticosterone for 16h led to a strong induc-
tion of Firefly production when cotransfected with any of the three MR plasmids.
The pRSV-MR plasmid (which was used in NS-1 cells) showed the lowest, but still









































































































Figure 3.5: YFP-MR is robustly expressed in N1E-115 neuroblastoma cells
(A) Representative western blot assessed for MR. Transfection of increasing amounts of YFP-MR shows
robust expression of YFP-MR protein (125 kDa). Similarly transfection with two different MR constructs
results in expression of MR protein (107 kDa), with low levels after pRSV-MR transfection. α-tubulin is
coassessed as loading control. (B) IF imaging shows clear YFP-MR fluorescence in transfected N1E-115
cells and nuclear translocation after corticosterone (10n , 4h) treatment. (C) Transactivation essay. In
MR-transfected N1E-115 cells the ratio between MR-driven Firefly and control-Renilla luminescence is in-
creased as compared to EV-transfected cells. Additionally, the ratio is further increased after application
of corticosterone (10n , 16h) in cells transfected with MR plasmids and not with EV. (D) RT-qPCR on
N1E-115 cells shows increasing amount of MR mRNA after transfection with 1, 5 and 10 µg of pRSV-MR.
Statistics. Independent-samples t-test against corresponding vehicle conditions in B and C and against
untransfected condition in D. # = p < 0.1, ∗ = p < 0.05, ∗∗ = p < 0.01, ∗∗∗ = p < 0.001
mRNA expression with increasing levels of MR transfection in N1E-115 cells 48h af-
ter transfection (Figure 3.5 ) and still detectable mRNA expression (2–3 fold lower
compared to 48h) after 5 days of differentiation (data not shown).
Corticosterone does not affect potassium currents in N1E-115 cells
Subsequently, we assessed if we obtained currents with the expected properties in
differentiated N1E-115 cells. After 5 days of serum starvation and DMSO application
we observed a neuronal-like phenotype in the cells with strong neuritogenesis (Fig-
ure 3.6 ).We patch clamped N1E-115 cells after 4–6 days of differentiation andmain-
tained the cells in voltage clamp mode to measure ion currents. Similar to what was
reported before (Hirsh andQuandt, 1996; Lima et al., 2008), we found large outward
currents, that showed both a slow-inactivating and a non-inactivating component
























Figure 3.6: Patch protocols for N1E-115 cells
(A) N1E-115 cells develop a neuronal-like phenotype within 5 days of serum deprivation and DMSO treat-
ment. (B) The general experimental outline of single-cell patch clamp experiments. (C) Voltage depen-
dency of the potassium currents are obtained with the activation (top) and inactivation protocols (bot-
tom). A combination of a sustained and an inactivating current is seen in N1E-115 cells. A prepulse of
+10mV generates only the sustained component, subtracting this from the total current generated the
inactivating component. Typical traces are shown next to the corresponding protocols.
of 2366 ± 317pA (n = 19). As expected (Lima et al., 2008), both current compo-
nents were sensitive to TEA and 4-AP. Thus, at a dose of 1m , both TEA and 4-AP
reduced the currents roughly by half, while an even stronger reduction was seen
when both inhibitors were given simultaneously (Figure 3.7 ). This is in sharp con-
trast to the A-type currents in NS-1 cells, which were recorded with 10m TEA
in the recording medium. Finally, a hyperpolarized prepulse did not potentiate the
potassium currents in N1E-115 cells. Thus, maximal potassium currents were already
induced at resting potential, while the currents were partially inactivated by a pre-
ceding depolarization as expected (half maximum inactivation at −28.9 ± 3.8mV,
Figure 3.7 ). In NS-1 cells hyperpolarizations did lead to larger A-type currents
(½ max of −71.6 ± 2.8mV). Finally, as compared to NS-1 cell A-type currents, in
N1E-115 cells the voltage dependency of the currents was shifted marginally to the
right (half maximal activation at +23.7 ± 3.8mV; Figure 3.7 ). Thus, we found an
overall potassium current in N1E-115 cells which is seemingly the combination of
slow-inactivating and non-inactivating channels as was previously reported (Hirsh
and Quandt, 1996; Lima et al., 2008).
We then chose to transfect YFP-MR instead of untagged MR to be absolutely
sure that we only recorded from MR (protein) expressing cells. Thus, prior to patch-
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Figure 3.7: Potassium A-type currents show different kinetics in N1E-115 cells and are
unresponsive to corticosterone
Differentiated N1E-115 cells are transfected with YFP-MR and YFP-expressing cells are identified and
patched. (A) The potassium currents in N1E-115 cells are sensitive to both TEA (1m ) and 4-AP (1m ).
The two compounds also have an additive effect. (B) The voltage dependency of the N1E-115 potassium
currents is obtained with the activation and inactivation protocols. The potassium current in N1E-115
cells is not potentiated by a hyperpolarized prepulse. (C) Typical potassium currents elicited with a
−100mV prepulse (total), a +10mV prepulse (sustained) and by subtracting the two (activated) shows
in baseline and 5–10min after 100n corticosterone (all +60mV depolarization step). (D) Total potas-
sium currents are assessed with the activation protocols before and 10–15 minutes after treatment with
100n corticosterone. Corticosterone does not affect the amplitude or voltage dependency of potassium
currents in YFP-MR expressing N1E-115 cells (n = 19 cells). (E) Maximal amplitudes (at +60mV) of ei-
ther the total current, the sustained current or the inactivated current are only marginally lower than
baseline values after corticosterone treatment. Statistics. (D) Paired sample t-test (n = 19). Significance
with p < 0.01 is shown. ∗∗ = p < 0.01
stricted ourselves to cells with moderate levels of YFP). As before, we measured
the activating and inactivation characteristics of the potassium currents in base-
line condition and within 5–10 minutes of corticosterone treatment; the results are
presented in Figure 3.7 - . The data shows that corticosterone application did not
affect the overall potassium current in N1E-115 cells. Neither activation, nor inac-
tivation voltage dependency were affected by corticosterone treatment. There was
a marginal decrease in maximal amplitude (8.4 ± 3.0%), but this was more indica-
tive of some run down of the currents than of a corticosterone-specific effect. As
the potassium current in N1E-115 cells is comprised of two components we also
tested the effect of corticosterone treatment on each component separately. To do
so, we inactivated the transient component with a depolarizing prepulse (+10mV)
and thus obtained only the sustained component. The inactivating component was
then obtained by subtraction of the sustained components from the total current
(Figure 3.6 ). However, neither the sustained current nor the inactivated current
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were affected by corticosterone treatment (maximal amplitudes of 89.7 ± 5.5% and
98.2 ± 5.3% of baseline levels respectively, Figure 3.7 ).
3.4 Discussion
Rapid, non-genomic actions of corticosterone are increasingly accepted as function-
ally important action of corticosteroids. Within minutes after a stressful event or
an otherwise achieved surge in corticosteroids a shift in neuronal excitability is
induced in multiple brain areas (Karst et al., 2005, 2010; Tasker et al., 2006), po-
tentially resulting in increased learning and behavioral reactivity (Khaksari et al.,
2007; Groeneweg et al., 2011). The MR is required for many of these effects and in-
volves a membrane-associated receptor, but the downstream signaling pathways
and structure-function relationship remain ill understood.
We here sought to mimic a functional non-genomic action of corticosterone on
neuronal excitability in a cell line, affording the possibility to alter theMR structure
and signaling through transfection. Initially, in NS-1 cells we found the amplitude
of rapidly-inactivating potassium currents to be strongly and significantly reduced
by 100n corticosterone in a rapid, membrane-initiated and MR-dependent fash-
ion (Figure 3.2). A lack of a corticosterone-induced effect in empty vector trans-
fected NS-1 cells further suggests that the presence of the MR is sufficient to ren-
der (neuronal-like) cells responsive to non-genomic corticosterone actions. We did
not observe the shift in voltage dependencies of the channels which was shown
in CA1 neurons (Olijslagers et al., 2008). In N1E-115 cells, the sustained and slowly-
inactivating potassium currents were not affected by corticosterone (Figure 3.7),
suggesting that corticosterone only affects the kinetics of a specific subset of potas-
sium channels.
Instability of the MR in cell lines
Much caremust be taken in interpreting our current results as we were unable to re-
liably show the presence of the MR protein in MR-transfected NS-1 cells. Moreover,
whereas we found a clear MR-specific effect of corticosterone in an initial large set
of experiments (n = 23), we were unable to replicate these results in a further
smaller subset of recordings (n = 13). We assessed potential MR protein expres-
sion by numerous methods, including Western blot, immunofluorescence staining,
YFP-tagged MR transcripts and transactivation essays. Interestingly, while MR ex-
pression and functionality was found on all occasions in both COS-1 and N1E-115
cells, none of the methods showed expression in transfected NS-1 cells. Only aldos-
terone did show some transactivational potency in MR and YFP-MR transfected
NS-1 cells, while this was absent in EV-transfected NS-1 cells. This finding could





The failure to detect a protein while mRNA is expressed could be caused by
either an inhibition of mRNA translation or by protein degradation. Silencing of
mRNA by microRNAs is recognized as an endogenous mechanism to inhibit trans-
lation (Lee et al., 1993; Bartel, 2004). The 3′ UTR region of the MR contains several
microRNA recognition sites (de Kloet et al., 2009; Sõber et al., 2010) but their effect
on MR expression has not been investigated. Moreover, the 3′ UTR region was not
included in the plasmid DNA, making mRNA silencing through this route unlikely.
As all steroid receptors, unliganded MR forms a multimer with several chaperones
and heat shock proteins that keep it in its inactive conformation and that also pro-
tect against degradation (Yang and Fuller, 2012). Indeed, inhibition of HSP90, one
of the main chaperones, leads to increased ubiquitylation and degradation of the
MR (Faresse et al., 2010). Insufficient amounts of HSP90 might thus explain rapid
degradation of transfected MR. However, HSP90 is endogenously expressed in PC12
cells. Moreover, steroid receptors share most, if not all, chaperones. To our knowl-
edge there are no indications for an enhanced degradation of the MR and one study
even found the opposite (Lightman et al., 2008). However, we and others have noted
that the MR is a peculiar protein in in vitro settings. I will discuss the apparent in-
stability of the MR in vitro in more detail in the general discussion (Chapter 7).
The lack of reliable MR protein expression is a likely explanation for the failure
to reproduce the functional effects of corticosterone through the MR observed in
the first series of experiments.We never assessedMR protein expression directly on
cells that were also used for electrophysiology, thus, it remains possible that in this
first series there was sufficient MR protein expression during recordings to induce
the functional effects. Indeed, either mRNA silencing or efficient protein degrada-
tion are likely strongly affected by the cell context and could thus result in small
fractions of viable MR protein depending on subtle differences in culturing condi-
tions. Regardless, the lack of MR stability in NS-1 cells make this cell line unsuitable
for further experiments.
Potassium channel subtypes and their responsiveness to
corticosterone
While corticosterone—at least in the first series of recordings— affected the rapidly
inactivating potassium currents in NS-1 cells, it had no effect on the potassium
currents in N1E-115 cells. This suggests that the corticosterone-induced effects are
specific for certain potassium channel subtypes. Potassium channels are the most
diverse group of ion channels. Functionally, potassium currents can be grouped
into transient or “A-type” channels and two subtypes of delayed rectifying chan-
nels; the slow-inactivating “D-type” and non-inactivating “M-type” channels. The
potassium pore is formed by homo- or hetero-tetramers of α-subunits, encoded by
one of the Kv families (Chandy et al., 1990; Vacher et al., 2008). Each type of cur-
rent can be generated by a variety of channels. For example, A-type currents are
generated by Kv1.4, Kv3.3, Kv3.4, Kv4.1, Kv4.2 or Kv4.3 channels (Vacher et al., 2008).
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To build onto the complexity, heterotetramers form channels with intermediate ki-
netics and auxiliary (β) subunits affect the kinetics of the channels (Rettig et al.,
1994). Neurons generally express multiple Kv subtypes, resulting in a summed cel-
lular potassium current of intermediate kinetics. Olijslagers et al. (2008), found a
reduction in A-type potassium currents by corticosterone in CA1 neurons. Within
these neurons, A-type channels Kv1.4 and Kv4.2 aremost abundantly expressed (Co-
etzee et al., 1999; Chen et al., 2006). The reduction in potassium amplitudes further
requiredG-proteins and likelyMAPK/ERK activation (Olijslagers et al., 2008). Kv4.2
is widely recognized as direct target of ERK1/2 (Schrader et al., 2006; Adams et al.,
2008). ERK activation results in reduced surface expression, inhibition of current
amplitude and a right-shift in activation kinetics of Kv4.2 (Yuan et al., 2002, 2006),
making this subtype a prime candidate for corticosterone-induced regulation of
potassium currents. However, ERK1/2 potentially affects other Kv subtypes as well
(Yuan et al., 2006).
In PC12 cells, at least 4 different voltage-dependent potassium currents have
been identified (Hoshi and Aldrich, 1988; Conforti and Millhorn, 2000). These in-
clude sustained, slow-inactivating and fast-inactivating currents. Of note, multiple
studies reported transient A-type currents in only a small subset of differentiated
PC12 cells (Hoshi and Aldrich, 1988; Conforti and Millhorn, 2000; Castillo et al.,
2001), while others found them more frequently (Pannaccione et al., 2005, 2007).
Although we did not quantify it here, we found clear A-type currents in the ma-
jority of NS-1 cells. It is possible that NS-1 cells represent a subclone of PC12 cells
associated with larger (transient) potassium currents. Which Kv channels underlie
the observed currents in PC12 cells remains a matter of debate; expression of many
Kv subtypes, including the Kv1.2/1.3/1.4, Kv2.1, Kv3.1/3.2/3.3/3.4 and Kv4.2/4.3 chan-
nels, was found in PC12 cells (Conforti and Millhorn, 2000; McCrossan et al., 2003;
Pannaccione et al., 2007). Highest expression of A-type channels was observed for
the Kv3.4 and Kv4.2 channels. In NS-1 cells we recorded high amplitude A-type cur-
rents in the presence of 10m TEA. Whereas Kv3 channels are sensitive to TEA
(Pannaccione et al., 2005), Kv4 subtypes are highly resistant (Coetzee et al., 1999).
We thus presume that we recorded mainly from Kv4.2 mediated A-type channels. It
thus seems likely that the reduction in A-type current amplitude found in CA1 neu-
rons (Olijslagers et al., 2008) and here in NS-1 cells by corticosterone (albeit only in
the first series) both involve actions on Kv4.2 channels. However, in CA1 neurons
a decrease in maximal A-type current amplitude was seen in concert with a shift
in the activation kinetics towards higher depolarizations (Olijslagers et al., 2008).
In NS-1 cells we found no indications for a shift in kinetics. Whether this is due to
different signaling cascades, different auxiliary subunits or a different Kv subunit
composition remains to be established.
N1E-115 cells show two main potassium currents, a sustained current and a
slowly-inactivating current (Quandt, 1988; Lima et al., 2008). Also for N1E-115 cells





mined in detail. One study, however, associated a reduction in Kv3.1 mRNA with a
reduction in the slow-inactivating current (Hirsh and Quandt, 1996). Moreover, the
inactivating current in N1E-115 cells is highly TEA sensitive, is not potentiated by a
hyperpolarized prepulse and has slow inactivation kinetics, which all fit with Kv3.1
or Kv3.2 channels (Coetzee et al., 1999). Thus, we presume that the inactivating com-
ponent of the N1E-115 potassium current is generated through a Kv3 channel (most
likely Kv3.1) and this current is insensitive to corticosterone. Altogether, the data in-
dicates that the suppressive effect of corticosterone on inactivating potassium cur-
rents is specific for some Kv channel subtypes and is not seen for slowly-inactivating
Kv3.1 channels. Expression of specific Kv subtypes in isolation in non-neuronal cells
could narrow down which Kv subtypes are responsive to rapid corticosterone ac-
tions.
In conclusion, the current experiments show that neuronal-like cell models can
be used to reproduce a functional non-genomic effect of corticosterone on neuronal
excitability. With the combination of NS-1 and N1E-115 cells we show that the reduc-
tion in potassium current amplitudes is Kv subtype specific. However, the stability
of the MR in cell lines (at least the two we recorded from) is a limiting factor and
must always be carefully monitored. Better understanding of MRs dynamics and
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T mineralocorticoid receptor (MR) mediates both genomic and
non-genomic actions of its ligands. It is known to be localized
in the cytoplasm and in the nucleus. However, over the previous
decade, evidence has accumulated showing that the MR also has a
smaller membrane-associated population that is involved in rapid
non-genomic actions of its ligands. This membrane localization has
been confirmed by electron microscopy, but the relative size of the
membrane population, its regulation and its dynamics remain un-
known. Total Internal Reflection Fluorescence (TIRF) microscopy is
a well-established technique to image membrane proteins, since the
background signal from cytoplasmic proteins is very low. Here, we
utilize the combination of wide-field and TIRF single-molecule mi-
croscopy to study the dynamics of the MR near the membrane and
compare this to the dynamics of the cytoplasmic population. We find
that, in two different cell lines, YFP-tagged MR shows two diffusing
populations, with a 30–100 fold difference in diffusion coefficients.
In TIRF, a larger fraction of the imaged molecules show slow diffu-
sion (35–51% versus 11–30% in wide-field microscopy). Our data
suggest that this is not due to a loss of fast moving molecules in
TIRF and thus represents an enriched fraction of slow-moving MRs
at or near the membrane. Short-term treatment with corticosterone
or membrane-impermeable corticosterone did not affect the dynam-
ics of the MR near the membrane. In conclusion, the combination of
TIRF and wide-field SMM provides a suggestion for the existence of






The MR is a member of the family of steroid receptors. This family encompasses
a group of structurally related receptors that exert their main action within the
nucleus where they bind DNA and act as transcription factors. As such they are
dubbed nuclear receptors. Without hormone bound, most MRs are located in the
cytoplasm while hormone binding induces nuclear translocation (Nishi et al., 2001;
Sarabdjitsingh et al., 2009). In addition to its well-known nuclear function, the MR
has more recently been found to mediate rapid actions of its hormones (corticoste-
roids and mineralocorticoids) (Grossmann et al., 2005; Karst et al., 2005, 2010; Mi-
hailidou and Funder, 2005; Olijslagers et al., 2008; Qiu et al., 2010). These effects do
not involve de novo transcription or protein synthesis and are therefore called non-
genomic effects. Non-genomic actions are not restricted to the MR but have been
found for most, if not all, steroid receptors (Hammes and Levin, 2007). Intriguingly,
non-genomic effects can be induced by membrane-impermeable conjugates of the
hormones and the receptors have thus been suggested to be present at the plasma
membrane (Hammes and Levin, 2007; Chapter 2). Immunohistochemical staining
with new antibodies (Gomez-Sanchez et al., 2011), cell fractionation studies (Qiu et
al., 2010) and electron microscopy (Prager et al., 2010) indeed found indications for
membrane localization of the MR. However, this membrane-associated fraction is
postulated to be very small and does not show up with conventional microscopy.
The size of this fraction, its submembrane localization and its regulation all remain
unknown.
TIRF microscopy is a well-established technique for imaging of fluorescently la-
beled membrane-associated molecules. In TIRF microscopy, the laser is redirected
so that it hits the glass-water interface between the coverglass and the specimen at
a large angle relative to the optical axis. As a result, the beam is totally internally re-
flected, which generates an electromagnetic field, termed the evanescent field that
penetrates into the specimen perpendicular to the interface. This evanescent field,
is capable of exciting fluorophores present in a thin plane of 60–100nm above the
coverglass (Axelrod et al., 1983; Axelrod, 2001; Martin-Fernandez et al., 2013). TIRF
microscopy thus provides images of cultured cells plated on a coverglass with a
very strong enrichment for membrane-associated molecules, although membrane-
associated fluorescent proteins are not exclusively excited. This technique is there-
fore widely used to study membrane-associated receptors, membrane-association
of vesicles and near-membrane cytoskeletal dynamics (Vale et al., 1996; Sako et al.,
2000; Lommerse et al., 2006; Toonen et al., 2006). In the current study, we have
combined TIRF with single-molecule microscopy (SMM). In SMM, a highly sensi-
tive CCD camera enables the imaging of single fluorophores. Time lapse imaging of
single fluorophores enables an analysis of protein dynamics with very high spatial
and temporal resolution (Schmidt et al., 1996; Lord et al., 2010; Persson et al., 2013).
SMM can be applied using both TIRF and wide-field microscopy.
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In the present study we have tested the feasibility of using TIRF microscopy to
acquire images that are enriched for the membrane-associated subpopulation of
(fluorescently-tagged) MR and thereby distinguish it from the cytoplasmic subpop-
ulation.Membrane-associatedmolecules generally showmuch slower kinetics than
free cytoplasmic molecules (Murase et al., 2004; Owen et al., 2009). Thus, if a suf-
ficiently big fraction of MR exists at the membrane this should display slower pro-
tein dynamics in TIRF versus wide-field single-molecule microscopy. Indeed, we ob-
served a larger slowly diffusing fraction of YFP-taggedMRmolecules in TIRF as com-
pared to wide-field recordings, suggesting the presence of a membrane-associated
population of MR molecules. Surprisingly, short-term treatment with either corti-
costerone or BSA-conjugated corticosterone did not affect the kinetics of YFP-MR
molecules as recorded using TIRF single-molecule microscopy.
4.2 Methods
Cell culture and DNA constructs
Generation of the expression plasmid pcDNA3.1-YFP-C10H-Ras has been described previ-
ously (Lommerse et al., 2004; Schaaf et al., 2009). YFP-MR contains the human MR gene
cloned in frame into the pEFYP-C1 vector (Invitrogen), which generates an N-terminally
tagged YFP-MR (described in detail in Chapter 6). In all experiments, either CHO (Chinese
Hamster Ovary) or COS-1 cells were used. CHO cells were grown in F12 medium (GIBCO),
supplemented with 10% FBS, 0.5% streptomycin and penicillin. COS-1 cells were grown in
high glucose D-MEM (GIBCO), supplemented with 10% FBS, 0.5% streptomycin and peni-
cillin. All cells were maintained at 37 °C and 5% CO₂. One day before transfection, the cells
were plated on glass coverslips (ø 13mm) in 6-well plates, at a density of 300 000 cells per
well. Glass cover slips were cleaned by sonication and 1% RBS50 treatment and bleached by
a UV-lamp tominimize (fluorescing) contaminations. The next day the cells were transfected
with TransIT-CHO kit or TransIT-COS-1 kit (both Mirus) according to the manufacturer’s in-
structions. YFP-C10H-Ras and YFP-MR were transfected at a concentration of 5 µg / 10 cm2.
Cells were incubated with the transfection mixture overnight, then washed once with PBS
and placed on growth medium. 24h before measuring, medium was replaced with serum-
free medium (F-12 or D-MEM).
TIRF microscopy
For TIRF recordings we used a homebuilt microscopy setup (previously described in Koop-
mans et al., 2007), equippedwith a 100× oil-immersion TIRF objective (NA 1.45, Nikon, Tokyo,
Japan). A 100 by 100 pixel region of interest was defined at a pixel size of 213nm. Excitation
was performed using a 514nm Arg⁺ laser (Coherent, Santa Clara, CA), illuminating an area
of ∼600mm2 with a power of 1.7 µW for 12ms. The beam was circularly polarized and dis-
placed parallel to the optical axis of the objective, so an evanescent wave was generated by
total internal reflection at the glass-water interface (Figure 4.1 ). The critical angle for TIRF
was checkedmanually (Snaar-Jagalska et al., 2013). Fluorescence light was filtered using a cus-



















Figure 4.1: Microscopy setup
(A) Schematic diagram showing the principles of TIRFmicroscopy. Inwide-field fluorescencemicroscopy
the excitation light beam is directed perpendicular to the coverglass and excites fluorophores in a thick
section (∼1 µm). In TIRF, the excitation beam is redirected to the periphery of the objective lens and
reaches the sample at a large angle relative to the optical axis. When this angle is critically large, the
laser light is totally internally reflected at the glass-water interface. As a result an evanescent wave field
is generated that excites fluorophores in a thin section of 60–100nm above the coverglass. (B) Single
fluorescence intensity peaks attributed to single YFP-C10H-Ras molecules are clearly discernable from
the background in TIRF mode. To obtain kinetics, data sequences of 2000 images with an interval of
50ms are obtained. (C-D) Confocal images of YFP-MR in both CHO (C) and COS-1 (D) cells. YFP-MR is
seenmostly in the cytoplasmwithout hormone and the putative membrane-associated subpopulation is
not distinguishable from the surrounding cytoplasm. After treatment with 100n corticosterone (16h),
YFP-MR translocates to the nucleus. Scale bars: 5 µm.
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images were recorded by a multiplication-gain CCD camera (Cascade 512B, Roper Scientific,
Trenton, NJ).
Wide-field microscopy
For wide-field recordings a customized wide-field setup (Axiovert 100TV, Zeiss) was used,
equipped with a 100× / 1.4NA oil-immersion objective (Zeiss). A region-of-interest (ROI) of
50 × 50 pixels (pixel size of 220nm) was selected. The sample was illuminated by a 514nm
argon laser at an intensity of 2 kW/cm2 (measured at the sample). The pulse length is con-
trolled by an acousto-optical tunable filter (AA optoelectronics, France). The YFP fluores-
cence signal was detected through a combination of filters (DCLP530, HQ570/80 (Chroma
Technology, Brattleboro, VT) and OG530-3 (Schott, Mainz, Germany)), by a liquid-nitrogen
cooled CCD camera (Princeton Instruments, Trenton, NJ). Camera read out andAOTF timing
were tightly controlled.
Single-molecule imaging
For both TIRF andwide-field imaging the general procedureswere identical. Transfected cells
were used 2 or 3 days post transfection. For a recording, a coverslip with cells was mounted
on a custom made sample-holder, the cells were washed with PBS and kept in 1ml PBS at
room temperature. Cells with moderate fluorescence intensity were selected. Cells were pho-
tobleached until single diffraction-limited spots could be distinguished. These fluorescence
intensity profiles of these spots were fitted by a 3D-gaussian peak, and the center of this peak
was defined as the location of the fluorescent molecule. We used a signal-to-noise ratio of
> 5 and a maximal peak width of ∼600nm as exclusion parameters.
Analysis of protein dynamics
For each cell, an image sequence of 2000 frames was recorded with a time lag of 50ms (Fig-
ure 4.1 ). We used the Particle Image Correlation Spectroscopy (PICS) method to determine
the molecular mobility pattern. In PICS, the correlation between peak positions at two dif-
ferent time points (for example t = 0ms and t = 50ms) is calculated. The cumulative








Where rai is the position of a molecule in image A and ma/mb is the number of molecules
in images A and B (see for further details Semrau and Schmidt, 2007). Ccum includes both
contributions from diffusingmolecules as well as distances due to random proximity to other
molecules. We can then rewrite the equation as:
Ccum(l, ∆t) = Pcum(l, ∆t) + cπl2 (4.2)
In which Pcum(l, ∆t) is the cumulative probability function of displacement steps over the
time lag, and c is the peak density. As proximity to unrelatedmolecules is independent of dis-
tance and solely dependent on peak density, we can fit this fraction with a straight line with
offset Pcum(max) and slope of cπ and subtract it from the raw data to obtain Pcum. Pcum then





the diffusion pattern of the molecules. Given that the population of molecules is homoge-
neous, a single population of displacing molecules is determined by:







Here MSD0 is the mean squared displacement of one population of molecules over the time
lag. However, this one fraction model did not fit the experimental data. Therefore a second
fraction was introduced and the resulting equation reads as follows:















Where MSD1 and MSD2 denote the mean squared displacement of the first (fast) and the
second (slow) fractions respectively, and α is the fraction size of the first (fast) fraction. PICS
analysis was repeated for each time lag and α, MSD1 and MSD2 were plotted as a function of
time (∆t). The data from each experimental day (on average 6.8 ± 0.7 cells/day) was pooled
and analyzed together. Data is always presented as mean ± SEM. Fitting of the MSD plots
was performed with SEMs as a weighting factor, and diffusion coefficients (Dfast and Dslow)
were calculated using the following equation:
MSD(∆t) = 4 · D · ∆t (4.5)
Hormone treatments
For the hormone treatments, corticosterone was prediluted to a concentration of 0.1m in
100%EtOHand further diluted in PBS to its final concentration of 1m .Corticosterone-BSA
(cort-BSA) was dissolved in 0.9%NaCl, 0.25%carboxymethyl cellulose and 0.2%Tween (sol-
vent A) to 12.5m (1mg/ml) and further diluted in PBS to its final concentration of 43.6n .
There are 23 molecules of corticosterone bound to a BSA molecule, therefore the concen-
tration of corticosterone molecules equals that of 1 µ free corticosterone. Each recorded
cell was measured first without hormone (baseline) in 900 l PBS. Hereafter, the appropriate
hormone (diluted in 100ml PBS at room temperature) was added. Five minutes after the hor-
mone was added, cells were measured again. As vehicle both 1% EtOH and 0.4% solvent A
were used, but as the kinetics of YFP-C10H-Ras or YFP-MR was not different between the
two types of vehicle solutions, they were combined for further analysis.
Statistics
In order to test for statistical significance between imaging methods we determined diffu-
sion patterns of YFP-MR for each day of recording separately and tested significance (n =
number of recording days). Significance was tested with repeated measures tests, with cell
type, microscopy setup or hormone treatment as between-subject factors. Statistical analy-
sis for the peak characteristics was performed with one-way ANOVAs, with post-hoc tests
according to Fisher’s LSD (least significant difference) method. Statistical significance was
accepted at p < 0.05.
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4.3 Results
Single-molecule imaging using TIRF microscopy
First, as a proof-of-principle the combination of single-molecule imaging and TIRF
microscopy was performed using a membrane-associated protein. For this purpose
we used YFP C-terminally tagged to the membrane anchor of H-Ras, YFP-C10H-Ras.
Themobility pattern of YFP-C10H-Ras has been described in previous studies (Lom-
merse et al., 2004; Schaaf et al., 2009). CHO cells were transiently transfected with
YFP-C10H-Ras and imaged on the TIRF setup 2 to 3 days after transfection. Very
low background fluorescence levels were found as well as single diffraction-limited
spots(Figure 4.1 ). The fluorescence intensity profiles of these spots were fitted by a
3D-gaussian peak, and peaks that could be attributed to single YFP molecules were
selected using criteria based on previous studies (Harms et al., 2001).
To verify the validity of our approach, we compared the average background
intensity, peak intensity, peak width and number of recorded peaks for cells trans-
fected with YFP-C10H-Ras or YFP-tagged MR to untransfected cells. As can be seen
in Figure 4.3 8–20 fold more peaks were identified in YFP transfected cells as com-
pared to untransfected cells. This indicates that the vast majority of selected peaks
can be attributed to individual YFP molecules. In addition, higher peak intensity
and peak width was obtained from peaks identified in cells transfected with either
of our YFP fusion proteins (Figure 4.3 – ). We also found a larger peak width for
YFP-MR transfected versus YFP-C10H-Ras transfected cells (Figure 4.3 ). This larger
peak width could be due to faster protein diffusion (displacement during the cam-
era opening time) or due to a larger distance of the peak to the focus point of the
objective. Both explanations could be valid, since YFP-MR generally shows faster dif-
fusion than YFP-C10H-Ras (Table 4.1) and its partial cytoplasmic localization will
also result in a larger distance to the focus point. Furthermore, more peaks per im-
age were found for YFP-C1-H-Ras compared to YFP-MR cells. This is due to a higher
percentage of molecules within the focal plane for the purely membrane localized
YFP-C10H-Ras.
Series of 2000 subsequent images of these cells were obtained with time lags
of 50ms to investigate the dynamics of YFP-C10H-Ras. The mobility pattern of
YFP-C10H-Ras was analyzed by PICS (Semrau and Schmidt, 2007). In this method,
for each identified peak, the distances to all peaks in the subsequent image are
recorded. This includes distances from two sources: random proximity of unre-
lated molecules and molecular displacements. The cumulative distribution of all
distances (Ccum) was determined for each time lag (light grey line, Figure 4.3 ). As
proximity to other molecules is not dependent on distance, its contribution to Ccum
will show a linear increase over distance (fine dotted line, Figure 4.3 ). The inter-
cept of the fit of this linear curve represents the size of the fraction due tomolecular




































































































Figure 4.2: Peak properties of the fluorophores
measured in TIRF
The characteristics of fluorescence intensity peaks selected
from background-subtracted single-molecule recordings of
untransfected cells (white), YFP-C10H-Ras (light grey) and
YFP-MR (dark grey). (A) Number of peaks per image. (B)
Mean peak intensity. (C)Mean peak width. Untransfected cells
showed fewer peaks per image than cells transfected with ei-
ther YFP construct. The identified peaks also showed lower
intensity and smaller width. In addition, YFP-C10H-Ras trans-
fected cells displayed smaller peak width and more peaks per
cell than cells transfected with YFP-MR. Our imaging condi-
tions thus result in primarily YFP peaks and include only a
small, negligible contribution of autofluorescence. Untrans-
fected n = 7, YFP-C10H-Ras n = 15 and YFP-MR n = 37.
∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001.
ular displacements (Pcum). For YFP-C10H-Ras, the size of the diffusing fraction is
27%, 21% and 18% over increasing time lags (50, 100 and 150ms respectively).
The resulting cumulative plot of molecular displacements (Pcum, dark grey line,
Figure 4.3 ) can be fitted with multiple population models. A one-population
model failed to fit the curves well, while a two-population model did give an accu-
rate fit (coarse dotted line, Figure 4.3 ). Introduction of a third population hardly
improved the fit and gave inconsistent results over different time lags (data not
shown). We found that the mobility of membrane-associated YFP could be best de-
scribed by two fractions each moving with a different speed: a large ‘fast’ fraction
of 83 ± 2% (Figure 4.3 ), and a small ‘slow’ fraction of 17 ± 2%. Subsequently, the
mean squared displacements (MSDs) determined for both the fast and the slow frac-
tion for each time lag were plotted as a function of the time lag (Figure 4.3 ). For
the fast fraction this resulted in a linear curve, indicating free diffusion of this frac-
tion of molecules. Based on the slope of this curve a diffusion coefficient (Dfast) of
0.23 ± 0.01mm2/s was determined. The slow fraction, on the other hand showed dis-
placements around our positional accuracy (0.0068 µm2; indicated by triangle in Fig-
ure 4.3 ). In previous studies, themobility of the slow fraction of YFP-C10H-Ras was
best described by confined diffusion, in which the molecules diffuse freely within
a domain with impermeable borders (Lommerse et al., 2004; Schaaf et al., 2009).
Different cell types showed large differences in the size of these restricted mem-
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Figure 4.3: Proof of principle of TIRF microscopy using YFP-C10H-Ras
(A) PICS analysis. Shown is the cumulative plot of distances (l2) for YFP-C10H-Ras with a time lag of
100ms. The raw data (light grey line) contains contributions from both random proximity and molecule
displacements. The contribution of distances due to random proximity can be fitted with a straight line
(fine dotted line) and subtraction of these from the raw data leaves only the distances due to molecular
displacement (dark grey line). The cumulative displacements are well fitted with a 2-population model
of two moving fractions (coarse dotted line). (B-C) Quantification of diffusion of YFP-C10H-Ras. For
YFP-C10H-Ras, 84% of all molecules belong to the fast, freely diffusing fraction (B: grey bar, C: left
panel). The remaining 16% shows negligible displacement steps (B: white bar, C: right panel, positional
accuracy indicated by the triangle) and are considered immobile. Data is shown as mean of recording
days. n = 3/17 (days/cells).
% slow Dslow(µm2/s) % fast Dfast (µm2/s)
YFP-C10H-Ras TIRF 16 ± 2 n.a. 84 ± 2 0.23 ± 0.01
YFP-MR (CHO) TIRF 51 ± 7 0.005 ± 0.001 49 ± 7 1.06 ± 0.48Wide-field 30 ± 2 0.031 ± 0.002 70 ± 2 1.45 ± 0.05
YFP-MR (COS-1) TIRF 35 ± 6 0.015 ± 0.003 65 ± 6 0.36 ± 0.07Wide-field 11 ± 11 0.039 ± 0.018 89 ± 11 0.85 ± 0.17
Table 4.1: Comparison of single-molecule kinetics of YFP-C10H-Ras, YFP-YFP and YFP-MR
between TIRFM and wide-field microscopy
% diffusing is the fraction of distances due to molecule displacements obtained from PICS analysis of
the shortest time lag (50ms).
brane domains. In the current study YFP-C10H-Ras does not show displacements
larger than the spatial resolution, which suggest that in CHO cells this fraction rep-






Fraction of molecular displacements
50ms 100ms 150ms
YFP-C10H-Ras TIRF 27% 21% 18%
YFP-MR (CHO) TIRF 18% 13% 12%Wide-field 12% 12% 13%
YFP-MR (COS-1) TIRF 14% 13% 12%Wide-field 13% 11% 9%
Table 4.2: Fraction of distances due to molecule displacement
Lower mobility of YFP-MR in TIRF than in wide-field microscopy
suggestive for the existence of a membrane-associated population of
YFP-MRs
Next, YFP-tagged human MR was examined. We chose to perform our experiments
in CHO cells, since Grossmann et al. (2005, 2008) showed non-genomic,membrane-
initiated signaling through the MR in these cells. In CHO cells, YFP-MR is seen
throughout the cytoplasm in the absence of hormone and translocates to the nu-
cleus upon stimulation with corticosterone (Figure 4.1 ). When analyzed with con-
ventional confocalmicroscopy, no obvious enrichment of YFP-MR at themembrane
can be discerned (Figure 4.1 , insert).
We next imaged single-molecules of YFP-MR in CHO cells in TIRF and
wide-field microscopy. In both TIRF and wide-field modus clear single YFP-MR
molecules were observed. The molecular dynamics were analyzed using PICS, and
the cumulative plot of observed peak distances was generated (Ccum; Figure 4.4 ).
We found that the fraction of measured distances as a result of molecular displace-
ments of YFP-MR is larger in TIRF than in wide-field (for 50ms: 18% in TIRF and
12% in wide-field; see also Table 4.2). Next, we fitted Pcum with a 2-population
method and determined fraction sizes and MSDs of both fractions. In wide-field,
a small fraction (30 ± 2%) of YFP-MR showed small displacement steps. Plotting
MSDs against the time lag resulted in a curve that could be fitted with a straight
line, indicating free diffusion of this slow fraction. The diffusion coefficient (Dslow)
was 0.031 ± 0.002 µm2/s. The remaining 70 ± 2%also showed free diffusion, but with
∼50 fold larger displacements and a diffusion coefficient Dfast of 1.45 ± 0.05 µm2/s
(Figure 4.4 , ). Interestingly, when imaged in TIRF, the size of the slow fraction was
larger: 51 ± 7% (Figure 4.4 ). At the same time, the displacements of both fractions
were smaller (Figure 4.4 ; Dslow = 0.005 ± 0.001 µm2/s; Dfast of 1.06 ± 0.48 µm2/s).
To examinewhether the observed difference inmobility patterns for YFP-MRbe-
tween wide-field and TIRF imaging was specific for the cell line used, we repeated
the same procedure in a second cell line, COS-1 cells. Also in COS-1 cells, conven-
tional confocal microscopy failed to show an obvious enrichment of YFP-MR at
the membrane (Figure 4.1 insert). Subsequently, YFP-MR expressing COS-1 cells
were imaged using TIRF and wide-field single-molecule microscopy. The size of the
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fraction of measured distances due to molecular displacements was highly similar
between TIRF (14%) and wide-field (13%), see also Table 4.2. We found a larger
slowly diffusing fraction in TIRF modus, highly comparable to what we observed in
CHO cells. Only 11 ± 11% of molecules showed slow diffusion in wide-field record-
ings, and in TIRF this fraction was increased to 35 ± 6% (Figure 4.4 ). In COS-1
cells, the measured diffusion coefficients of both the slow and the fast fraction
were slightly decreased in TIRF (Dfast of 0.36 ± 0.07 µm2/s versus 0.85 ± 0.17 µm2/s in
wide-field and Dslow of 0.015 ± 0.003 µm2/s versus 0.039 ± 0.018 µm2/s in wide-field;
Figure 4.4 ). In order to test for statistical significance we analyzed the diffusion
patterns of YFP-MR separately for each recording day and tested significance for
the full data set (CHO and COS-1 cells combined; n = recording days). We found a
significant difference between TIRF andwide-field recordings for the displacements
of the slow fraction (p = 0.04) and for the size of the slow fraction (p = 0.01). No
significant differences were seen between the two cell lines.
Corticosterone and BSA-bound corticosterone do not affect the
mobility pattern of YFP-MR
In order to determine whether hormone treatment affects the kinetics of the re-
ceptor, a set of experiments was designed in which the receptor was exposed to
its ligand. Ligand binding is known to alter the conformation of the receptor (at
least in the cytoplasm) and to induce protein-protein interactions of membrane-
associated steroid receptors (Levin, 2008). CHO cells were exposed to 1 µ corticos-
teronewhich is known to saturateMRbinding (Karst et al., 2005), or to a similar con-
centration of BSA-conjugated corticosterone (cort-BSA). Cort-BSA is membrane-
impermeable and any alteration in the kinetics of YFP-MR induced by this ligand
will be the result of changes in the mobility of a membrane-associated YFP-MR. We
assessed the mobility of YFP-MR by SMM before treatment and at 5 minutes after
hormone treatment. The imaging took approximately 2 minutes, so diffusion was
measured from 5–7 minutes post hormone treatment. We restricted ourselves to
this short term treatment as it is known that membrane-associated receptors can
become internalized by prolonged hormone treatment (Razandi et al., 2002; Wang
andWang, 2009; Karst et al., 2010). As a control, we tested the effects of the different
hormone treatments on the kinetics of YFP-C10H-Ras.
Figure 4.4 (preceding page): A smaller diffusing fraction of YFP-MR near themembrane in CHO
and COS-1 cells
The diffusion behavior of YFP-MR recorded in TIRF and wide-field modes in both CHO (A-C) and COS-1
(D-F) cells. (A & D) Cumulative distances plots. (B & E) Fraction distributions. For both cell lines, the
fraction of molecules that shows slow diffusion (white bars) is larger in TIRF than in wide-field. (C & F)
MSD plots for both fractions (left panels: fast fractions, right panels: slow fractions). For CHO cells, the
displacements of the slowly diffusing fraction are smaller in TIRF. Data is shown as mean of recording
days. CHO: TIRF, n = 5/45; wide-field, n = 4/43; COS-1: TIRF, n = 3/32; wide-field, n = 2/26
(days/cells).
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Figure 4.5: Corticosterone and cort-BSA do not affect diffusion behavior of YFP-C10H-Ras or
YFP-MR
The effect of short-term treatment (5–7min) with 100n corticosterone (cort) or BSA-conjugated corti-
costerone (cort-BSA) on fraction distribution was examined for both YFP-C10H-Ras (A-B) and YFP-MR
(C-D). (A-B) Neither cort, cort-BSA, or vehicle treatment affected the fraction distribution (A) or the
MSDs (B) of YFP-C10H-Ras, an inert membrane-associated molecule. (C-D) Hormone administration
did not affect the fraction distribution (C) or the MSDs (D) of YFP-MR either. Data is shown as mean of
recording days. YFP-C10H-Ras: baseline, n = 4/18; vehicle, n = 3/7; cort, n = 2/5; cort-BSA, n = 2/6.
YFP-MR: baseline, n = 6/64; vehicle, n = 5/18; cort, n = 4/21; cort-BSA, n = 4/25 (days/cells).
% slow Dslow (µm2/s) % fast Dfast (µm2/s)
YFP-C10H-Ras
Baseline 10 ± 1 n.a. 90 ± 1 0.28 ± 0.01
Vehicle 13 ± 0 n.a. 87 ± 0 0.27 ± 0.00
Cort 13 n.a. 87 0.23
Cort-BSA 13 ± 3 n.a. 87 ± 3 0.29 ± 0.01
YFP-MR
Baseline 39 ± 4 0.04 ± 0.00 61 ± 4 0.77 ± 0.03
Vehicle 40 ± 5 0.05 ± 0.01 60 ± 5 1.00 ± 0.07
Cort 36 ± 6 0.04 ± 0.01 64 ± 6 0.58 ± 0.07
Cort-BSA 43 ± 8 0.06 ± 0.00 57 ± 8 1.46 ± 0.14






Treatment with vehicle, corticosterone or cort-BSA did not change the displace-
ments nor the relative fraction sizes of YFP-C10H-Ras (Figure 4.5 – ; Table 4.3).
Next, we subjected the same treatments to YFP-MR-transfected CHO cells. How-
ever, no effects were seen with either treatment. Thus, the slowly diffusing fraction
of YFP-MR (measured using TIRF microscopy) remains around 40% with either
treatment (Figure 4.5 ). MSDs and diffusion coefficients were not affected by hor-
mone treatment either (Figure 4.5 ; Table 4.3).
4.4 Discussion
In the present study we have investigated YFP-tagged MR using single-molecule
microscopy in TIRF and wide-field mode. The results are summarized in Tables 4.1
till 4.3. TIRF is a well-established method that provides images that are strongly
enriched for near-membrane molecules (Axelrod, 2008). Thus, if a membrane-
associated subpopulation of YFP-MR was present in the investigated cell lines, it
would have been be strongly enriched for in TIRF. We analyzed the protein dynam-
ics of YFP-MR with SMM in wide-field and TIRF in two cell lines, and observed a
larger slow fraction of YFP-MR molecules in TIRF versus wide-field modes in both
cell lines (51% versus 30% and 35% versus 11%, see Table 4.1). In one cell line
(CHO), the slow fraction also showed slower diffusion in TIRF as compared to wide-
field microscopy.
In general, membrane-associated proteins are less mobile than cytoplasmic
proteins (Owen et al., 2009; Sanderson, 2012), mainly due to the higher viscosity
of the membrane. Diffusion of membrane-anchored proteins ranges from 0.01 to
1.0 µm2/s (Owen et al., 2009). The diffusion of the observed slow fraction of YFP-MR
(Dslow of 0.012 and 0.015 µm2/s in CHO and COS-1 cells respectively) fits within this
expected range for membrane-anchored proteins. Cytoplasmic MR, in contrast, is
expected to diffuse much faster. The diffusion of steroid receptors has never been
analyzed within the cytoplasm, but has extensively been measured in the nucleus.
We found that both the MR and GR diffuse with a diffusion coefficient of 2–3 µm2/s
(Chapters 5 and 6) within the nucleus, and similar diffusion would be expected for
the cytoplasmic fraction. Here, we obtained a fast diffusing fraction with Dfast of 1.4
and 0.9 µm2/s (in CHO and COS-1 cells respectively), which is slightly lower than
expected for freely diffusing cytoplasmicMR. TheMR is bound by a large chaperone
complex within the cytoplasm (Picard, 2006), which could underlie this slower dif-
fusion. Taken together, the slow fraction shows diffusion that fits to what is known
for membrane-associated proteins and the fast fraction diffuses slightly slower than
what is expected for cytoplasmic steroid receptors.
Of note, we did find a slowly diffusing fraction of 11–30% in wide-field record-
ings where we expect a negligible contribution of the membrane-associated popu-
lation. This suggests that also cytoplasmic MR encompasses a slowly diffusing frac-
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tion (potentially due to protein complex formation) and we thus do not presume
that the entire slow fraction will represent membrane-associated MR. The larger
size of the slowly diffusing fraction measured using TIRF microscopy fits very well
with the notion of a mixed cytoplasmic (both fast and slow diffusing populations)
and membrane-associated (purely slow diffusing) population of the MR in TIRF.
There is one large difference between TIRF and wide-field recordings that could
influence the obtained protein diffusion: the thickness of the optical slice (or
Z-depth). By default, the Z-depth of TIRF is very small and estimated to be around
60–100nm thick. In contrast, our wide-field recordings will have a Z-depth of 0.5–
1 µm (van Royen et al., 2014). As proteins diffuse in 3D, they will ‘escape’ from the
field of view during the time lag. This effect will be larger when a smaller Z-depth is
used (as in TIRF) andwill occurmost readily for fast diffusingmolecules (van Royen
et al., 2014). Thus, a smaller Z-depth will enrich for slowly moving molecules and
the larger size of the slow fraction observed using TIRF could therefore represent
an artifact of the imaging conditions. However, the results from our PICS analysis
show that in TIRF mode fewer molecules ‘escape’ than in wide-field mode. With
PICS analysis we could directly calculate the fraction of recorded distances that are
due to molecule displacements from the Ccum graphs (Figure 4.3 ). When this frac-
tion is large, many molecules are imaged in two consecutive images, so only few
molecules leave the z-plane during the interval between the images. We found that
a similar or even larger fraction of molecules can be imaged in two consecutive im-
ages in TIRF mode (Table 4.2). In CHO cells, for example, 18% of molecules can be
imaged in two consecutive images, while this drops to 12% in wide-field recordings.
Thus, even though the z-depth is a lot smaller in TIRF mode, more molecules are
imaged in two consecutive images, indicating that fewermolecules ‘escape’ from the
z-slice. We therefore conclude that there is a true enrichment for slowly diffusing
YFP-MRs near the membrane in TIRF mode, and that the increased size of the slow
fraction observed in TIRF recordings of YFP-MR is not an artifact of the imaging
conditions.
Conclusively, we find a larger fraction of slowly diffusing molecules for YFP-MR
in TIRF as compared to wide-field microscopy, and this difference cannot be ac-
counted for by technical artifacts. The most likely explanation for the increased
size of this fraction in TIRF would be the enrichment for membrane-associated pro-
teins in TIRF that show slower diffusion. Alternatively, the slower diffusion near the
membrane may not result from association with the membrane, but may be due to
steric hindrance or a higher concentration of signaling partners in the cytoplasmic
region near the membrane.
Manipulation of the membrane-associated fraction
In the current study we applied corticosterone or its membrane-impermeable con-
jugate cort-BSA to YFP-MR expressing cells. Unfortunately, we did not find any ef-





that themobility of a putativelymembrane-associatedMR population is not altered
upon ligand binding. It has been reported for many membrane receptors that lig-
and activation affects protein mobility within our time range. For example, treat-
ment with insulin led to rapid (within 5 minute) recruitment of H-Ras to smaller
microdomains (Lommerse et al., 2005). In another study, the chemotactic recep-
tor cAR1 was activated by its ligand cAMP. This resulted, within a minute, into a
larger diffusing fraction (Keijzer et al., 2008). On the other hand, ligand treatment
does not necessarily affect protein dynamics. The available literature suggests that
a membrane-associated MR will bind adaptor proteins upon activation, but is also
bound to other proteins (such as caveolin-1) before activation (Grossmann et al.,
2010; Pojoga et al., 2010b), which could result in no net change in diffusional char-
acteristics after activation.
Other options remain to specifically alter the dynamics of the membrane-
associated MR population. Disruption of lipid rafts, caveolae or actin compartmen-
talization are all known to affect the kinetics of membrane-associated proteins (La-
joie et al., 2007; Ganguly et al., 2008). Moreover, as the MR is presumably also
localized in caveolae (Pojoga et al., 2010b) and is known to associate with lipid
rafts (Grossmann et al., 2010), disruption of these structures would likely affect the
membrane-association of the MR as well. Future studies that specifically disrupt
the membrane-associated fraction of the MR would provide the final proof that
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R advances in live cell imaging have provided a wealth of data
on the dynamics of transcription factors. However, a consistent quan-
titative description of these dynamics, explaining how transcription
factors find their target sequences in the vast amount of DNA inside
the nucleus, is still lacking. In the present study, we have combined
two quantitative imaging methods, single-molecule microscopy and
fluorescence recovery after photobleaching, to determine the mo-
bility pattern of the GR, a ligand-activated transcription factor. For
dexamethasone-activated GR, both techniques showed that approxi-
mately half of the population is freely diffusing, while the remaining
population is bound to DNA. Of this DNA-bound population about
half the GRs appeared to be bound for short periods of time (∼0.7 s)
and the other half for longer time periods (∼2.3 s). Inactive recep-
tors (mutant or antagonist-bound receptors) show a decreased DNA
binding frequency and duration, but also a highermobility for the dif-
fusing population. Likely, very brief (∼1ms) interactions with DNA
induced by the agonists underlie this difference in diffusion behav-
ior. Surprisingly, different agonists also induce different mobilities of
both receptors, presumably due to differences in ligand-induced con-
formational changes and receptor complex formation. In summary,
our data provide a consistent quantitative model of the dynamics of
the GR, indicating three types of interactions with DNA, which fit
into a model in which frequent low-affinity DNA binding facilitates






In the past decade, imaging studies of fluorescently tagged proteins inside living
cells have enormously increased our understanding of transcription factor dynam-
ics (Stenoien et al., 2001; Schaaf and Cidlowski, 2003; Stavreva et al., 2004; Schaaf et
al., 2005, 2006; Hager et al., 2009; van Royen et al., 2009a, 2012; Mueller et al., 2010).
These studies have shown that transcription factors display a remarkably high mo-
bility in the nucleus. Even in its most activated state a typical transcription factor
appears to be able to diffuse through the entire nucleus, and to be immobilized
only transiently (Gorski et al., 2006; Biddie and Hager, 2009; Hager et al., 2009).
One often-studied transcription factor is the GR. This cytoplasmically localized re-
ceptor translocates to the nucleus upon binding of naturally occurring glucocorti-
coids (corticosterone and cortisol) or their synthetic analogs. In the nucleus the
steroid-GR complexes can bind either directly or indirectly (through interactions
with other transcription factors) to DNA and alter transcription rates of respon-
sive genes (Beato and Sanchez-Pacheco, 1996; Heitzer et al., 2007; Datson et al.,
2008). Like other transcription factors, ligand-activated GRs display a high mobil-
ity within the nucleus in FRAP studies (McNally et al., 2000; Schaaf and Cidlowski,
2003; Stavreva et al., 2004; Schaaf et al., 2005; Mueller et al., 2008). Using GR mu-
tants with reduced DNA-binding capacity or antagonist-bound GR, a negative cor-
relation was shown between GR mobility and the capacity to initiate transcription
(Schaaf and Cidlowski, 2003; Elbi et al., 2004; Stavreva et al., 2004).
In the last decade many new imaging techniques have become available that
open possibilities for more detailed quantifications of protein dynamics (Stasevich
et al., 2010b; Li and Xie, 2011; Mazza et al., 2012; Gebhardt et al., 2013). One such
approach is single-molecule microscopy (SMM). In SMM, conventional wide-field
fluorescence microscopy is combined with a fast, ultra-sensitive CCD camera to en-
able the visualization of single fluorescent molecules with high temporal (∼6ms)
and spatial (positional accuracy of ∼40nm) resolution (Lord et al., 2010; Li and Xie,
2011). Initially, SMM was used to study the mobility patterns of membrane proteins
(Lommerse et al., 2004; Suzuki et al., 2005; Schaaf et al., 2009; Kasai et al., 2011;
Serge et al., 2011), and it has now been adapted for studies of nuclear proteins (Yang
et al., 2004; Yang and Musser, 2006) and transcription factors (Elf et al., 2007; Li
and Elf, 2009; Mazza et al., 2012), including a recent study on the GR (Gebhardt et
al., 2013). Importantly, the analysis of single-molecule displacement patterns gives
a very direct and unbiased picture of protein dynamics (Schutz et al., 1997; Semrau
and Schmidt, 2007). For the more conventional population-based approaches, the
correct control for confounding factors such as laser irregularities and the require-
ment of many a priori assumptions and independent variables introduce bias in the
outcomes and have been a major challenge for the field (Mueller et al., 2008, 2010;
van Royen et al., 2009a,b). To control for any confounding factors that might still
exist in the SMM analysis, we combine SMM analysis with an established Monte
Carlo quantification approach of FRAP imaging (Farla et al., 2004; van Royen et al.,
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2009b). The combination with FRAP not only gives independent cross-validation
of the SMM predictions, but also enables a quantification of protein kinetics over a
longer time frame than SMM.
Our data show that this combination of techniques provides a very consistent
quantitative analysis of GR dynamics. Based on our data, we can distinguish three
states of agonist-activated GR molecules; one diffusing state and two DNA-bound
states, one with short (< 1 sec) and one with a longer (2–4 sec) binding duration.
Transcriptionally inactive GR variants show a reduction in the frequency and in the
duration of bothDNAbinding events, and an increase in the diffusion rate of the dif-
fusing population. This suggests that within this diffusing population an additional
very brief DNA-binding event is hidden, resulting in a lower effective diffusion rate.
5.2 Methods
Cell culture and plasmids
In most experiments, COS-1 cells were used, grown in high-glucose D-MEM (Invitrogen) sup-
plemented with 10% FBS and 1% penicillin/streptomycin (both GIBCO). 24h prior to trans-
fection, cells were plated on sterile coverglasses (25mm diameter). Cells were transfected
with the TransIT-COS kit (Mirus) according to themanufacturer’s instructions at a concentra-
tion of 500ng DNA / 10 cm2. Transfected cells were used in experiments 2–5 days after trans-
fection. For one experiment, Hep3B cells were used, stably transfected with the pEYFP-hGR
expression vector (Schaaf andCidlowski, 2003). These cells were grown in α-MEM (Cambrex),
supplemented with 5% FBS, 2m L-glutamine, 1% Penicillin/Streptomycin and 600 µg/ml
G418 (Invitrogen). The generation of the pEYFP-GR plasmid, the three deletion mutants of
this vector (pEYFP-GRΔ9–385, pEYFP-GRΔ428–490, and pEYFP-GRΔ551–777, and the point
mutant (pEYFP-GR F623A) have been described previously (Schaaf and Cidlowski, 2003;
Schaaf et al., 2005).
Compounds
The following ligands were used in these studies: dexamethasone, corticosterone, cor-
tisol, Δ-fludrocortisone (1,4-pregnadien-9α-fluoro-11β,17,21-triol-3,20-dione), predniso-
lone (1,4-pregnadien-11β,17,21-triol-3,20-dione) and RU486 (4,9-estradien-17α-propynyl,
11β-[4-dimethylaminophenyl]-17β-ol-3-one). All steroids were purchased from Sigma-Aldrich
and diluted in 100% EtOH to a concentration of 1m . All steroids were used at a final
concentration of 1 µ in the medium.
Single molecule microscopy
For all SMM experiments, COS-1 cells were grown on coverslips and transiently transfected
with the corresponding plasmid (500ng / 10 cm2) 3–5 days prior to analysis. Before SMM
recordings, cells were exposed to 1 µ of corresponding hormones for 3–6h. For SMM mea-
surements, this mediumwas replaced by serum- and phenol red-free D-MEMmedium (Invit-
rogen), which is also supplemented with 1 µ of the corresponding hormone. Subsequently,





fluorescence microscope (Axiovert 100TV, Zeiss) was used, equipped with a 100× / 1.4NA
oil-immersion objective (Zeiss). A region-of-interest (ROI) of 50 × 50 pixels (pixel size of
220nm) was selected. The sample was illuminated by an 514nm argon laser at an intensity
of 2 kW/cm2. The pulse length of 3ms was controlled by an acusto-optical tunable filter (AA
optoelectronics, France). The EYFP fluorescence signal was detected through a combination
of filters (DCLP530, HQ570/80 (Chroma Technology, Brattleboro, VT) and OG530-3 (Schott,
Mainz, Germany)), by a liquid-nitrogen cooled CCD camera (Princeton Instruments, Tren-
ton, NJ), camera read out and AOTF timing were tightly controlled. Healthy and moderately
fluorescent nuclei were selected and then photobleached until single fluorescence intensity
peaks could be distinguished. The position of each individual molecule was fitted with the
intensity profile of a 2D Gaussian model of EYFP peaks (Harms et al., 2001). Our peaks were
identified with a signal to noise ratio of ∼8 (peak fluorescence intensity divided by the vari-
ation of the background), which resulted in a positional accuracy of ∼40nm in the X- and
Y -direction (determined by the quotient of the full-width-at-half-maximum of the Gaussian
fit and the square root of the number of photons detected (Bobroff, 1986)). On average, each
picture contained ∼1.5 peaks. Image sequences were recorded in series of 8 subsequent im-
ages with a time lag of either 6.25ms or 12.5ms (Figure 5.1 ). Data on molecular dynamics
were obtained for multiple step sizes. We used all time lags from 6.25 to 37.5ms in our anal-
ysis. From each cell 180 series of 8 images were taken and data from 20 independent cells
(imaged on at least 3 different days) was combined for the analysis.
PICS analysis of single-molecule kinetics
We used the Particle Image Correlation Spectroscopy (PICS) method to determine peak dis-
placement over time (Semrau and Schmidt, 2007). In PICS, the cross-correlation between
peak positions at two different time lags (for example t = 0ms and t = 6.25ms) is calcu-
lated. This yields the cumulative probability distribution (Ccum) of all ‘diffusion steps’ de-
tected within 6.25ms. Ccum includes both contributions from diffusing molecules as well as
random correlations between unrelated molecules in the two frames. The latter follows a
linear relation in the cumulative plot and was subtracted prior to further analysis. From the
remaining cumulative probability function (Pcum) of diffusion steps l, we use populationmod-
eling to calculate diffusion characteristics of the nuclear population of YFP-GR (Figure 5.1 ).
Given that the population of molecules is homogeneous, a single population of displacing
molecules is determined with







Here MSD0 is the mean square displacement of one population of molecules over the time
lag. However, this one fraction model could not explain the experimental data (Figure 5.1 ).
Therefore a second fraction was introduced and the equation reads as follows:















Where MSD1 and MSD2 denote the mean square displacement of the first (fast) and the
second (slow) fractions respectively, and α is the fraction size of the first (fast) fraction. A two-
population model fitted the experimental data with high accuracy (Figure 5.1 ). Although



































































Figure 5.1: SMM and FRAP procedures
(A) Representative confocal images show complete nuclear translocation of YFP-GR after 3 hours of
1 µ dexamethasone treatment. (B) A representative CCD image of single molecules of YFP-GR after
background subtraction shows two discernible Gaussian peaks of YFP fluorescence. (C) Regime for single
molecule kinetics; images are taken with a time lag of 6.25ms or 12.5ms in 300 series of 8 per cell. In
background-subtracted images, single molecules of YFP fluorescence are easily discernible. (D). PICS
analysis of single molecule displacements, shown for dexamethasone-bound YFP-GR at time delay of
6.25ms. The cumulative probability distribution as a function of the squared distance l (black line)
is best fitted with a 2-population model (red line), while a 1-population model gives a suboptimal fit
(blue line) (n = 20 cells). (E) FRAP procedure of dexamethasone-bound YFP-GR. At t = 0 a 100ms
bleach pulse is applied to a strip spanning the nucleus. Subsequently, FRAP recovery curves of 30 cells
are recorded, combined and adjusted to baseline fluorescence (black line). Subsequently, Monte Carlo
simulations are generated using a 3-population model and fitted to the combined FRAP curve. The top
10 fits are combined (red line) and show a good fit of the experimental data with small residuals.
data due to molecules ‘escaping’ in 3D space, we restrict ourselves to only small time lags (up
to 42.5ms). In simulation experiments, we have demonstrated that within this time from the
effects of ‘escaping’ molecules can be neglected (data not shown). The analysis was repeated
for each time lag and α, MSD1 and MSD2 were plotted against time (∆t). The displacements
over time were best described using a free diffusion model in 2D, from which the diffusion
coefficients (Dfast and Dslow) were calculated using the following equation:
MSDi(∆t) = 4 · Di · ∆t (5.3)
OriginPro software was used to obtain weighted, linear fits, to calculate Dfast and Dslow. The





all groups. Due to this effect, we always report the fraction distribution of the smallest time
step (6.25ms) as a representative of the overall fraction distribution. All analyses were first
performed on all data from each treatment group pooled together (n = 20). Subsequently,
all analyses were run again in 3 fractions (n = 6/7) and these 3 separate analyses are used to
generate standard errors of the mean.
FRAP
For FRAP recordings, COS-1 cells were grown on coverslips and transiently transfected with
500ng / 10 cm2 of the corresponding plasmid and used 2–3 days after transfection. Before
FRAP recordings, cells were exposed to 1 µ of the appropriate ligand for 3–6hours in nor-
mal growth medium. For each experiment, a coverglass with transfected COS-1 cells was
placed in a preheated ring and medium was replaced for empty D-MEM without phenol red,
supplemented with 1 µ of the corresponding ligand. Cells were used for no longer than
90 minutes and kept at 37 °C and 5% CO₂. We used a Zeiss LSM510 META confocal laser
scanning microscope equipped with a 40× / 1.3NA oil-immersion objective, an argon laser
(30mW) and an AOTF. For FRAP analysis a narrow strip spanning the entire width of the
nucleus was scanned at 514nm excitation with short intervals (100ms) at low laser power
(0.2%). Fluorescence intensity was recorded using a 560nm longpass filter. After 40 scans, a
high intensity (100% laser power), 100ms-bleach pulse at 514nmwas applied over the whole
strip. Subsequently, the recovery of the fluorescence intensity in the strip was followed for
another 55 seconds at 100ms intervals. For each treatment group 30 cells were measured by
FRAP on two separate days. All curves were normalized to baseline fluorescence intensity
and combined.
Monte Carlo quantification of FRAP curves
The FRAP data was quantitatively analyzed by comparing the experimental data to curves
generated usingMonte Carlo modeling (van Royen et al., 2009b). TheMonte Carlo computer
simulations used to generate FRAP curves for the fit were based on amodel that simulates dif-
fusion of molecules in three dimensions and binding to immobile elements in an ellipsoidal
volume. In short, simulated FRAP curves were generated with a 3-population model, con-
taining a diffusing fraction and two bound (immobile) fractions. We take the Dfast obtained
from SMM analysis as a fixed parameter in these simulation, leaving 4 parameters as vari-
ables: short bound fraction, long bound fraction (both ranging from 0–90%), and time spent
in short and long bound state (ranging from 0.1 s to 1 s and from 1 s to 300 s respectively).
The laser bleach pulse was simulated based on experimentally derived three-dimensional
laser intensity profiles, which were used to determine the probability for each molecule to
get bleached considering their 3D position. The simulation of the FRAP curve was run using
discrete time steps corresponding to the experimental scan interval of 21ms. Diffusion was
simulated at each new time step t + ∆t by deriving the new positions (xt+∆t, yt+∆t, zt+∆t)
of all mobile molecules from their current positions (xt, yt, zt) by xt+∆t = xt + G(r1),
yt+∆t = yt + G(r2), and zt+∆t = zt + G(r3), where ri is a random number (0 ≤ ri ≤ 1)
chosen from a uniform distribution, and G(ri) is the inverse of a cumulative Gaussian func-
tion with µ = 0 and σ2 = 2D∆t, where D is the diffusion coefficient (obtained from SMM








where Fimm is the relative number of immobile molecules and Fmob = 1 − Fimm. The proba-
bility for each particle to become immobilized (representing chromatin-binding) is defined
as:




where Timm is the characteristic time spent in the immobile state. The probability to be re-
leased is given by:




As our model includes two bound fractions with different immobilization times, two immo-
bilization/mobilization probabilities were evaluated for each unit time step. In all simula-
tions, the size of the ellipsoid was based on the average size of measured nuclei, and the
FRAP region used in the measurements determined the size of the simulated bleach region.
The laser intensity profile using the simulation of the bleaching step was previously derived
from confocal image stacks of chemically fixed nuclei containing GFP that were exposed to
a stationary laser beam at various intensities and varying exposure times. The unit time step
(∆t) corresponded to the experimental sample rate of 21ms. The number of molecules in
the simulations was 106, which was empirically determined by producing curves that closely
approximate the data with comparable fluctuations. The parameters of the top 10 best fitting
Monte Carlo curves (by ordinary least squares) were averaged to represent the properties of
the fractions in the experimental data.
5.3 Results
We first investigated the nuclear dynamics of the GR by SMM. We used COS-1 cells,
transiently transfected with EYFP-tagged human GR (YFP-GR). This YFP-GR fu-
sion protein was previously shown to retain a good transcriptional activity (Schaaf
and Cidlowski, 2003). Before analysis, cells were exposed for 3 to 6 hours to a
saturating dose (1 µ ) of the high affinity GR agonist dexamethasone, which in-
duces nuclear translocation of YFP-GR (Figure 5.1 ). Nuclei were photobleached
until single diffraction-limited fluorescence intensity peaks could be distinguished
(Figure 5.1 ). These peaks are attributed to single YFP-GR molecules as they had
comparable width and intensity as fluorescence intensity peaks derived from single
EYFP molecules previously observed using the same setup (Harms et al., 2001). In
our current approach, EYFP molecules were identified with a positional accuracy
of ∼40nm in one dimension (x or y). Next, GR mobility was analyzed by assess-
ing molecule displacements over image sequences with short time lags (6.25ms
and 12.5ms; Figure 5.1 ), using the PICS analysis method (Semrau and Schmidt,
2007). We use PICS analysis instead of single particle tracking, as PICS is less af-
fected by blinking of YFP or overlapping trajectories of multiple molecules (Schutz
et al., 1997; Semrau and Schmidt, 2007). PICS analysis calculates the cumulative
probability distribution for each displacement, which is subsequently fitted with





model with only fractions of moving molecules instead of a model encompassing a
bound (immobile) fraction, because this is the more general model without a pri-
ori assumptions. DNA-bound and thus immobile molecules should show negligible
displacement steps in this model. For YFP-GR, a one-population model was unable
to describe the experimental data (Figure 5.1 ), while a three-populationmodel did
not give consistent results over different time lags or resulted in two fractions with
similar displacements. A two-population model fitted the observed displacements
consistently, and with high accuracy, and was chosen for all analyses. Thus, we ob-
tained the relative size and mean squared displacement (MSD) of two fractions of
YFP-GR molecules that differed in their relative displacements over time.
We plotted the MSDs of the two identified fractions versus the time lag and cal-
culated the diffusion coefficients (Dfast and Dslow; Figure 5.3 ). The displacements
of the “slow” fraction never exceeded our detection limit (0.009 µm2) by more than
2-fold and only increased marginally over time: Dslow of 0.03 ± 0.01 µm2/s. This is
very similar to the slow restricted movement of chromatin (Blainey et al., 2006; Elf
et al., 2007), indicating that this “slow” fraction describes DNA-bound molecules.
In contrast, the remaining fraction showed > 40-fold higher displacements and a
Dfast of 1.31 ± 0.13 µm2/s, representing YFP-GR molecules diffusing through the nu-
cleus. The nuclear GR population is approximately evenly distributed over the two
fractions; 55.1 ± 2.0% belongs to the diffusing fraction, which leaves 44.9 ± 2.0% as
bound fraction (Figure 5.3 ).
FRAP analysis of dexamethasone-bound YFP-GR
Subsequently, we employed a quantitative FRAP approach on similarly treated
YFP-GR expressing COS-1 cells. In selected nuclei a small strip, spanning the width
of the nucleus, was bleached with a 100ms pulse of maximal laser power. This ef-
fectively bleached most fluorescence within this area. The subsequent recovery of
the fluorescence in this strip was recorded (with 100ms intervals) for 55 seconds
(Figure 5.1 ). Comparable to previous results (Schaaf and Cidlowski, 2003; Schaaf
et al., 2005), a complete recovery of YFP-GR fluorescence was seen well within 30
seconds (Figure 5.1 ). The obtained recovery curves were quantitatively analyzed by
fitting them to FRAP curves generated using Monte Carlo simulations (van Royen
et al., 2009a,b). Our data was best fitted with a model in which freely diffusing
molecules (diffusion rates as obtained by SMM were used) show transient bind-
ing with two different durations (‘short’ and ‘long’; Figure 5.1 ). Quantitative FRAP
analysis of dexamethasone-treated GR identified a diffusing fraction of 44 ± 2%, a
‘short’ bound fraction of 33 ± 2% (average binding of 0.7 ± 0.1 s) and a ‘long’ bound
fraction of 23 ± 2% (average binding of 2.3 ± 0.3 s) (Figure 5.3 , ). As both bound
fractions in FRAP remain bound for much longer time periods than the time range
used in SMM (less than 50ms), these two fractions could be distinguished using
FRAP, but not by SMM. Indeed, the size of the single bound fraction in SMM, is





























































Dfast = 1.31 ± 0.13 µm
2/s 
Dslow = 0.03 ± 0.01 µm
2/s 
Time lag (ms) 
Figure 5.2: SMM and FRAP
analyses provide a consistent
model of the intranuclear
mobility of the GR
(A) A two-population fit of SMM
analysis for dexamethasone-bound
YFP-GR identifies two fractions of
approximately equal size. (B) Both
fractions show a linear increase in
mean squared displacement (MSD)
over time, but with a 40-fold dif-
ference in MSD. Diffusion coeffi-
cients (Dfast and Dslow) are calcu-
lated from a linear fit of the exper-
imental data (dashed lines; D =
slope/4). The Dfast of 1.31 µm2/s
fits to diffusing molecules, while
the Dslow of only 0.03 µm2/s best
fits to the slow movement of chro-
matin and the molecules bound to
it. (C) Monte Carlo simulation of
dexamethasone-bound YFP-GR with a 3-population model identifies 3 fractions of dexamethasone-
bound YFP-GR; almost half of the nuclear population is diffusing, while the remainder is subdivided
into two bound fractions that differ in their immobilization times. The fraction size of the diffusing
fraction is similar in size as that obtained from SMM analysis. (D) Both bound fractions are only
transiently immobilized, with a 3-fold difference in duration. (A and B) Data represented as best fit ±
SEM (of 3 separate PICS analyses). (C and D) Data represented as average of top 10% best fits ± SEM.
pare Figure 5.3 and 5.3 ). Therefore, the mobility patterns assessed by SMM at the
millisecond range are confirmedwith realistic accuracy using an independent FRAP
approach.
YFP-GRmobility is dependent on ligand structure
Next we used our combined SMM and FRAP approach to investigate how binding
of different ligands affects GR-DNA binding dynamics. We have previously shown
by FRAP that the structure of the ligand is an important determinant of GR affin-
ity, with important roles for the 17-hydroxyl and 9-fluoro groups on the steroids,
which induce a decrease in GR mobility (Schaaf and Cidlowski, 2003; Schaaf et al.,
2005). In the present study, this was studied in more detail in order to investigate
which of the mobility parameters were affected. Therefore, we tested a panel of
GR agonists that enabled us to study the effects of the 17-hydroxyl, 9-fluoro, and
16-methyl groups and the 1,4-pregnadien structure of the A ring. We used dexa-
methasone (which contains all four structural elements), Δ-fludrocortisone (same
structure as dexamethasone, but lacking the 16-methyl group), prednisolone (same
structure as Δ-fludrocortisone, but lacking the 9-fluoro group), cortisol (same struc-





and corticosterone (same structure as cortisol, but lacking the 17-hydroxyl group).
In addition to this panel of agonists, the GR antagonist RU486 was used. Impor-
tantly, all hormones were administered at a saturating concentration (1 µ ), thus
the fraction of bound receptor should be similar for all ligands (Rupprecht et al.,
1993; Hellal-Levy et al., 1999; Grossmann et al., 2004; Schaaf et al., 2005).
Again, the two independent experimental approaches gave a consistent pattern
of fraction sizes for all 6 ligands tested. On average the size of the diffusing fractions
identifiedwith SMMandFRAPdiffered by only 7.8 ± 2.6%(Table 5.1). The data show
that the 16-methyl group does not affect GR mobility, but the other structural el-
ements decrease the mobility of the receptor, indicating increased DNA binding
(Figure 5.3 – ). Interestingly, this decreased mobility was reflected in all parame-
ters measured. Both the size of the bound fractions and their respective binding
time were affected, so both on- and off-rates of DNA binding were altered. In ad-
dition, the diffusion coefficient of the diffusing fraction was decreased suggesting
that DNA binding results in slower diffusion of the receptor (Figure 5.3 and Ta-
ble 5.1). Binding of the antagonist RU486 induces a very mobile nuclear YFP-GR
(Figure 5.3 – ).
It is known that the 9-fluoro group (present on Δ-fludrocortisone and dexameth-
asone) creates a strong hydrogen bond with phenylalanine at position 623 of GR’s
ligand binding pocket (Bledsoe et al., 2002), suggesting that this amino acid is cru-
cial in conferring the effects of the 9-fluoro-group. To test this association in our
setup, phenylalanine 623 was mutated to an alanine (F623A). We tested the mobil-
ity of F623A with SMM in presence of prednisolone and Δ-fludrocortisone, which
are identical except that Δ-fludrocortisone contains a 9-fluoro group and predniso-
lone does not. In presence of either steroid the F623A mutant translocates fully to
the nuclear compartment (Figure 5.3 ). Within the nucleus, no difference in F623A
mobility was observed between ∆-fludrocortisone and prednisolone (Figure 5.3 ).
Therefore we conclude that the effect of the 9-fluoro group on mobility is indeed
mediated by phenylalanine 623.
Specific receptor domains determine YFP-GR mobility
In order to elucidate the role of the different domains of GR on DNA-binding dy-
namics, we tested three different GR deletion mutants, each lacking one of its three
functional domains. Thus, we obtained YFP-GR ∆AF-1 (lacking the N-terminal do-
main containing the AF-1 (amino acids 9–385)), YFP-GR ∆DBD (lacking the DNA-
binding domain (amino acids 428–490)) and YFP-GR ∆LBD (lacking the ligand-
binding domain (amino acids 551–777)), see Figure 5.4 . We investigated the mobil-
ity of the three deletion mutants of YFP-GR by SMM and FRAP in the presence of
dexamethasone or corticosterone. All results are shown in Figure 5.4 and Table 5.1.
Deletion of the AF-1 showed the smallest effect on receptor mobility. Dexametha-
sone binding to the ∆AF-1 mutant induces a large DNA-bound fraction and long








































































































Figure 5.3: Ligand structure determines the nuclear mobility of the GR
A range of natural and synthetic agonists (black bars) and an antagonists (red bar) were tested for their ef-
fect on the intranuclearmobility of theGRby both SMM(A) and FRAP (B, C) analysis.Multiple structural
elements of the steroids are associated with a reduced mobility of the receptor, with the strongest effects
observed for the 9-fluoro (9-F) and the 17-hydroxyl (17-OH) groups. Alteredmobility is generally reflected
in all aspects of mobility: a larger bound fraction (SMM; white bars and FRAP; white and light grey bars
combined), a lower diffusion coefficient (in µm2/s, written in its corresponding bar in A) and longer
immobilization times (C). (D and E) A mutation of phenylalanine 623 to alanine (F623A) prevents inter-
actions of the 9-fluoro group of steroids within the ligand binding pocket of the GR. (D) F623A YFP-GR
still translocates completely to the nucleus after 3 hours of 1 µ prednisolone or ∆-fludrocortisone treat-
ment (E). SMM analyses of nuclear F623A YFP-GR shows that the mobility of F623A YFP-GR is highly
similar after either Δ-fludrocortisone or prednisolone treatment (black bars for the diffusing fraction,
with their corresponding diffusion coefficient (in µm2/s) written within their corresponding bar). SMM:
n = 20, FRAP: n = 30. Data represented as total fit ± SEM (of 3 separate PICS analyses) for SMM and as
average of top 10% fits ± SEM for FRAP. Δ-flu; Δ-fludrocortisone, dex; dexamethasone, predn; prednis-
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Figure 5.4: Loss of either the DNA-binding or the ligand-binding domain results in a high GR
mobility
(A) Schematic representation of three functional YFP-GR deletion mutants tested. (B and C) Fraction
distributions as analyzed by SMM (B) and FRAP (C). Diffusion coefficients are written within the corre-
sponding bars in B (in µm2/s). (D) Immobilization times of the short and long bound fractions. While
loss of the AF-1 domain hardly affects GR’s nuclear mobility, deletion of the DBD and especially the
LBD leads to a very mobile receptor with reduced frequency and average duration of DNA-binding and
a higher diffusion coefficient. SMM: n = 20, FRAP: n = 30. Data represented as total fit ± SEM (of 3
separate PICS analyses) for B and as average of top 10% fits ± SEM for C and D. The data for wild type
GR is the same as in Figure 5.3.
results in a much faster receptor with less stable DNA-binding (Figure 5.4). Thus,
without its N-terminal domain, the GR’s intranuclear mobility is still differently af-
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Figure 5.5: A similar pattern of YFP-GR’s nuclear mobil-
ity in stably transfected Hep3B cells
SMM analysis of YFP-GR’s nuclear mobility after treatment
(3–6h with 1 µ ) with either dexamethasone or corticoster-
one was performed in Hep3B cells stably transfected with
YFP-GR. These experiments were performed to check for ef-
fects of differences in cellular context and a lower level of
YFP-GR expression on the mobility patterns. Both the size
of the diffusing fraction (filled bars) and the diffusion coef-
ficients (written in their corresponding bars in µm/s2) were
highly similar between COS-1 and Hep3B cells. COS-1 data is
the same as in Figure 5.3. All groups: n = 20. Data is repre-
sented as total fit ± SEM (of 3 separate PICS analyses).
As expected, deletion of the DBD did affect the receptor’s mobility (Figure 5.4).
For corticosterone-bound GR, deletion of the DBD slightly increased the size of the
diffusing fraction and completely prevents the longer binding events, resulting in
two bound fractions with almost equal immobilization times: 0.5 ± 0.1 s (18 ± 3.9%)
and 0.6 ± 0.3 s (3 ± 1.5%, Figure 5.4 ). For dexamethasone-bound ΔDBD not all
stable DNA-binding is lost; here 25 ± 2.7% remains bound for 0.5 ± 0.1 s and even
9 ± 2.3% remains bound for 1.4 ± 0.3 s. Dexamethasone-bound YFP-GR ΔDBD does
show a large increase of the size of the diffusing fraction (from 44–55% (wild type)
to 76–66% (∆DBD)), and a ∼2-fold higher diffusion coefficient (Figure 5.4). Thus,
deletion of the DBD induces less frequent and shorter DNA-binding for both dex-
amethasone and corticosterone bound GR, but a fraction of longer bound YFP-GR
ΔDBD remains when bound to dexamethasone. Deletion of the DBD abolishes all
direct binding of the GR to the DNA but leaves some of its indirect binding to DNA
intact, which has been shown to occur through (direct or indirect) interactions with
other transcription factors (Reichardt et al., 1998; Kassel andHerrlich, 2007). There-
fore, the DNA-bound fraction of ΔDBD probably reflects indirect DNA-binding.
Deletion of the LBD prevents the ligand-induced conformational change that is
required for any type of stable interaction with DNA. As expected, YFP-GR ∆LBD
was the most mobile receptor variant, it had the smallest DNA-bound fraction
(13.5% to 18% in SMM and FRAP respectively) with a single (short) binding state
of 0.4 ± 0.1 s and a high diffusion coefficient (2.71 ± 0.08 µm2/s; Figure 5.4). Most
importantly, this DNA-binding deficient mutant indeed did not show any stably-
bound fraction.
YFP-GRmobility is stable across cell lines and expression levels
In order to test whether overexpression or transient transfection had produced
artifacts in our experiments, we stably transfected Hep3B cells with the same
YFP-GR expression vector. The resulting cell line showed a much lower expression
level of YFP-GR than that observed in the transiently transfected COS-1 cells. The
DNA-binding dynamics were studied of corticosterone- and dexamethasone-bound







D (µm2/s) Fraction Imm.size (%) size (%) time (s)
GR wt
Δ-Flu
Diffusing 46.3 ± 2.6 1.38 ± 0.11 43.0 ± 2.6 -
Short 53.7 ± 2.6 0.050 ± 0.004 33.0 ± 2.1 0.8 ± 0.1Long 24.0 ± 2.2 2.9 ± 0.5
Dexamethasone
Diffusing 55.1 ± 2.0 1.31 ± 0.13 44.0 ± 2.2 -
Short 44.9 ± 2.0 0.030 ± 0.009 33.0 ± 2.6 0.7 ± 0.1Long 23.0 ± 2.6 2.3 ± 0.3
Prednisolone
Diffusing 60.7 ± 3.1 2.20 ± 0.11 42.0 ± 2.5 -
Short 39.3 ± 3.1 0.090 ± 0.008 36.0 ± 1.6 0.7 ± 0.1Long 22.0 ± 2.5 4.0 ± 0.8
Cortisol
Diffusing 55.6 ± 3.5 1.77 ± 0.10 58.0 ± 2.0 -
Short 44.4 ± 3.5 0.040 ± 0.003 19.0 ± 3.8 0.5 ± 0.1Long 23.0 ± 2.6 2.0 ± 0.0
Corticosterone
Diffusing 74.1 ± 3.3 2.49 ± 0.24 66.0 ± 2.2 -
Short 25.9 ± 3.3 0.080 ± 0.024 26.0 ± 3.7 0.6 ± 0.1Long 8.0 ± 2.5 1.2 ± 0.3
RU486
Diffusing 69.1 ± 2.4 2.86 ± 0.11 66.0 ± 1.6 -




Diffusing 46.5 ± 1.9 0.61 ± 0.08 57.0 ± 3.0 -
Short 53.5 ± 1.9 0.000 ± 0.006 18.0 ± 3.6 0.6 ± 0.1Long 25.0 ± 3.4 2.1 ± 0.4
Corticosterone
Diffusing 64.7 ± 2.8 2.69 ± 0.08 62.0 ± 2.5 -




Diffusing 75.6 ± 3.4 2.27 ± 0.15 66.0 ± 1.6 -
Short 24.4 ± 3.4 0.010 ± 0.006 25.0 ± 2.7 0.5 ± 0.1Long 9.0 ± 2.3 1.4 ± 0.3
Corticosterone
Diffusing 81.3 ± 1.0 2.37 ± 0.19 79.0 ± 3.1 -
Short 18.7 ± 1.0 0.060 ± 0.004 18.0 ± 3.9 0.5 ± 0.1Long 3.0 ± 1.5 0.6 ± 0.3
GR
∆LBD Dexamethasone
Diffusing 86.5 ± 1.9 2.71 ± 0.08 82.0 ± 3.3 -
Short 13.5 ± 1.9 0.030 ± 0.010 16.0 ± 3.1 0.4 ± 0.1Long 2.0 ± 1.3 0.4 ± 0.3
Table 5.1: SMM and FRAP analyses of all YFP-GR and deletion mutants
Short, ‘short’ bound fraction; long, ‘long’ bound fraction; imm. time, average immobilization time; Δ-Flu,
Δ-Fludrocortisone; Results are represented as best fit ± SEM (of three separate fits) for SMM and as
average ± SEM of top 10% fits for FRAP.
of 52.9 ± 1.6% and a diffusion coefficient of 1.16 ± 0.08 µm2/s in Hep3B cells (Fig-
ure 5.5). As expected, corticosterone treatment induced a more mobile YFP-GR,
with a diffusing fraction of 71.6 ± 3.4% and a Dfast of 1.70 ± 0.16 µm2/s (Figure 5.5).
These results were very similar to those obtained in COS-1 cells, indicating that our
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results are not cell-type specific or affected by expression levels obtained by tran-
sient transfection.
5.4 Discussion
Here we report on a combination of SMM and quantitative FRAP analysis to charac-
terize the intranuclear dynamics of the GR. In our SMM experiments, we find that
single molecules of nuclear YFP-GR can be detected with high spatial and tempo-
ral resolution and that by subsequent data analysis two fractions of GR molecules
are detected; a diffusing and a (DNA-)bound fraction. For all 11 treatment groups
studied, this two-population model consistently fitted the experimental data with
high accuracy. For dexamethasone-bound GR, 55%of nuclear GRmolecules are dif-
fusing with a diffusion coefficient of 1.31 ± 0.13 µm2/s. The remaining 45% show a
> 40-fold lower diffusion coefficient, which fits the low, restricted mobility of DNA-
bound molecules (Blainey et al., 2006; Elf et al., 2007; Li and Xie, 2011). To enable
cross-validation with an established technique, we combined our SMM analysis
with a second technique, FRAP. We analyzed the FRAP curves using established
Monte Carlo simulations (Farla et al., 2004; van Royen et al., 2009b). To best de-
scribe the FRAP recovery curves we required two bound fractions (for most recep-
tors), which differed 2–4 fold in their binding duration. The binding times of both
bound fractions are orders of magnitude longer than the time scale used in our
SMM experiments and these fractions combined represent the single bound frac-
tion detected in SMM, providing two independent estimates of the size of this (com-
bined) fraction. Within our 11 experimental conditions, the sizes of the combined
bound fractions determined by SMM and FRAP showed an average difference of
only 6.9 ± 1.6%. This high level of consistency between the two independent tech-
niques shows that a combination of techniques generates a reliable quantitative
description of protein dynamics.
Combinations of FRAP and FCS have been reported earlier (Stasevich et al.,
2010b;Mazza et al., 2012). Here, FSC and FRAP generally gave comparable estimates,
although large discrepancies were found for binding times, due to laser irregulari-
ties. Recently, Mazza and colleagues reported on a similar combinational approach
with FRAP and single-molecule microscopy, in their case also combined with FCS
(Mazza et al., 2012). In this study the mobility of p53, a well-known transcription
factor was assessed and single-molecule tracking was used to guide the choices in
models used for FRAP and FCS quantitation. Wild type p53 showed a much smaller
DNA-bound fraction (∼20%) than agonist-activated GR does in our study, but in
both studies mutations in the DNA-binding domains give a large reduction in size
and residence time of the DNA-bound fractions (Mazza et al., 2012). In a recent
study, Gebhardt et al. applied SMMon the GR as well, using reflected light sheet mi-





GR and the ΔDBD mutant were analyzed. Their data are well in line with ours, es-
pecially the obtained values for the sizes of the diffusing and bound fractions and
of binding times (Gebhardt et al., 2013). Discrepancies exist in the analysis of the
diffusing fraction. Gebhardt et al. found two diffusing fractions, whereas we only
detect one. As shown by Mazza et al., it is likely that any diffusion coefficient is
a simple representation of the more complex nature of the continual scale of true
transcription factor diffusion (Mazza et al., 2012).
Ligand structure affects the DNA-binding profile of nuclear GR
We observed profound differences in the nuclear dynamics of the GR depending
on the ligand it was bound to (Figure 5.3), even among agonists. For example, the
synthetic GR agonists dexamethasone and Δ-fludrocortisone induce a larger DNA-
bound fraction with longer residence times than the naturally occurring agonists
cortisol and corticosterone. Structure-function studies showed that the 17-hydroxyl,
and 9-fluoro groups and the 1,4-pregnadien structure of the A ring of these steroids
were involved in the increased DNA binding of GR. We further showed that the ef-
fect of the 9-fluoro group depends on the presence of phenylalanine at position 623
of the GR LBD, the amino acid it is known to interact with (Bledsoe et al., 2002).
This phenylalanine residue, like the glutamine residue at position 642, which inter-
acts with 17-hydroxyl group, is located in a region of the LBD that has been shown to
be involved in receptor dimerization (Bledsoe et al., 2002). It may therefore be sug-
gested that these specific interactions shape the receptor into a conformation that
favors receptor dimerization, and that these dimers have higher DNA binding affin-
ity. We have previously suggested a similar model for AR dimerization and DNA
binding (van Royen et al., 2012).
Many of these structural elements also affect the affinity of the ligand and it
could therefore be argued that the affinity of the ligand determines the receptormo-
bility. However, affinity and mobility are not always correlated. In a previous study
we have shown that the 16-hydroxy group of triamcinolone dramatically decreases
the binding affinity for GR, but leaves GRmobility unaffected (Schaaf andCidlowski,
2003; Schaaf et al., 2005). Furthermore, mechanistically it is unlikely that ligand
affinity is a determinant of receptor mobility since all ligands are administered at
above saturating concentrations (Schaaf and Cidlowski, 2003). Finally, ligand disso-
ciation rates are in the order of minutes (corticosterone) to hours (dexamethasone)
(Munck and Foley, 1976; Meijsing et al., 2007), whereas the immobilizations of the
receptor observed in this study are in the order of seconds.
Amodel of GR-DNA interactions
Interestingly, our data shows a strong correlation between different components of
the mobility pattern. Immobilization times correlate to the size of the bound frac-
tions, but more surprisingly, we also found that a low frequency and duration of
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binding events correlated with a higher diffusion coefficient throughout our differ-
ent experiments. Thus, where antagonist-bound or low-affinity agonist bound GR,
and the ΔDBD and ∆LBDmutants were all associated with a low frequency of DNA-
binding, these same receptors all showed a high diffusion coefficient (1.5 to 2-fold
higher than that of highest-potency agonist bound GR, see Table 5.1). This suggests
that all components of the mobility pattern are associated with each other and pre-
sumably are representations of a same biological phenomenon, i.e. DNA-binding.
A plausible explanation could be that changes in the diffusion coefficient are due to
DNA-binding events shorter than the temporal resolution of our SMM experiments
(∼6ms), which result in a decreased effective diffusion coefficient as long as the sys-
tem is in equilibrium. Alternatively, reduced diffusion coefficients can be caused by
an increased size of the diffusing protein complex (e.g. through increased co-factor
binding affinity).
Thus, for agonist-bound GR we identified three possible DNA-binding events:
frequently in a very transient manner (< 6ms), intermitted with transient binding
(∼0.5 s) and occasionally more stable interactions (> 1 s). This fits well with the
idea that steroid receptors and other transcription factors search the DNA by dif-
ferent forms of low affinity DNA interactions and are only occasionally bound for
longer time periods at their high-affinity target sites. Indeed, steroid receptors do
not show competition for high-affinity binding sites, and in fact seem to do the op-
posite (assisted loading), suggesting that high-affinity DNA-binding cannot make
up a large population (Voss et al., 2011). Multiple in vitro studies and theoretical
modeling approaches have suggested that frequent low-affinity interactions with
DNA increase the efficiency of transcription factor target finding, because it keeps
the transcription factor in close proximity of open DNA (Gowers et al., 2005; Elf
et al., 2007; van den Broek et al., 2008). We suggest that the more transient inter-
actions identified in our quantitative analysis represent non-specific DNA binding
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S receptors are remarkably dynamic within the nucleus
where they exert a combination of free diffusion and frequent tran-
sient DNA binding events. The frequency and duration of DNA bind-
ing is positively correlated to transcriptional potency. Previously we
showed that specific interactions between agonist side groups and
amino acids within the ligand-binding pocket determine the DNA-
binding dynamics of the GR and AR. Here, we study the closely re-
lated MR by a combination of single-molecule microscopy and FRAP.
This is the first detailed study of the DNA-binding dynamics of the
MR. We determined that, when bound to a potent natural agonist,
the receptor is bound to chromatin for roughly 50% of the time in
either short (∼0.6 sec, ∼30%) or prolonged (2–3 sec, ∼20%) bind-
ing events. This mobility pattern is shifted towards less frequent and
shorter DNA-binding events for antagonist-boundMR and, to a lesser
extent, when bound to the weak synthetic agonist dexamethasone.
We also compared the chromatin binding dynamics of the MR when
bound to natural glucocorticoids or mineralocorticoids. Our results
show that the two classes of endogenous MR-ligands do not induce
different MR-DNA binding dynamics. However, the receptor was less
often DNA-bound when activated by the weaker mineralocorticoid
DOC, which suggest that specific ligand-receptor interactions do af-






The family of steroid receptors encompasses a large group of related receptors
that are present in the nucleus, or translocate to the nucleus upon ligand binding,
and act as ligand-induced transcription factors (Fuller, 1991). All family members
share key features, but differ largely in ligand specificity, ligand-binding dynamics
and in their choice of co-factors, which enables the enormous variety of biologi-
cal functions that steroid receptors have. In the past decade, imaging studies of
fluorescently tagged proteins inside living cells showed that steroid receptors, and
transcription factors in general, display a remarkably high mobility in the nucleus
(Stenoien et al., 2000, 2001; Stavreva et al., 2004; Schaaf et al., 2005, 2006; Hager et
al., 2009; van Royen et al., 2009b, 2014; Mueller et al., 2010). This high mobility is
characterized by free diffusion intermitted by frequent, but transient, DNA binding
(Gorski et al., 2006; Biddie and Hager, 2009).
We have previously employed a combination of imaging techniques to study
the nuclear dynamics of two steroid receptors, the GR and the AR (van Royen et
al., 2014). In these studies, we combined SMM and FRAP and, for the AR, also FCS.
SMM enables an unbiased quantification of protein dynamics with high temporal
and spatial resolution (Semrau and Schmidt, 2007; Lord et al., 2010; Li and Xie, 2011).
The combination with FRAP allows cross-validation with an independent analysis
method and greatly extends the time line (from 50ms for SMM to a minute with
FRAP), thus enabling quantification of DNA-binding times (Farla et al., 2004; van
Royen et al., 2009a).We found that this combination of techniques gave a consistent
pattern of both AR and GR nuclear dynamics and identified 3 fractions for each
steroid receptor; one diffusing fraction, and two transiently bound fractions, with
DNA-binding times of half a second to several seconds (van Royen et al., 2014).
In the current study, we utilize the same combinational approach of SMM sup-
plemented with FRAP to study the nuclear dynamics of a third steroid receptor: the
MR. The chromatin binding dynamics of the MR have not been studied extensively
(Tirard et al., 2007; Nishi et al., 2011). The receptor shares a high sequence anal-
ogy with both the GR and AR (Fagart et al., 1998). It is activated by the naturally
occurring glucocorticoids (cortisol or corticosterone) and bymineralocorticoids (al-
dosterone and DOC) (Arriza et al., 1987; Joëls et al., 2008; Funder, 2010). As such
the MR shares part of its endogenous ligands with the GR, but with different affini-
ties. Cortisol and corticosterone have a much higher affinity for the MR than for
the GR (Reul and de Kloet, 1985), whereas many synthetic glucocorticoids, such as
prednisolone and dexamethasone, have a very high affinity for the GR but only little
affinity for the MR (Arriza et al., 1987; Grossmann et al., 2004). Interestingly, for the
GR we found that agonist properties determine the receptor’s DNA-binding prop-
erties in a manner unrelated to receptor-ligand binding dynamics (Chapter 5). We
propose that ligand-induced effects are due to their specific binding profile within
the receptors ligand-binding groove, which ultimately affects the receptor’s affin-
ity for DNA (Chapter 5). Although the MR and GR share ∼55% sequence homology
109
N M R
within their LBD, they differmuchmore in their ligand-binding pocket architecture
(Fagart et al., 1998; Li et al., 2005) and a different set of interactions occur between
the steroids and the receptor’s ligand-binding pocket (Bledsoe et al., 2002, 2005;
Huyet et al., 2012). Thus, we expect different steroid side groups to affect binding
strength to the MR and thus likely to affect its nuclear mobility.
Here, we report that agonist-bound MR shows three functionally distinct states
within the nucleus. MRs spend approximately 50% of the time diffusing through
the nucleus, the remaining time the receptor is transiently bound to chromatin for
either short (∼30%: 0.5–0.8 sec) or longer (∼20%: 2–3 sec) binding events. When
bound to an antagonist, the MR spends more time diffusing (∼70%), with a mod-
erately higher diffusion coefficient and loses most of its capacity for longer DNA-
binding; short DNA-binding is hardly affected. Finally, we find that agonist proper-
ties affect MR’s nuclear mobility, with a role for the 11-hydroxyl group. No overall
difference in MR’s nuclear dynamics was found when bound to endogenous gluco-
corticoids or mineralocorticoids.
6.2 Methods
Cell culture and transfection
For all experiments transiently transfected COS-1 cells were used. Cultures were maintained
in high glucose D-MEM, supplemented with 10% FBS and 1% Pennicillin/Streptomycin (all
Invitrogen). Transfections were performed with the TransIT-COS kit (Mirus), according to
the manufacturer’s instructions (500ng DNA / 10 cm2). Transfected cells were used in exper-
iments 2–5 days after transfection. pEYFP-hMR was generated by PCR amplification (Phu-
sion HF polymerase, Finnzymes) of the human MR gene from a pRSV human MR template
(kindly provided by Dr. R. Evans and described in Arriza et al. (1987)). A set of primers was
designed to generate BglII and SmaI sites at the 5′ and 3′ end of theMR coding sequence. Sub-
sequently, the PCR fragment was digested with BglII and SmaI, purified and cloned into the
pEYFP-C1 vector, resulting in a vector with an in-frame fusion of hMR with EYFP, separated
by 17, mostly nonpolar, amino acids. Plasmid integrity was checked by sequencing. YFP-YFP
is a fusion product of EYFP with a second non-fluorescent YFP in the original pEYFP-C1 con-
struct.
Confocal microscopy, western blot and luciferase assays
For confocal analysis, COS-1 cells were grown on coverslips and transfected with YFP-MR
(500ng / 10 cm2). 48h after transfection cells were fixated with 4% PFA for 15 minutes and
nuclei were stained with 1 µg/ml Hoechst 33258 (Invitrogen) in 0.1% PBST for 10 minutes
and mounted with Aqua Poly/Mount (Polysciences Europe). Confocal images were obtained
with a Nikon TE-2000 E confocal microscope equipped with a 60× oil-immersion objective.
eYFP expression was analyzed using the 488 excitation laser and emission collected at 510–
530nm. Exposure and gain settings were adjusted as to prevent over or underexposure. Image





For western blot, COS-1 cells transfected with the required plasmids (500ng / 10 cm2)
were harvested 48h after transfection and prepared for western blot. Protein lysates,
SDS-polyacrylamide gel electrophoresis and western blotting were performed as described
previously (Vreugdenhil et al., 2007). MR protein was detected with 1:1000 MR 1D5 (gener-
ous gift of Gomez-Sanchez (Gomez-Sanchez et al., 2006)) and all samples were co-assessed
for α-tubulin (1:5000; Sigma-Aldrich) in combination with 1:5000 goat-anti-mouse IgG HRP.
All antibodies were diluted in TBST with 0.5% milk powder. Detection was performed with
the ECL detection system (GE Healthcare).
For the luciferase assay, COS-1 cells were transfected with a combination of 500ng
/ 10 cm2 YFP-YFP, YFP-MR or MR together with 100ng / 10 cm2 TAT3-Luciferase (tyro-
sine amino transferase triple hormone response element) and 2ng / 10 cm2 pCMV-Renilla
(Promega). 24h after transfection cells were treated with 10n corticosterone, 10n aldos-
terone or 0.001% EtOH in culture medium supplemented with charcoal stripped FBS. Af-
ter 20h, cells were lysed with passive lysis buffer and firefly and renilla luciferase lumines-
cence was determined according to the general prescription of the dual label reporter essay
(Promega) on a luminometer (CENTRO XS3 LB960, Berthold).
Compounds
The following hormones were used in these studies: aldosterone, corticosterone, corti-
sol, deoxycorticosterone (21-hydroxy-4-pregnene-3,20-dione, 4-pregnen-21-ol-3,20-dione), spi-
ronolactone (4-pregnen-21-oic acid-17α-ol-3-one-7α-thiol γ-lactone 7-acetate, 7α-(acetylthio)-
17α-hydroxy-3-oxopregn-4-ene-21-carboxylic acid γ-lactone), eplerenone (pregn-4-ene-7,21-
dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-, γ-lactone, methyl ester) and dexamethasone.
All steroids were purchased from Sigma-Aldrich and diluted in 100% EtOH to a concen-
tration of 1m , except for eplerenone, which was diluted in DMSO. Steroids were further
diluted to their required concentrations in the respective media.
Single-molecule microscopy
For all SMM experiments, COS-1 cells were grown on coverslips and transiently transfected
with YFP-MR (500ng / 10 cm2) 3–5 days prior to analysis. Before SMM recordings, cells
were exposed to 1 µ of corresponding hormones for 3–6h. For SMM measurements, this
medium was replaced by serum- and phenol red-free D-MEMmedium (Invitrogen), which is
also supplemented with 1 µ of the corresponding hormone. Subsequently, cells were trans-
ferred to the SMM setup and imaged for up to 90min at 35 °C. A wide-field fluorescence
microscope (Axiovert 100TV, Zeiss) was used, equipped with a 100× / 1.4NA oil-immersion
objective (Zeiss). A region-of-interest (ROI) of 50 × 50 pixels (pixel size of 220nm) was se-
lected. The sample was illuminated by an 514nm argon laser at an intensity of 2 kW/cm2.
The pulse length of 3ms was controlled by an acusto-optical tunable filter (AA optoelec-
tronics, France). The EYFP fluorescence signal was detected through a combination of filters
(DCLP530, HQ570/80 (Chroma Technology, Brattleboro, VT) and OG530-3 (Schott, Mainz,
Germany)), by a liquid-nitrogen cooled CCD camera (Princeton Instruments, Trenton, NJ),
camera read out and AOTF timing were tightly controlled. Moderately fluorescent nuclei
were selected and photobleached until single fluorescence intensity peaks could be distin-
guished. The position of each individual molecule was fitted with the intensity profile of a 2D
Gaussian model of EYFP peaks (Harms et al., 2001). Our peaks were identified with a signal
to noise ratio of ∼8 (peak fluorescent intensity divided by the variation of the background),
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which resulted in a positional accuracy of ∼40nm in the X- and Y -direction (determined
by the quotient of the full-width-at-half-maximum of the Gaussian fit and the square root of
the number of photons detected (Bobroff, 1986)). On average, each picture contained ∼1.5
peaks. Image sequences were recorded in series of 8 subsequent images with a time lag of
either 6.25ms or 12.5ms (Figure 6.1 ). Data on molecular dynamics were obtained for mul-
tiple step sizes. We used all time lags from 6.25 to 37.5ms in our analysis. From each cell
180 series of 8 images were taken and data from 20 independent cells (imaged on at least 3
different days) was combined for the analysis.
PICS analysis of single-molecule kinetics
We used the Particle Image Correlation Spectroscopy (PICS) method to determine peak dis-
placement over time (Semrau and Schmidt, 2007). PICS procedures are described in detail in
Chapters 4 and 5. In short, random correlations between unrelated molecules are subtracted
from the cumulative cross-correlation between peak positions at two different time lags. This
gives a cumulative probability function (Pcum) of diffusion steps l. We use population model-
ing to calculate diffusion characteristics of the nuclear population of YFP-MR molecules and
found that a two-populationmodel best describes YFP-MR’s dynamics (Figure 6.1 ). The two
populations are determined with Given that the population of molecules is homogeneous, a
single population of displacing molecules is determined with.















Where MSD1 and MSD2 denote the mean square displacement of the first (fast) and the
second (slow) fractions respectively, and α is the fraction size of the first (fast) fraction. The
analysis was repeated for each time lag and α, MSD1 and MSD2 were plotted against time
(∆t). The displacements over time were best described using a free diffusion model in 2D,
from which the diffusion coefficients (Dfast and Dslow) were calculated using the following
equation:
MSDi(∆t) = 4 · Di · ∆t (6.2)
OriginPro software was used to obtain weighted, linear fits, to calculate Dfast and Dslow. The
fraction size α decreased slightly (on average −0.27 ± 0.07%/ms) over increasing time lags in
all groups. Due to this effect, we always report the fraction distribution of the smallest time
step (6.25ms) as a representative of the overall fraction distribution. All analyses were first
performed on all data from each treatment group pooled together (n = 20). Subsequently,
all analyses were run again in 3 fractions (n = 6/7) and these 3 separate analyses are used to
generate standard errors of the mean.
FRAP
For FRAP recordings, COS-1 cells were grown on coverslips and transiently transfected with
500ng / 10 cm2 YFP-MR and used 2–3 days after transfection. Before FRAP recordings, cells
were exposed to 1 µ of the appropriate ligand for 3–6 hours in normal growth medium. For
each experiment, a coverglass with transfected COS-1 cells was placed in a preheated ring and
mediumwas replaced for empty D-MEMwithout phenol red, supplemented with 1 µ of the
corresponding ligand. Cells were used for no longer than 90 minutes and kept at 37 °C and





















































Figure 6.1: SMM and FRAP procedures
(A) A 11 µm × 11 µm area within a nucleus is bleached to obtain single fluorescent peaks represent-
ing single YFP molecules. A representative CCD image of single molecules of YFP-MR after background
subtraction shows single discernible Gaussian peaks of YFP fluorescence. (B) Regime for single molecule
kinetics; imageswere takenwith a time lag of 6.25msor 12.5ms in 300 series of 8 per cell. In background-
subtracted images, single molecules of YFP fluorescence are easily discernible. (C) PICS analysis of single
molecule displacements, shown for corticosterone-bound YFP-MR at time delay of 6.25ms. The cumu-
lative probability distribution as a function of the squared distance l2 (black line) was best fitted with
a 2-population model (red line), while a 1-population model gives a suboptimal fit (blue line) (n = 20
cells). (D) FRAP procedure of corticosterone-bound YFP-MR. At t = 0 s a 100ms bleach pulse was ap-
plied to a strip spanning the nucleus. Subsequently, FRAP recovery curves of 30 cells were recorded,
combined and adjusted to baseline fluorescence (black line). Subsequently, Monte Carlo simulations
were generated using a 3-population model and fitted to the combined FRAP curve. The top 10 fits were
combined (red line) and showed a good fit of the experimental data with small residuals (blue line).
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40× / 1.3NA oil-immersion objective, an argon laser (30mW) and an AOTF. For FRAP analysis
a narrow strip spanning the entire width of the nucleus was scanned at 514nm excitation
with short intervals (100ms) at low laser power (0.2%). Fluorescence intensity was recorded
using a 560nm longpass filter. After 40 scans, a high intensity (100% laser power), 100ms-
bleach pulse at 514nm was applied over the whole strip. Subsequently, the recovery of the
fluorescence intensity in the strip was followed for another 55 seconds at 100ms intervals.
For each treatment group 30 cells were measured by FRAP on two separate days. All curves
were normalized to baseline fluorescence intensity and combined.
Monte Carlo quantification of FRAP curves
The FRAP data was quantitatively analyzed by comparing the experimental data to curves
generated using Monte Carlo modeling (van Royen et al., 2009b). The Monte Carlo simula-
tion is described in detail in Chapter 5. In short, simulated FRAP curves were generated with
a 3-population model, containing a diffusing fraction and two bound (immobile) fractions.
We take the Dfast obtained from SMM analysis as a fixed parameter in these simulation, leav-
ing 4 parameters as variables: short bound fraction, long bound fraction (both ranging from
0–90%), and time spent in short and long bound state (ranging from 0.1 s to 1 s and from
1 s to 300 s respectively). A description of the calculation for all parameters can be found
in Chapter 5. The laser bleach pulse was simulated based on experimentally derived three-
dimensional laser intensity profiles, which were used to determine the probability for each
molecule to get bleached considering their 3D position. In all simulations, the size of the
ellipsoid was based on the average size of measured nuclei, and the FRAP region used in the
measurements determined the size of the simulated bleach region. The laser intensity pro-
file using the simulation of the bleaching step was previously derived from confocal image
stacks of chemically fixed nuclei containing GFP that were exposed to a stationary laser beam
at various intensities and varying exposure times. The unit time step (∆t) corresponded to
the experimental sample rate of 21ms. The number of molecules in the simulations was 106,
which was empirically determined by producing curves that closely approximate the data
with comparable fluctuations. The parameters of the top 10 best fitting Monte Carlo curves
(by ordinary least squares) were averaged to represent the properties of the fractions in the
experimental data.
6.3 Results
Characterization of YFP-tagged MR
A fusion of the human MR gene, N-terminally tagged with enhanced YFP, was gen-
erated. We assessed if the YFP-tag does not affect the function of the MR. First, we
showed that YFP-MR is present throughout the cytoplasm and nucleus when un-
bound and translocates to the nucleus upon application of a high concentration of
ligand (Figure 6.2 ). Next, we showed that the YFP-MR fusion protein retains its pre-
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Figure 6.2: Characterization of YFP-MR
(A) Representative confocal images of YFP-MR transfected COS-1 neurons after 3h treatment with ve-
hicle (0.1% EtOH) or 1 µ of hormone. YFP fluorescence was distributed over both cytoplasm and
nucleus in the vehicle condition and translocated fully to the nucleus for all tested hormones. (B) COS-1
cells transfected with YFP-MR or untagged MR were analyzed on western blot and stained for MR and
α-tubulin. A 60 kDa α-tubulin band was observed for all samples. MR transfected cells showed an ad-
dition band at the expected size of MR (107 kDa), while YFP-MR transfection gave a slightly larger
MR band, representing the fused MR-YFP protein (134 kDa). (C) Transactivation assay. COS-1 cells
were transfected with YFP-YFP, YFP-MR or untagged MR in combination with TAT3-Firefly and CMV-
renilla luciferases and analyzed for firefly and renilla luciferase luminescence. Corticosterone or aldos-
terone treatment (10n for 20h) led to a significant increase in TAT3-luciferase luminescence in both
the MR and YFP-MR transfected cells, while only corticosterone had a small effect in YFP-YFP trans-
fected cells. Thus, YFP-MR has transactivational capacity, although to a lesser extent as untagged MR.
n = 8, ∗ = p < 0.05, ∗∗ = p < 0.01, ∗∗∗ = p < 0.001, unpaired t-test. Scale bars: 5 µm.
detectable MR expression was seen in untransfected COS-1 cells. The YFP tag does
lead to slightly reduced expression levels of MR. Finally, we assessed the transcrip-
tional activities by cotransfection with a luciferase gene under control of a triple-
GRE (TAT3-luciferase) (van Leeuwen et al., 2011). Both YFP-MR and MR lead to a
clear induction of luciferase activity with 10n corticosterone or aldosterone (Fig-
ure 6.2 ). Control transfected cells (with YFP-YFP) showed only a small induction
after corticosterone treatment, probably due to endogenous GR expression in these
cells. However, the induction of TAT3-luciferase by YFP-MR was ∼2-fold less effi-
cacious than that with MR alone (Figure 6.2 ). Concluding, we see that YFP-MR is
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fully functional, although its relative expression levels and transcriptional activity
are slightly reduced.
SMM analysis of agonist-activated YFP-MR
The combination of SMM and FRAP analysis has been successfully applied to study
the nuclear mobility patterns of YFP-AR and YFP-GR (van Royen et al., 2014). For
both steroid receptors, three distinctive fractions were identified; a single diffusing
fraction and two immobilized fraction (which differed in their respective immobi-
lization times). However, it is not to say that a similar model would best fit the
nuclear dynamics of YFP-MR also. Thus, we first applied a full, unbiased analysis
of the nuclear dynamics of corticosterone-bound YFP-MR. We prepared YFP-MR
transfected COS-1 cells for SMM analysis 3 to 5 days after transfection. For SMM,
cells are exposed to a saturating dose (1 µ ) of corticosterone for 3 to 6 hours,
which leads to complete nuclear translocation of YFP-MR (Figure 6.2 ). Selected
nuclei were photobleached until single fluorescent peaks could be distinguished
(Figure 6.1 ). These peaks were attributed to single YFP-MR molecules as they had
comparable width and intensity as fluorescence intensity peaks derived from single
EYFP molecules previously observed using the same setup (Harms et al., 2001). In
our current approach, EYFP molecules were identified with a positional accuracy of
∼40nm in one dimension (x or y). Next, MR mobility was analyzed by analyzing
image sequences with 6.25ms and 12.5ms time lags (Figure 6.1 ) by the Particle Im-
age Correlation Spectroscopy (PICS) analysis method (Semrau and Schmidt, 2007).
PICS detects the average mean square displacement (MSD) of YFP-MR molecules
for each time lag. These displacements are subsequently fittedwithmultiple popula-
tion models. We found that, comparable to the AR and GR, the mobility of YFP-MR
could best be describedwith a two-populationmodel. A one-populationmodel gave
a less accurate fit (Figure 6.1 ), while a three population model did not improve the
fit substantially and gave inconsistent fractions over different time lags. We thus
determined the relative fraction sized and mean squared displacements (MSD) of
two separate fractions of YFP-MR, a ‘fast’ and a ‘slow’ fraction.
In Figure 6.3 , the size of the ‘fast’ fraction is plotted against the time lag. For
corticosterone-bound YFP-MR the fast fractionmakes up about ∼50%of all nuclear
molecules. This percentage decreases slightly with increasing time delays. This has
been reported earlier as an experimental artifact (due to fast moving molecules ‘es-
caping’ in the Z-direction) and the population distribution of the shortest time lag
was shown to be a good approximation of the real distribution (van Royen et al.,
2014). Using this approach, we found a ‘fast’ fraction of 50.7 ± 1.4% and a ‘slow’
fraction of 49.3 ± 1.4% (Figure 6.3 ). Next we plotted the MSD over time for both
fractions of MR molecules (Figure 6.3 ). The displacement of molecules from the
‘slow’ fraction did not exceed our detection limit (of 0.009 µm2) by more than 2 fold
and only increases slightly over time (Dslow of 0.080 ± 0.005 µm2/s). This type of dif-
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Figure 6.3: SMM and FRAP analyses provide a consistent model of the DNA-binding dynamics
of agonist-bound MR
The nuclear dynamics of YFP-MR bound with corticosterone (1 µ ) was analyzed by SMM (A and B)
and FRAP (C and D). (A) Fraction distribution obtained with SMM. All time lags were analyzed with a
two-population fit and consistently found a diffusing fraction of ∼50%. To represent the overall fraction
size the smallest time lag (6.25ms) was used. Bar graph: diffusing fraction (black bar) and DNA-bound
fraction (white bar). (B) Mean squared displacements (MSD) of both fractions in SMM. Both fractions
show a linear increase in MSD over time, but with a 50-fold difference in MSD. Diffusion coefficients
(Dfast and Dslow) were calculated from a linear fit of the experimental data (dashed lines; D = slope/4).
The Dfast of 1.37 µm2/s fits to diffusingmolecules, while the Dslow of only 0.08 µm2/s best fits to the slow
movement of chromatin and thus DNA-bound molecules. (C) Fraction distribution obtained with FRAP.
Monte Carlo simulation of corticosterone-bound MR with a 3-population model identified 3 fractions;
almost half of the nuclear population is diffusing (black bar), while the remainder is subdivided into two
DNA-bound fractions that differ in their immobilization times (white bar is transient bound fraction,
light grey bar is more stably bound fraction). The fraction size of the diffusing fraction is similar in size
as that obtained from SMM analysis. (D) Both bound fractions in FRAP are transiently immobilized, but
with a 4-fold difference in duration. (A and B) Data represented as best fit ± SEM (of 3 separate PICS
analyses). (C and D) Data represented as average of top 10% best fits ± SEM.
et al., 2006; Elf et al., 2007; van Royen et al., 2014). We presume this fraction thus
contains DNA-bound YFP-MR. For the ‘fast’ moving fraction, we saw a substantial
and linear increase in displacements over time (Dfast of 1.37 ± 0.13 µm2/s), repre-
senting YFP-MR molecules diffusing freely throughout the nucleus.
Quantitative FRAP analysis of agonist-activated YFP-MR
Next, we analyzed the longer term dynamics of corticosterone-bound MR with
quantitative FRAP analysis. We previously established that this technique, which
uses an independent approach to quantify mobility patterns, reproduces the rela-
tive fraction sizes (of immobile and diffusing molecules) with very high accuracy
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(Chapter 5; van Royen et al., 2014). In addition, FRAP analyzes the mobility pattern
of fluorescentmolecules over time frames from 100msup to aminute and can there-
fore distinguish immobilization times. As with SMM, YFP-MR transfected COS-1
cells were treated for 3–6 hours with 1 µ corticosterone. Moderately fluorescent
nuclei were identified and a small strip spanning the entire nucleus was bleached
with a short pulse of full laser power (Figure 6.1 ).We observed that all fluorescence
recovered within 30 seconds, suggesting that YFP-MR is completely mobile within
this time frame (Figure 6.1 ). The obtained recovery curves were quantitatively ana-
lyzed by fitting them to FRAP curves generated using Monte Carlo simulations (van
Royen et al., 2009a, 2014). Diffusion rates as obtained by SMM were used as a fixed
parameter in the simulations. Our data was best fitted with a model in which freely
diffusingmolecules show transient bindingwith two different durations (‘short’ and
‘long’; Figure 6.1 ).
First, we established that FRAP analysis gives a comparable fraction distribu-
tion as observed in the SMM analysis. Indeed, where SMM analysis found that
50.7 ± 1.4% of all corticosterone-bound YFP-MR molecules were diffusing, FRAP
analysis gave a 47 ± 2.1% diffusing fraction (Figure 6.3 ). Additionally, within this
longer time frame, we can subdivide the immobile fraction into two immobile frac-
tions, which differ in their immobilization time. The 53%of immobilizedmolecules
were further subdivided into a fraction of 31 ± 2.3% with an immobilization time
of 0.8 ± 0.1 s and a second fraction of 22 ± 2.5% with a longer immobilization time
of 3.4 ± 0.8 s (Figure 6.3 ).
Taken together, we show that the combination of FRAP and SMMgives a reliable
quantitative picture of YFP-MR intranuclear mobility patterns. The combination of
techniques shows that upon activation by corticosterone,MR spends approximately
half of the time diffusing throughout the nucleus and the other half being immobi-
lized for short periods (0.1 to 3 seconds).
Combined SMM and FRAP analysis of antagonist-bound YFP-MR
To investigate the effect of different types of ligands on MR’s nuclear mobility
we first analyzed its nuclear mobility pattern when bound to an antagonist. We
treated YFP-MR expressing COS-1 cells with 1 µ of two MR antagonists, spirono-
lactone and eplerenone, and analyzed the receptor mobility by SMM and FRAP.
This high dose was sufficient to induce complete nuclear translocation of the MR
with both antagonists (Figure 6.2 ). YFP-MR bound to either spironolactone or
eplerenone remained highly mobile within the nucleus. A larger fraction of nu-
clear YFP-MR was diffusing: for spironolactone 78.8 ± 2.3% to 71 ± 3.5% and for
eplerenone 68.2 ± 6.6% to 66 ± 1.6% and (obtained with SMM and FRAP analysis
respectively; Figure 6.4 , ), which is approximately 1.5 × higher as what was ob-
served for corticosterone-bound MR. This diffusing fraction also diffused approxi-
mately twice as fast as compared to corticosterone-bound MR (Dfast of 2.71 ± 0.05








































































Figure 6.4: Antagonist-boundMR shows a shift towards shorter and less frequent DNA-binding
The nuclear dynamics of YFP-MR bound to its antagonists: spironolactone and eplerenone (both 1 µ )
was analyzed by SMM (A and B) and FRAP (C and D). (A) Fraction distribution obtained with SMM. For
all time lags a large diffusing fraction was found for both antagonists. Diffusing fraction (grey bar) and
DNA-bound fraction (white bar). (B) Mean squared displacements (MSD) of both fractions in SMM. The
diffusing fraction shows large displacements over time, while the DNA-bound fraction shows the small
displacements expected from chromatin boundmolecules. (C) Fraction distribution obtainedwith FRAP.
Monte Carlo simulations with a 3-populationmodel identified 3 fractions; a large diffusing fraction (grey
bar), a transiently bound fraction (white bar) and a very small longer-bound fraction (light grey bar).
The fraction size of the diffusing fraction is similar in size as that obtained from SMM analysis. (D) Both
bound fractions are only transiently immobilized, with a 2–3 fold difference in immobilization times. (A
and B) Data represented as best fit ± SEM (of 3 separate PICS analyses). (C and D) Data represented as
average of top 10% best fits ± SEM.
Finally, especially the fraction of longer DNA-binding events was much reduced for
antagonist-boundMR. Spironolactone-boundMR induces a 23 ± 3.7% fraction that
is transiently immobilized (0.5 ± 0.1 sec), but has a negligible fraction of 6 ± 1.6%
that shows longer immobilizations (of 1.2 ± 0.3 sec). A similar pattern was observed
for eplerenone: 25 ± 2.7% immobilized for 0.6 ± 0.1 seconds and only 9 ± 2.3% im-
mobilized for 1.7 ± 0.5 seconds (Figure 6.4 ). Thus, the entire population of nuclear
MR is shifted towards a more mobile state with longer stretches of ‘free’ diffusion,
a higher diffusion coefficient and fewer and shorter immobilizations.
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A general pattern of intranuclear mobility after activation by
different agonists
For the GR we established that a faster intranuclear mobility was seen not only for
antagonist-bound receptors but also when bound to lower efficacy agonists (Chap-
ter 5; Schaaf and Cidlowski, 2003). This effect was associated with multiple func-
tional side-groups of the agonists and their interactions with specific amino acids
within the ligand-binding groove of the receptor. The GR and MR share a number
of (natural) agonists, but with very different relative affinities and associated differ
in a number of the amino acids lining their ligand binding groove (Fagart et al.,
1998; Bledsoe et al., 2005; Li et al., 2005). To assess the relationship between lig-
and side-groups and MR’s intranuclear mobility, we tested an array of different ago-
nists (natural and synthetic) on the mobility pattern of YFP-MR. A panel was tested
that enabled us to study the effects of the P18-keto, and 11- and 17-hydroxyl groups
on naturally occurring mineralocorticoid receptor agonists. We used aldosterone
(which contains an 18-keto and 11-hydroxyl group), corticosterone (same structure
as aldosterone, but lacking the 18-keto group), cortisol (same structure as corticos-
terone, but containing an additional 17-hydroxyl group), and deoxycorticosterone
(DOC; same structure as corticosterone, but lacking the 11-hydroxyl group) (see Fig-
ure 6.5 ). We also added the GR agonist dexamethasone, which is a weak MR ago-
nist (Arriza et al., 1987; Hellal-Levy et al., 1999).
All ligands used induced complete nuclear translocation of YFP-MR at the high
dose used (1 µ ; Figure 6.2 ). As compared to corticosterone, aldosterone and cor-
tisol induced a similar mobility of the MR, which indicates that the 18-keto and
17-hydroxyl groups are not involved in determining MR’s mobility (Figure 6.5 and
Table 6.1). In contrast, DOC induced a highermobility, with a 57±1.5 to 60.5 ± 3.6%
diffusing fraction and smaller DNA-bound fractions (but no effect on immobiliza-
tion times). This suggests that the presence of the 11-hydroxyl group results in less
frequent DNA-binding. As expected, the GR agonist dexamethasone induced a very
mobile receptor, intermediate between agonist- and antagonist-bound MR (Fig-
ure 6.5).
6.4 Discussion
Here we utilized a combination of SMMand FRAP to quantify the nuclear dynamics
of theMR.With SMMwe reliably identified two fractions ofMRmolecules: one that
shows diffusion and one that is DNA-bound (Table 6.1). These two populations of
nuclear MR molecules were found for both agonist and antagonist bound MR, but
with a decrease of the fraction size of the DNA-bound molecules for antagonists.
We complemented SMM with a quantitative FRAP approach, and found two bound
fractions and a single diffusing fraction. The binding times of both bound fractions






Fraction size (%) D (µm2/s) Fraction size (%) Imm. time (s)
Aldosterone
Diffusing 54.1 ± 3.4 1.43 ± 0.04 45.0 ± 1.7 -
Short 45.9 ± 3.4 0.050 ± 0.002 32.0 ± 2.0 0.8 ± 0.1Long 23.0 ± 2.1 2.9 ± 0.5
Corticosterone
Diffusing 50.7 ± 1.4 1.37 ± 0.13 47.0 ± 2.1 -
Short 49.3 ± 1.4 0.080 ± 0.005 31.0 ± 2.3 0.7 ± 0.1Long 22.0 ± 2.5 3.4 ± 0.8
Cortisol
Diffusing 51.5 ± 0.8 1.96 ± 0.19 44.0 ± 2.2 -
Short 48.5 ± 0.8 0.050 ± 0.002 32.0 ± 2.9 0.6 ± 0.1Long 24.0 ± 2.7 2.3 ± 0.3
DOC
Diffusing 60.5 ± 3.6 1.60 ± 0.13 57.0 ± 1.5 -
Short 39.5 ± 3.6 0.060 ± 0.003 23.0 ± 3.0 0.6 ± 0.1Long 20.0 ± 3.1 2.3 ± 0.3
Dexamethasone
Diffusing 64.3 ± 6.0 1.74 ± 0.20 67.0 ± 2.1 -
Short 35.7 ± 6.0 0.040 ± 0.003 22.0 ± 4.4 0.7 ± 0.1Long 11.0 ± 3.1 1.7 ± 0.5
Eplerenone
Diffusing 68.2 ± 6.6 2.49 ± 0.12 66.0 ± 1.6 -
Short 31.8 ± 6.6 0.060 ± 0.004 25.0 ± 2.7 0.6 ± 0.1Long 9.0 ± 2.3 1.7 ± 0.5
Spironolactone
Diffusing 78.8 ± 2.3 2.71 ± 0.05 71.0 ± 3.5 -
Short 21.2 ± 2.3 0.060 ± 0.018 23.0 ± 3.7 0.5 ± 0.1Long 6.0 ± 1.6 1.2 ± 0.3
Table 6.1: SMM and FRAP analyses of all MR ligands
Short, ‘short’ bound fraction; long, ‘long’ bound fraction; imm. time, average immobilization time. Re-
sults are represented as best fit ± SEM (of three separate fits) for SMM and as average ± SEM of top
10% fits for FRAP.
and these fractions combined represent the single bound fraction detected in SMM,
providing two independent estimates of the size of this (combined) fraction.Within
our 7 different treatment groups, the sizes of the combined bound fractions deter-
mined by SMM and FRAP showed an average difference of only 5.2 ± 1.1%. This
high level of consistency between the two independent techniques shows that a
combination of techniques generates a reliable quantitative description of protein
dynamics. We have previously shown that this combination of techniques reliably
assessed chromatin-binding dynamics of the GR (Chapter 5) and the AR (van Royen
et al., 2014) as well.
We assessed the nuclear dynamics of theMRwhen bound to a number of natural
agonists, a weak synthetic agonist and two antagonists. In general, we found that
the three most potent natural agonists (aldosterone, corticosterone, and cortisol)
induce a very similar pattern of nuclear MR dynamics (see Table 6.1). When bound
to either of these agonists, approximately ∼50% of all MR molecules are diffusing
(with a diffusion coefficient of ∼1.5 µm2/s) while the remaining half is DNA-bound









































































Figure 6.5: A panel of agonists identi-
fies a structural determinant MR’s DNA-
binding dynamics
A range of natural agonists and one syn-
thetic agonist were tested for their effect
on the intranuclear mobility of the MR
by both SMM (A) and FRAP (B-C) analy-
sis. (A-B) Black bars represent the diffus-
ing fraction with the diffusion coefficient
written within its corresponding bar in A
(in µm2/s). White and light grey bars repre-
sent the DNA-bound fractions. (C) Immo-
bilization times of the short-bound (white
bars) and long-bound (light grey bars) frac-
tions. With the combination of 5 agonists
tested, we could examine the effect of 3
structural steroid side groups. Only for the
11-hydroxyl group (11-hydroxyl) an associa-
tion with MR’s DNA-binding pattern was
found: DOC that lacks this group shows
a lower frequency of (short) DNA-binding
events. The poor MR agonist dexametha-
sone induced a very mobile MR with a low
frequency and duration of DNA-binding
events. SMM: n = 20, FRAP: n = 30.
Data represented as total fit ± SEM (of 3
separate PICS analyses) for SMM and as
average of top 10% fits ± SEM for FRAP.
aldo: aldosterone, cort: corticosterone, csol:
cortisol, dex: dexamethasone. The data for
corticosterone-bound MR is the same as in
Figure 6.1.
to 2–3 seconds (20% of MRs). When bound to an antagonist (spironolactone or
eplerenone), the same three fractions still exist, but the entire population is shifted
towards a more mobile and less stably (DNA-)bound MR. Under these conditions,
only ∼30% of all nuclear MR molecules are associated with DNA. In addition we
alsomeasuredMR’s DNA-binding dynamics when bound to dexamethasone, a high
affinity GR agonist. Dexamethasone is known to bind with moderate affinity to the
MR but has little potency for MR activation in cells (Arriza et al., 1987; Hellal-Levy
et al., 1999). Associated, dexamethasone-bound MR shows high nuclear mobility,
and takes up an intermediate position between the natural (highly potent) agonists
and the two antagonists (Table 6.1). In most cases, the entire pattern of nuclear
mobility was affected: reduced DNA-bound fractions, immobilization times and a
higher effective diffusion coefficient (Table 6.1). A similar relationship between dif-





GR (Chapter 5). This correlation suggests that the same process, i.e. decreased DNA-
binding affinity, underlies these effects. A lower effective diffusion coefficient could
be obtained if very transient (< 6ms) DNA-binding events are ‘hidden’ in the dif-
fusion coefficient and the frequency of these transient events is affected by ligand
properties.
The MR has long remained an understudied receptor. Few studies have assessed
its nuclear dynamics (Tirard et al., 2007; Nishi et al., 2011), and none has compared
different ligands. Here, we show that the MR has a similar rapid dynamics within
the nucleus as seen for other steroid receptors: a combination of free diffusion and
transient DNA-interactions (Stenoien et al., 2000; Rayasam et al., 2005; van Royen
et al., 2014).Within the family of steroid receptors, theMR is most closely related to
the GR with a high sequence homology, shared ligands and even the possibility to
form MR-GR heterodimers on the DNA (Trapp et al., 1994; Liu et al., 1995; de Kloet
et al., 1998). Therefore, we expected the MR to also support similar DNA-binding
dynamics as the GR. Indeed, when compared to the GR and AR that were studied
with the same combination of imaging techniques (van Royen et al., 2014), we find
that the MR and GR display highly similar characteristics. For example, agonist-
bound AR shows much longer stable DNA-binding (∼8 s) than agonist-bound MR
and GR (both: 2–3 s).
Mineralocorticoids and glucocorticoids do not differentially affect
MR’s nuclear dynamics
The MR can be bound by two functionally distinct groups of ligands, mineralocorti-
coids (aldosterone and DOC) and the naturally occurring glucocorticoids (cortisol
and corticosterone) (Joëls et al., 2008). Brain MR binds these steroids equally well,
but in the kidney MR is shielded from glucocorticoids because of enzymatic break-
down, rendering the kidney MR selective for mineralocorticoid only (Edwards et
al., 1988; Funder et al., 1988). Aldosterone-bound MR is known to bind to a differ-
ent set of genes (Sato and Funder, 1996; Wilson et al., 2009; Fuller et al., 2012) and
was recently found to also bind to different cofactors as MR bound to endogenous
glucocorticoids (Fuller et al., 2012). However, despite these differences we found
no major differences in DNA-binding frequency or stability between aldosterone-
bound or cortisol/corticosterone-bound MR. Thus, the subtle differences in the set
of genes targeted by aldosterone-bound MR and cortisol/corticosterone-bound MR
appear not to affect its overall binding profile to DNA. In addition, aldosterone has
3–4 fold slower dissociation from the MR than cortisol or corticosterone (Hellal-
Levy et al., 1999, 2000), suggesting that ligand dissociation dynamics do not affect
the DNA-binding dynamics of the receptor in our experiments either.
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Structure-function relationship of agonist binding
For the GR, we have previously established a relationship between specific steroid
side groups and the duration and frequency of DNA binding of the receptor. Most
notably steroids containing the 17-hydroxyl and / or the 9-fluoro groups were shown
to lead to longer and more frequent DNA-binding of the GR (Chapter 5). A similar
relationship could be expected for the MR as well. However, as the ligand-binding
pockets of the GR and MR differ in a number of key features (Fagart et al., 1998;
Li et al., 2005) different functional side groups of the agonists are known to affect
binding strength of the ligands to theMR (Huyet et al., 2012). Here, we tested the ef-
fects of the 18-keto (=O) and 11- and 17-hydroxyl (−OH) groups. The only side group
we found to affect MR’s DNA-binding dynamics was the 11-hydroxyl group. When
bound to DOC, that lacks this side group, the MR shows reduced DNA-binding
as compared to corticosterone, cortisol and aldosterone (all of which have the 11-
hydroxyl group; Figure 6.5 & Table 6.1). Interestingly, the strongest effect was seen
on the frequency of short, and not of longer, binding events. In vitroDOC is a selec-
tive activator of the MR, with transactivational activities that are within the same
range as those of aldosterone, corticosterone and cortisol (Hellal-Levy et al., 1999;
Bledsoe et al., 2002; Quinkler et al., 2002). In vivo, however, its potency is debated as
it shows near-aldosterone potency on some MR actions (e.g. on sodium retention),
but retains only limited potency on other MR actions (e.g. potassium excretion)
(Vinson, 2011). That the 11-hydroxyl group is important is clearly illustrated by the
fact that oxidation of this group renders cortisol and corticosterone inactive (Ed-
wards et al., 1988; Funder et al., 1988). But, how the 11-hydroxyl group affects the
ligand-receptor binding is unclear. It has not been found to undergo specific inter-
actions within the LBP directly (Fagart et al., 1998; Auzou et al., 2000; Bledsoe et al.,
2005). Another difference between binding of DOC and aldosterone/corticosterone
has been found for the strength of binding to Asparagine 770 (Asn770), a key amino
acid that aids in the folding of helix 12 and thereby enables exposure of the AF-2 do-
main (Fagart et al., 1998; Bledsoe et al., 2005). Asn770 makes two hydrogen bonds
with agonist side groups for both corticosterone and aldosterone, only one with
DOC and none with any of the known antagonists (Bledsoe et al., 2005; Huyet et
al., 2012). Mutation of Asn770 results in an almost complete inhibition of transacti-
vation efficacy for all agonists (Fagart et al., 1998; Bledsoe et al., 2005). Mutational
studies should be undertaken to show which of the LBP amino acids are involved in
the differential effect of DOC and the other steroids tested on MRs DNA-binding
pattern. Thus, also for the MR a difference in its DNA-binding dynamics is corre-
lated to a specific steroid side group, but the relationship with the interactions of
ligand side-groups to the receptor seems more complicated than what we observed
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7.1 Summary of main conclusions
Despite considerable knowledge regarding the molecular basis of corticosteroid ac-
tions within target cells, much still remains poorly understood. The molecular and
cellular effects of corticosteroids ultimately determine their actions at the tissue
and organism levels and a detailed understanding is required to understand how
corticosteroids promote adaptation to stress. In this thesis I aimed to explore fur-
ther finesses in the cellular dynamics of the MR and GR in both their membrane-
associated and their nuclear subpopulations. I specified three aims.
1. To investigate the non-genomic effects of corticosteroids in different brain ar-
eas and to explore how these effects fit within the onset of the stress response.
2. To set up in vitro models to show the presence and function of a distinct
membrane-associated population of the MR.
3. To characterize the chromatin binding dynamics of the MR and GR and to
explore the effect of mutations within the receptors and of different ligands
on their nuclear dynamics.
In Chapter 2 I evaluated the current state of knowledge regarding the non-
genomic actions of corticosteroids through membrane-associated receptors and
their relevance for brain functioning. One of the most striking conclusions was that
rapidly after stress, corticosteroids affect the excitability of multiple limbic brain ar-
eas, but in different response patterns over various time domains. These patterns
include rapid non-genomic and slower genomic actions of the hormones that are
mediated in a complementary manner by MR and GR. In addition, I discussed the
rapid, non-genomic effects of corticosteroids on endocrine output and behavior and
found that these effects correlate well with the observed patterns of neuronal ex-
citability changes. Finally, I addressed the current state of knowledge regarding the
underlying signaling cascades of these steroid effects and listed the main caveats
in the current knowledge. For example, the regulation of MR and GR translocation
to the membrane is still elusive, as is the proportion of the membrane population
involved and its potential localization in specialized membrane compartments.
In Chapters 3 and 4 we developed in vitro models to study the molecular path-
ways underlying the non-genomic effects of corticosteroids. In Chapter 3we showed
that NS-1 cells have potassium A-type currents upon NGF-induced differentiation.
These A-type currents are inhibited by corticosterone and cort-BSA within minutes,
but only when the MR was present. We thus showed that the MR is required and
sufficient for this rapid corticosteroid action. Moreover, this effect is specific for
some subtypes of potassium channels. In N1E-115 cells, another type of potassium
currents were observed: Kv3-generated slowly-inactivated currents. These currents
were not affected by corticosterone. We also observed a remarkable instability of





SMM to explore whether this combination of imaging techniques is a valid method
to show and explore themembrane localization of YFP-taggedMR.One of ourmain
findings here was that the MR shows a larger slow diffusing fraction near the mem-
brane in two cell lines; CHO and COS-1 cells. As membrane-associated proteins are
known to diffuse much slower than cytoplasmic proteins, this is a strong indication
for the existence of a membrane-associated subpopulation of the MR. The mobility
of the membrane-associated population was not affected by hormones.
In Chapters 5 and 6 I explored the nuclear subpopulation of both GR (Chapter 5)
and MR (Chapter 6) with a combination of SMM and FRAP. Here I found that the
combination of both imaging techniques gave a detailed and reproducible quantifi-
cation of the intranuclear dynamics of both receptors. Both GR andMR showed free
diffusion within the nucleus interspersed with short (presumptively nonspecific)
and long (presumptively specific) DNA-binding events. GR deletion mutants de-
void of (most) DNA-binding showed a stark reduction of these DNA-binding events.
The mobility pattern of the MR and GR were highly similar when bound to a high
affinity agonist. When bound to an antagonist, both receptors showed less frequent
nonspecific binding and less frequent and shorter specific DNA-binding events. In-
terestingly, intermediate patterns were seen for the GR andMR bound to less potent
agonists, and this was correlated with steroid structure. Due to differences in their
ligand-binding pocket, different steroid side-groups affected the DNA-binding of
the MR and GR. This suggests that specific ligand-receptor interactions strongly
affect the affinity for DNA binding in a receptor specific manner.
In conclusion, in this thesis I described a set of experiments that focuses on
the function and the dynamics of the two phases of the (cellular) stress response:
membrane-initiated / non-genomic and nuclear / genomic actions. The main re-
sults are graphically illustrated in Figure 7.1. In the next sections I will discuss a
number of interesting observations we made in more detail.
7.2 The presence of the MR at the plasma membrane
In Chapters 3 and 4 we set up two different in vitro models to study the role of
the membrane-associated subpopulation of the MR in the rapid non-genomic ac-
tions of corticosterone. First, in Chapter 3 we found that in differentiated NS-1 cells
MR-transfection is required for a rapid reduction in potassium A-type current am-
plitudes by corticosterone. Importantly, we found here that a similar reduction in
A-type amplitude is obtained with an equivalent dose of cort-BSA, which is mem-
brane impermeable. These results thus strongly suggest that the MR is present at
the cell membrane. InChapter 4we studied themobility of YFP-taggedMR in COS-1
and CHO cells with a combination of imaging techniques. Here we found that a
larger fraction of YFP-MR molecules shows very slow diffusion when imaged near
















Figure 7.1: Cellular corticosteroid effects through the MR and GR
Without hormone, the bulk of the population of theMR and GR is present within the cytoplasmwhere it
is bound to chaperones. Presumably, a small fraction of cytoplasmic receptors associate with caveolin-1,
which induces membrane translocation. As discussed in Chapters 2, 3, and 4, at the membrane, hormone
binding to the receptors attracts new binding partners and results in the activation of non-genomic sig-
naling pathways. Putatively, ligand association also leads to receptor internalization. Ligand also reaches
the cytoplasm where it results in the release of the receptors chaperones and nuclear translocation.
Within the nucleus, the receptors interact with chromatin in either ultrashort, short or longer bind-
ing events. The first two likely represent nonspecific receptor-DNA interactions and aid in the search for
specific binding sites. Also at specific binding sites the receptors interact only transiently with the DNA,
as do all cofactors. Specific DNA-binding can occur as either homodimers (not shown), heterodimers
or monomers. Ultimately, both MR and GR induce the transactivation and transrepression of a large set
of responsive genes; i.e. genomic effects. The experiments presented in Chapters 4, 5 and 6 suggest that
the MR shows mostly very slow diffusion at the membrane, a mixture of slow and fast diffusion within
the cytoplasm and both MR and GR show a mixture of fast diffusion and numerous immobilization due
to chromatin binding within the nucleus. This is indicated by the dotted lines in the figure.
wide-field microscopy). Membrane-bound proteins generally show a much lower
mobility than cytoplasmic proteins (Owen et al., 2009), thus also these findings





Our findings are in line with the available literature. Numerous studies have
shown that cort-BSA was effective and intracellular corticosterone ineffective in
mimicking rapid MR-dependent corticosterone effects on glutamate transmission
in the brain (Karst et al., 2005; Olijslagers et al., 2008). The presence of amembrane-
associated MR has also been convincingly demonstrated using synaptosome ex-
tracts and at neuronal membranes using electron microscopy (Prager et al., 2009;
Qiu et al., 2010).Within neurons, theMR appeared to be enriched at the presynaptic
and postsynaptic membranes. However, the how andwhy of membrane-association
of the MR remain largely unknown. Regulation of membrane translocation of the
ERα has been studied in considerable detail. At the membrane, ERα has been found
primarily in caveolae, and binding to HSP27, palmitoylation and association with
caveolin-1 were all shown to be essential for translocation to the plasma membrane
(Razandi et al., 2002, 2010; Acconcia et al., 2005). The MR also binds caveolin-1 di-
rectly and seems to associate with lipid rafts (potentially caveolae) (Grossmann et
al., 2010; Pojoga et al., 2010b). This suggests that theMR is transported towards cave-
olae by caveolin-1 association as well, but direct evidence is still lacking. The motif
required for palmitoylation of the ERα is conserved among many steroid receptors
and was shown to be required for membrane translocation of the AR, PR and ERβ
(Pedram et al., 2007). However, the MR lacks the essential cysteine and can there-
fore not be palmitoylated at this sequence. Consensus palmitoylation sequences are
found elsewhere in the MR (Ren et al., 2008), but the MR was never shown to be
palmitoylated. Alternatively, the MR could use another pathway for translocation
to the membrane.
A characterization of the essential steps in MR membrane association is thus
still pending. Moreover, many questions exist regarding the signal partners the MR
may associate with at themembrane and it is still incompletely understoodwhether
the MR (and other steroid receptors) is located in the outer or the inner leaflet
of the membrane (see Chapter 2 for further discussion on these issues). Finally,
for the ERα it is predicted that 5–10% of the population exists at the membrane
(Chambliss et al., 2000). A similar or smaller percentage is expected for the MR,
but remains to be established and will probably depend on ligand binding and cell
context as well (Wang and Wang, 2009; Karst et al., 2010). With the combination
of TIRF and SMM we were already able to see a distinct diffusion of the MR near
the membrane. In future studies, these experiments could be supplemented with
disruptions of caveolin-1, palmitoylation or membrane compartments (lipid rafts).
This would shine further light on the membrane translocation pathway of the MR.
7.3 In vitroMR expression
In Chapter 3 we came across some important issues regarding the stability of the
MR in in vitro settings.
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i) First, we used MR transfection in the (non MR-expressing) cell line NS-1. Strik-
ingly, despite successful DNA transfection, we could not detect MR protein in this
cell line. MR mRNA was expressed in NS-1 cells after transfection but this did not
result in detectable MR protein levels, as assessed by numerous biochemical ap-
proaches:Western blot, immunofluorescence staining, detection of YFP-taggedMR
and transactivational assays. Functionally, we did observe an MR-specific effect of
corticosterone on potassium A-type currents in a large, well-controlled data set at
first, but failed to reproduce these effects in a second smaller data set. This dis-
crepancy we cannot explain. In Chapters 3, 4 and 6 we used a number of other non
MR-expressing cell lines: COS-1, CHO and N1E-115. In these three cell lines expres-
sion of the MR or YFP-MR was detected after transfections. The lack of MR protein
expression thus appears cell line specific.
ii) Secondly, we encountered problems with MR expression during stable trans-
fection in another cell line: CHO cells. We attempted to induce stable expression
of YFP-tagged MR in CHO cells. While the procedure led to successful protein ex-
pression in a control experiment (transfection of YFP-YFP) in 3 out of 4 clones, for
YFP-MR all YFP-positive clones only had fragments of the MR attached to the YFP.
This strongly suggests that MR expression is selected against in these cells.
iii) Thirdly, we tested MR protein expression in a cell line that had been stably
transfected with MR by the Grossmann-Gekle group (Krug et al., 2002; Grossmann
et al., 2005). However, we could not detect MR protein within these cells and also
the original investigators had noted a regression of MR levels in these cells even
while grown in selection media (personal communication with C. Grossmann),
again suggestive of selection against MR expression during cell division.
iv) In line with our observations, unexpected instability of the MR has been pub-
lished by the Gomez-Sanchez group as well (Gomez-Sanchez et al., 2006). While
testing an array of new MR-antibodies, this group found that the MR is easily de-
graded during in vitro handling. Thawing tissue samples (under protection of pro-
tease inhibitors and while kept cold) resulted in partially degraded MR, while such
procedures kept other steroid receptors intact. Together, these and our observa-
tions suggest a remarkable instability of the MR protein and a selection against MR
expression within (dividing) cell lines. One could expect that these types of obser-
vations have been made by others as well and more publicity on this issue would be
valuable for the field. Our current studies were not directed towards this question
and at present we can therefore merely speculate about underlying biochemical or
functional mechanisms.
Regarding the lack of (detectable) MR protein expression in NS-1 cells in the
light of detectable mRNA expression, a biochemical explanation remains elusive.
The failure to detect a proteinwhilemRNA is expressed could be caused by either an
inhibition ofmRNA translation or by protein degradation. First, microRNA induced





the MR are found on its 3′ UTR (de Kloet et al., 2009; Sõber et al., 2010), which
is not included in the MR plasmids used. Evidence for putative enhanced protein
degradation of the MR is lacking as well. Steroid receptors are normally protected
from degradation by chaperones, and therefore enhanced MR degradation is seen
when the key chaperoneHSP90 is inhibited (Faresse et al., 2010). However, HSP90 is
expressed in NS-1 cells and the chaperone complex is highly homogenous between
steroid receptors. Thus a lack of (common) chaperones is not expected in NS-1 cells
in the light of functional expression of the GR, PR and ERs in these cells (MacLusky
et al., 2003; Morsink et al., 2006).
Regarding the selection against MR expression during the generation and main-
tenance of stable cell lines, some speculations can be made. Functionally, MR is
found to be protective and anti-apoptotic rather than detrimental, at least in neu-
rons (Gass et al., 2000; Gomez-Sanchez and Gomez-Sanchez, 2012; Munier et al.,
2012). However, MR expression is generally restricted to well-differentiated tissues
and associated with cellular differentiation (Le Menuet et al., 2012). In line with
this, within dividing cell lines endogenous expression of the MR is rare and mostly
restricted to a small number of renal derived cell lines (Faresse et al., 2012; Hori
et al., 2012). Of note, this is in contrast to other steroid receptors which do show
widespread expression in commonly used cell lines (see for example Horwitz et al.,
1975; Kao et al., 2009; Polman et al., 2012). Hypothetically, MR expression could
be incompatible with undifferentiated, fast dividing cells and therefore selected
against in (some) cell lines.
7.4 Advanced imaging methods to examine protein function
and localization
In Chapter 4 I presented a novel approach to test for membrane presence of the MR
by a combination of SMM and TIRF microscopy. TIRF microscopy is an adaptation
to wide field fluorescence microscopy. In TIRF, the excitation laser is redirected to
exit the objective at a large angle relative to the optical axis and is totally internally
reflected at the glass-medium interface. As a result an evanescent wave field is cre-
ated that excites fluorophores in a very small (60–100nm) section above the glass-
medium interface (Axelrod et al., 1983; Axelrod, 2001; Martin-Fernandez et al., 2013).
As such, TIRF is the method of choice to image membrane-associated molecules in
the scope of unwanted cytoplasmic background. TIRF has been successfully com-
bined with FRAP, FCS and especially SMM (see for an overview Axelrod, 2008). We
were the first to utilize a combination of TIRF / wide field microscopy and SMM
to distinguish between membrane-associated and cytoplasmic proteins. With this
combination of techniques we found that a larger fraction of YFP-MR molecules
shows slow diffusion when imaged in TIRF (imaging both membrane-associated
and cytoplasmic MRs) than when imaged in wide field (negligible contribution of
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membrane-associated MR). Importantly, we found that the shift in population dis-
tribution was not due to the smaller Z-depth in TIRF mode. This is strongly sugges-
tive of the existence of a membrane-associated subpopulation. However, we found
that short-term hormone treatment did not affect the dynamics of theMRwhen im-
aged in TIRF, indicating that ligand activation of the putativemembrane-associated
population of MRs does not change its mobility. However, our pioneering study
does show great potential of combining imaging techniques to deduce protein lo-
calization and function.
In Chapters 5 and 6we used SMM in combination with quantitative modeling of
FRAP with Monte Carlo simulations to quantify the DNA-binding dynamics of the
GR (Chapter 5) and the MR (Chapter 6). More than a decade ago FRAP studies first
demonstrated the high dynamics of steroid receptors and other transcription fac-
tors within the nucleus (McNally et al., 2000; Stenoien et al., 2000; Schaaf and Cid-
lowski, 2003; Farla et al., 2004). However, quantification of this dynamic behavior
has been a major challenge. Quantitative analysis of FRAP is possible, but requires
a priori predictions, careful control for laser properties and complicated mathemat-
ical models (van Royen et al., 2009b; Mueller et al., 2010, 2013). In addition, FRAP is
not very accurate at predicting fast protein diffusion. SMM has an important advan-
tage over FRAP and associated techniques in that the quantitative analysis requires
fewer a priori assumptions. In addition, SMM has a very high temporal and spatial
resolution and is therefore more accurate in describing the dynamics of fast diffus-
ing proteins. A disadvantage of SMM is its shorter maximal time length (up to sev-
eral hundred milliseconds maximally), which makes the combination with FRAP
even more valuable (see for a comparison of imaging techniques: Table 1.1, Chap-
ter 1). A combination of two or more independent imaging techniques is widely
recognized as the most powerful approach to overcome modeling errors (Mueller
et al., 2013; Voss and Hager, 2014). We found that the combination of these two
independent quantitative models gave a very extensive and, most importantly, con-
sistent quantification of the DNA-binding dynamics of both receptors. Throughout
our studies we tested 18 experimental groups (including the MR and GR bound
by a variety of ligands and multiple GR (deletion) mutants). For these 18 groups
the quantification of the (combined) DNA-bound fraction was performed indepen-
dently by SMM and FRAP and we found that the two approaches were on average
within 6.5 ± 1.1% accuracy of each other. In addition, the combination of SMM and
FRAP is valuable as it gave us a very complete overview of the dynamics of the MR
and GR within the nucleus, from the millisecond to the minute time range. SMM
has the temporal and spatial resolution to accurately predict diffusion coefficients
of the freely diffusing fraction, while FRAP provides information over an extended
time range to predict average DNA-binding times. In another study (van Royen et
al., 2014), the accuracy of SMM to predict diffusion coefficients was compared to
FCS. FCS is very sensitive for fast diffusing proteins and FCS analysis replicated the





age difference of 0.4 ± 0.04 µm²/s,vanRoyenea2014). In addition to our current work
a number of recent studies have been published that used combinations of FRAP
with SMM and/or FCS (Stasevich et al., 2010a; Mazza et al., 2012; van Royen et al.,
2014). For example, Mazza et al. (2012) used SMM to guide the choice of modeling
parameters for FCS and FRAP and thereby restrict the degrees of freedom thatmade
the analysis of these imaging approaches so variable in the past.
In conclusion, advanced fluorescence microscopy techniques have shown their
merits for the study of many classes of proteins, including membrane-bound or nu-
clear proteins. New approaches such as SMM enable more precise quantifications
of protein dynamics with a high temporal and spatial resolution. As each analysis
method has its biases, a combination of multiple functional imaging approaches
limits these biases to skew the outcome and should be common procedure in quan-
titative studies on protein dynamics.
7.5 Towards a unifying model of steroid receptor
DNA-binding dynamics
In Chapter 5 we used a combination of SMM and FRAP to quantify the intranuclear
dynamics of the GR, and in Chapter 6 we used the same experimental approach
to study the dynamics of the MR. Here, we found that the diffusion behavior of
both receptors in their ligand-activated state was best described by the existence of
a single freely diffusing and multiple DNA-bound states. For example, GR bound
to a potent agonist (such as Δ-fludrocortisone or dexamethasone), spends ∼50%
of the time diffusing freely through the nucleus, intermitted by DNA binding for
either ∼0.5 second (∼30%) or 2 to 3 seconds (∼20%). A highly similar pattern of
DNA-binding events was identified for the MR bound to corticosterone, cortisol or
aldosterone.
Nonspecific and specific DNA-binding
As expected, GRmutants deficient forDNA-binding (the ΔDBDandΔLBDmutants)
had much reduced frequency and duration of the DNA-binding events, but in ad-
dition they also showed a higher effective diffusion rate. Whenever we observed
a less mobile receptor (GR and MR bound by less potent agonists, antagonists or
deletion mutants), this was always accompanied by both less frequent and shorter
DNA-binding events and a higher diffusion coefficient. These observations led us
to postulate that a further DNA-binding event was hidden in the diffusing fraction
of the receptor: ultra-short DNA-binding for < 6.25ms (our imaging time interval).
Such ultra-short (millisecond) interactions with the DNA have been recognized for
other transcription factors as well (Elf et al., 2007; Hammar et al., 2012). We thus
presume that the dynamics of the MR and GR within the nucleus is characterized
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by (1) free diffusion, (2) ultra-short DNA interactions (< 6 milliseconds), (3) short
DNA interactions (∼0.5 second) and (4) long DNA interactions (2–3 seconds).
There is still active debate regarding the proportion of specific and nonspecific
DNA binding events for transcription factors (extensively discussed in Mueller et
al., 2013). There are several indications to suggest that the two shorter DNA binding
events identified for the MR and GR represent predominantly nonspecific binding
to chromatin. Van Royen et al. (2014) examined the dynamics of the AR by SMMand
FRAP in a similar design as described in this thesis and reported the same three (pu-
tative) DNA-binding events. In these studies an AR point mutation that disrupted
specific DNA-binding abolished only the longest binding event, while the shorter
DNA-binding events were largely unaltered (van Royen et al., 2014). This finding is
reminiscent to observations for other transcription factors showing preservation of
a large fraction of DNA-binding events when only specific DNA-binding was inhib-
ited (Elf et al., 2007; Sekiya et al., 2009; Mazza et al., 2012). Transcription factors,
including steroid receptors, face the complicated task of finding their few target
sites within the bulk of DNA (Hager et al., 2009). It is thought that frequent non-
specific binding events aid in this targeting task. Indeed, in vitro studies supported
by theoretical modeling approaches have suggested that frequent low-affinity in-
teractions with DNA increase the efficiency of transcription factor target finding,
because such interactions may keep the transcription factor in close proximity to
open DNA (Gowers et al., 2005; Elf et al., 2007; van den Broek et al., 2008; Hager
et al., 2009). For this purpose two complementary modes of trafficking may occur.
These include both intersegmental jumps with frequent binding and unbinding to
the DNA as well as 50–100bp scanning events where the transcription factor moves
over the DNA (Gowers et al., 2005). We present a model that includes the set of
DNA-interactions that fit our experimental observations in Figure 7.2 .
In addition, part of the longer-lasting binding events we identifiedwill represent
specific binding of the MR and GR to their target sequences. We found that both
the ligand-activated MR and the GR spend ∼20% of their time being bound to the
DNA in a more prolonged fashion (approximately 2 to 3 seconds). This fraction of
prolonged DNA binding was almost completely lost in DNA-binding deletion mu-
tants. Antagonist-bound MR and GR do still show a fraction of < 1 second bound
molecules, albeit at reduced frequency (6–10%).Moreover, agonist structure affects
both the frequency and the duration of the longest DNA-bound state for both the
GR and MR. The exact relationship between steroid receptor DNA residence time
and transcriptional output is not known. Gene transcription requires many sub-
sequent events. The receptor dimerizes, attracts many co-factors and RNA poly-
merases and induces gene transcription as well as chromatin remodeling (Datson
et al., 2008). It seems reasonable to hypothesize that formation of a more stable co-
factor complex will lead to prolonged DNA-binding of a transcription factor, which

































Figure 7.2:Dynamic interactionsof theMRand
GR at chromatin
(A) A schematic representation of the types of
receptor-DNA interactions that are supported by
our observation. The receptor shows a combina-
tion of (1) free diffusion, (2) ultrashort (< 6ms)
interactions with the DNA, (3) short (∼0.5 s) in-
teractions with the DNA that could represent 1D
sliding along the DNA strands and least frequent
(4) longer (> 2 s) interactions with the DNA that
could represent specific binding to target genes.
(B) Squared displacements of “perfectly average”
MR and GR molecules (i.e. with the use of the av-
erage Dfast, binding times and fraction distribu-
tions as represented in Table 5.1, Chapter 5 and
Table 6.1, Chapter 6. This illustrates the differ-
ence in intranuclear dynamics of the MR and GR
when bound by corticosterone and the GR-∆LBD
mutant. Corticosterone-bound GR has fewer non-
specific interactions (both ultrashort and short)
with chromatin resulting in a larger distance trav-
eled before finding a specific binding site (encir-
cled) as compared to corticosterone-bound MR.
The specific binding event is also shorter in du-
ration. The GR-∆LBD mutant lost most capacity
for DNA-binding and only preserved a low fre-
quency of ultrashort and short DNA-interactions
while prolonged specific binding is lost altogether.
Ultrashort DNA-interactions are ‘hidden’ within
the diffusing fraction and result in a lower effective
diffusion.
Steroid-receptor interactions determine the affinity for DNA
A main finding from our sets of experiments was that subtle differences in agonist
structure have a profound effect on the frequency and duration of DNA-binding
events of the MR and GR. For the GR, we identified two steroid side groups (the
17-hydroxyl and the 9-fluor groups) that, when present, induced more frequent and
more stable GR-DNA interactions. For MR ligands, the 17-hydroxyl group is without
effect, while presence of the 11-hydroxyl group is associated with a higher frequency
of MR-DNA binding. We presumed that the more potent agonists make more con-
nections to the amino acids lining the LBP and can therefore induce a stronger
conformational shift of the receptor. Indeed, for the GR we found that mutation of
a single amino acid in GR’s LBP prevented the effect of the 9α-fluoro group (Chap-
ter 5). Likely differences in ligand-induced receptors conformational shifts affect
dimerization or cofactor binding and ultimately affinity for the DNA.We found that
binding of a less potent agonist generally affects both the frequency of nonspecific
DNA-interactions and the frequency and duration of binding to specific target sites.
We expect that fewer nonspecific binding events could result in a longer search time
for target sequence binding. A shorter duration of specific binding likely affects gene
transcription and modulation. What the effect of such different chromatin-binding
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dynamics entails on the level of gene regulation by the MR and GR remains to be
established. Assessment of the chromatin-binding patterns (e.g. by ChiP studies)
after stimulations with a set of different MR and GR agonists would be very valu-
able and could elucidate the relevance of nonspecific and specific DNA-binding for
gene regulation.
When both receptors are bound to a potent agonist, the DNA-binding patterns
of the GR and MR are very similar. This is in correspondence to the high sequence
homology of their DNA-binding domains, which results in both receptors recog-
nizing the same response elements (GREs). Of note, the longest binding event of
agonist-bound MR and GR was much shorter in duration as what was observed
for the AR. Van Royen et al. (2014) found a fraction of AR bound for ∼8 seconds,
whereas we found ∼3 seconds as longest binding event for the MR and GR. The AR
also binds to GREs, however differences known to exist in the groups of cofactors
bound and in the conformation of the receptors could underlie the observed pro-
longed DNA residence times of the AR (Centenera et al., 2008; van de Wijngaart et
al., 2012).
Notably, as the natural ligands corticosterone and cortisol have a lower affinity
for the GR than for the MR, within physiological conditions the chromatin binding
pattern of the two receptors will be very different. In response to its physiological
ligand, the MR will be DNA-bound more often and for longer periods than the GR
(illustrated in Figure 7.2 ). This observation is in in agreement with in vivo uptake
of tritium labelled corticosterone that shows amuch longer retention in the nucleus
of MR-expressing than GR-expressing tissues (Reul and de Kloet, 1985). These find-
ings were corroborated with an immunohistochemical study showing also a longer
retention of MR than GR in the nucleus (Conway-Campbell et al., 2007) and of
dexamethasone-bound GR than corticosterone-bound GR (Stavreva et al., 2009).
However, whether such a difference also exists on the level of DNA-binding itself
still needs to be established. Interestingly, in one recent study, binding of the GR
and MR was assessed for 10 genes (Polman et al., 2013). Here, a lower occupancy
rate was found for the MR then for the GR (contrary to our predictions), but this





Box I Future questions
From the experiments presented in this thesis many new questions came up and
some old ones remained partly unanswered. Here, I list a few of themost interesting
questions that sprang up from the current studies.
From Chapter 2
1. Within the scope of neuronal non-genomic effects of corticosteroids, how
do these integrate with rapid signaling of other stress hormones; i.e. cate-
cholamines and CRH?
2. How are non-genomic and genomic actions of corticosteroids integrated? This
question remains to be answered on both the cellular and the organism level.
From Chapters 2 to 4
3. What steps are required for membrane translocation of the MR and GR? Is the
MR palmitoylated as are other steroid receptors?
4. What fraction of both receptors associates with the membrane, and are they
located in specific membrane subdomains?
5. Is the larger slow diffusing fraction of YFP-MR caused by enrichment for
membrane-associated MR in TIRF?
6. Is the MR incompatible with cell division? If so, what is the best strategy to
create stable MR-expression in vitro?
From Chapter 5 and 6
7. What is the result of changes in the frequency of nonspecific DNA interactions
of the MR or GR on gene regulation?
8. What are the effects of differences in chromatin dwell time on the recruitment
of cofactors, the stability of the RNA polymerase cycle and on chromatin modi-
fications?
9. How do differences in the binding of agonists to the ligand-binding pocket affect
the conformation of the receptor’s functional domains?
10. With regard to the observed difference in the DNA-binding dynamics of the
MR and GR when bound to endogenous corticosteroids. What would be the ef-
fect of MR and GR co-expression on their respective DNA-binding dynamics
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S has many faces. A balanced activation and suppression of
our stress system enables a highly adaptive response to disturbances
in homeostasis. But when this balance is disrupted, for example when
stress responses are not terminated properly, stress acts as an impor-
tant risk factor for a large number of diseases. These diseases range
from obesity, heart and cardiovascular problems to psychiatric dis-
orders including major depression and posttraumatic stress disorder.
Key to understanding the cause of the shift from adaptive towards
detrimental effects is a comprehensive understanding of the different
players and phases involved in the stress response and their interac-
tions.
In this thesis, I focus on the actions of the corticosteroid hor-
mones: corticosterone and cortisol. Of note, I use the term cortico-
steroids throughout this thesis only in referral to corticosterone, cor-
tisol and their synthetic analogues (the term officially also includes
mineralocorticoids). Corticosteroids are one of the main hormones
released from the adrenals during stress. They exert their cellular ac-
tions through binding to two receptor types: the glucocorticoid re-
ceptor (GR) and the mineralocorticoid receptor (MR). The receptors
have two distinct modes of action. They translocate to the nucleus
upon activation, where they act as transcription factors and bind di-
rectly and indirectly to the DNA, regulating overlapping sets of stress-
responsive genes (i.e. genomic actions). Recently, a small subpopula-
tion of each receptor has been postulated to be present at the plasma
membrane. This subpopulation is essential for rapid corticosteroid
actions (i.e. non-genomic actions). In this thesis I aimed to explore
further finesses in the cellular dynamics of the MR and GR in both
their membrane-associated and their nuclear subpopulations. I spec-




Aim I “To investigate the multitude of non-genomic effects of
corticosteroids in different brain areas and to explore how these fit
within the onset of the stress response”
In Chapter 2 we evaluated the current state of knowledge on the non-genomic ac-
tions of corticosteroids throughmembrane-associated receptors and their relevance
for brain functioning. Many non-genomic actions have been described in the hy-
pothalamus and limbic brain areas. Interestingly, like the genomic steroid actions,
the vast majority of these effects are conditional; i.e. they increase or decrease the
threshold for neuronal activation. This implies that only in those brain areas that
are also activated by the context of the stressor, the non-genomic actions will affect
neuronal activity. The non-genomic actions of corticosteroids are followed up by
genomic actions at a later time point: this results in diverse temporal patterns of
enhanced or decreased excitability between brain areas. These temporal patterns
correlate well with rapid corticosteroid modulation of neuro-endocrine output and
behavior. Finally, we addressed the current state of knowledge regarding underly-
ing signaling cascades of these corticosteroid effects and listed the main caveats in
the current knowledge. For example, the regulation of MR and GR translocation
to the membrane is still elusive, as is the proportion of the membrane population
involved.
Aim II “To set up in vitromodels to show the presence and function
of a distinct membrane-associated population of the MR”
Corticosteroids rapidly affect the excitability status of neurons in multiple brain
areas. These actions arise from a membrane-localized receptor, but only bits and
pieces of the signaling cascades are known. In this regard, it would be very valu-
able to establish a functional in vitro model that enables manipulations of the
system and thereby investigations of the downstream and upstream molecular
pathways. In Chapter 3 we mimicked a functional non-genomic corticosteroid ef-
fect in a neuronal-like cell line. Potassium A-type currents have previously been
shown to be inhibited by corticosterone in a non-genomic, membrane-initiated
and MR-dependent manner within the hippocampus. We studied this same effect
in the neuronal-like cell line: NS-1 cells. NS-1 cells show large potassium currents,
including A-type currents. Only after MR-transfection, corticosterone induced a
> 25% reduction in A-type current amplitudes, while no effect was seen in control-
transfected cells. We could replicate this effect with a membrane-impermeable
corticosterone-BSA conjugate. In contrast, the slowly-inactivated potassium cur-
rents in N1E-115 cells were not affected by corticosterone in the presence of the MR.
TheMR is thus sufficient for a rapid inhibition of A-type potassium channels by cor-
ticosterone and this effect is specific for certain subtypes of potassium channels.
With EM microscopy a subfraction of the MR has been shown at the plasma
membrane where it functions as non-genomic corticosteroid receptor. However,
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this fraction of membrane-associated MR is very small compared to the bulk of cy-
toplasmically localized MR and conventional imaging methods fail to show the ex-
istence of this fraction. In Chapter 4 we imaged the putative membrane-associated
fraction of the MR using TIRF microscopy. In TIRF microscopy a thin wavefield
is created that excites fluorophores in a 60–100nm sheet from the coverglass. This
includes all membrane-associated molecules, but excludes the majority of cytoplas-
mic proteins. We imaged YFP-tagged MR using conventional wide-field (only cyto-
plasm) and TIRFmicroscopy (highly enriched for membrane-associatedmolecules)
and assessed protein dynamics in both imaging modes using single-molecule mi-
croscopy (SMM).We observed a > 1.5 fold larger fraction of slowly diffusing YFP-MR
molecules in TIRF. This fits with the notion of an enrichment of membrane-
associated molecules as these are known to diffuse very slowly. This effect was
also replicated in a second cell line. We next applied hormones. Ligand activation
has been shown to change the dynamics of most (membrane-associated) receptors.
However, we did not observe any effect of short-term corticosterone treatment on
YFP-MR’s dynamics at the membrane. In conclusion, the combination of TIRF and
SMM provides a strong suggestion for the existence of a membrane-associated MR
fraction. Future studies and further manipulations will show whether this imaging
approach is a valid method to distinguish between membrane-associated and cyto-
plasmic subpopulations of proteins.
Aim III “To characterize the chromatin binding dynamics of the MR
and GR and to explore the effect of mutations within the receptors
and different ligands on their nuclear dynamics”
The GR and MR bind to the DNA and regulate gene transcription. This process
is highly dynamic: the receptors do not stay bound to the DNA, but show only
transient interactions. Quantification of these rapid processes has remained diffi-
cult and small errors in modelling presumptions have resulted in a large variability
in outcomes between studies. New approaches such as SMM enable more precise
quantifications of protein dynamics with a high temporal and spatial resolution.
In Chapter 5, we assessed the intranuclear dynamics of the GR using both SMM
and FRAP. Importantly, we found that this combination of approaches gave a very
consistent quantification of the DNA-binding dynamics of the GR. We found that
agonist-bound GR is diffusing throughout the nucleus for ∼50% of the time, in-
terspersed with transient DNA-binding events of ∼0.5 seconds (∼30%) and 2–3
seconds (∼20%). GR deletion mutants devoid of DNA-binding showed predictably
a stark reduction of these DNA-binding events. Similarly, when bound to an an-
tagonist, the GR also showed a reduced frequency of DNA-binding events. In both
cases, the receptor also showed faster diffusion, therefore, we presume that a third
type of very short DNA-interactions were included in the diffusion coefficient. The




binding to the DNA. We presume that most of these DNA-interactions are nonspe-
cific binding to the chromatin and only part of the longer binding events represent
specific binding to GR-regulated genes. A final observation from these experiments
was that subtle differences in agonist structure have a profound effect on the fre-
quency and duration of DNA-binding events of the GR. The most potent agonists
make more connections to the amino acids lining the ligand-binding pocket. This
affects the conformational shift of the receptor and ultimately affects its affinity for
DNA.
The MR and GR share very high sequence homology. They share part of their
DNA binding sequences and part of their ligands, but there are also differences.
For example, the MR binds both mineralocorticoids and corticosteroids and has
∼10-fold higher affinity for the endogenous corticosteroids as the GR. In Chapter 6,
we utilized the same combination of SMM and quantitative FRAP to assess the in-
tranuclear dynamics of theMR. First, as for the GRwe found that the combinational
approach gave a highly consistent analysis ofMR’s DNA-binding dynamics. Also the
MR, when bound to a potent agonist, spends approximately 50% of its time diffus-
ing, and the remainder being transiently bound to the DNA. In correspondence to
the GR, MR binds the DNA with ultrashort, short and long binding events. Also
for the MR, small differences in agonist structure affected the MR’s DNA-binding
affinity. But, this effect was seen for different steroid side-groups, suggesting that
different ligand-receptor interactions affect the conformational shift of the MR. Fi-
nally, when bound to the natural corticosteroids (cortisol or corticosterone) the MR
shows more frequent and longer DNA-binding than the GR.
Conclusion
In conclusion, in this thesis I explored further finesses in the cellular action of cor-
ticosteroids. Membrane-initiated and non-genomic actions of corticosteroids are
shown throughout the brain and play an important role in the early phases of the
stress response. With use of TIRF and SMM microscopy we found a strong indica-
tion that theMR is present in a detectable amount at the plasmamembrane.Within
the nucleus, we focused on the highly dynamic behavior of the GR and MR and we
could quantify multiple nonspecific and specific DNA-binding events for both re-
ceptors. The finding that these DNA binding patterns are highly affected by specific




“ziekteverzuim neemt fors toe door stress”
“stress verdubbelt kans op onvruchtbaarheid”
“link tussen stress en verslaving”
“6 jaar ouder door stress”
Z wat koppen uit de krant. Stress wordt vaak gezien als iets
negatiefs, iets ongezonds en als risicofactor voor allerlei ziektes en
aandoeningen. En dat is waar:mensen die veelvuldig blootgesteld zijn
aan stress of zelfs eenmalig aan zeer ernstige stress hebben een ho-
ger risico op verschillende ziektes zoals hart- en vaat-aandoeningen
en vele psychiatrische aandoeningen (bijvoorbeeld depressie of post-
traumatisch stress syndroom). Maar dit is slechts één kant van de
medaille. Ons stress-systeem is in de basis een systeem dat er voor
zorgt dat wij heel snel en correct kunnen reageren als er een plotse-
linge dreiging wordt waargenomen. Pas wanneer de stress niet meer





De allereerste reacties na stress komen van het sympatisch zenuwstelsel en de af-
gifte van adrenaline. De hartslag wordt verhoogd en energie wordt gemobiliseerd
voor onmiddellijke actie: vechten of vluchten. Adrenaline verhoogt ook de algehele
alertheid: de oren zijn gespitst.
Een tweede belangrijk systeem dat wordt geactiveerd tijdens stress is de HPA-as
(hypothalamic-pituitary-adrenal axis). Deze as wordt zo genoemd omdat de activa-
tie ervan loopt vanaf de hypothalamus in de hersenen, via de hypofyseklier naar
de bijnierschors. Activatie van de bijnier leidt tot productie van het stresshormoon
cortisol bij de mens en het nauw verwante corticosteron bij de muis en de rat. Deze
hormonen worden afgegeven aan het bloed waardoor ze alle organen en weefsels
van ons lichaam bereiken.
De effecten van cortisol en corticosteron zijn veelzijdig. Al binnen enkele minu-
ten zorgt cortisol voor een snelle reactie op de stressvolle gebeurtenis. Via activatie
van verschillende hersengebieden zorgt cortisol bijvoorbeeld voor een verhoogde
alertheid en een juiste inschatting van de situatie: moet ik vluchten, vechten of is
er niets aan de hand? Deze onmiddellijke reactie is essentieel, maar wordt zelf scha-
delijk indien deze niet beteugeld wordt. Cortisol zorgt zelf voor deze beteugeling,
dit gebeurt via activatie van nieuwe genen en deze effecten komen met een vertra-
ging van een half uur tot zelfs enkele uren tot stand. Cortisol stimuleert ook het
geheugen. Zo komt het dat we stressvolle gebeurtenissen veel beter onthouden dan
de alledaagse routine. Cortisol is onderdeel van de familie der corticosteroïden. In
de experimenten beschreven in dit proefschrift heb ik verschillende corticosteroï-
den gebruikt en ik zal vanaf hier steeds spreken over corticosteroïden als algemene
term voor deze hormonen.
Een balans in het stress systeem; vanaf de cel tot het organisme
Bij milde en niet te langdurige stress werkt het stress-systeem heel adaptief: het
zorgt ervoor dat alle systemen die nodig zijn voor een snelle reactie ‘aan’ worden
gezet terwijl alle systemen die niet direct nodig zijn even op een laag pitje staan.
Maar in geval van langdurige of heel heftige stress kan de balans zoek raken. Dan
wordt de stressreactie nietmeer goed aangezet of (wat vaker voor komt) gaat hij niet
meer goed uit als dit nodig is. Al decennia lang proberen onderzoekers erachter te
komen hoe deze balans bijgestuurd kan worden.
In dit proefschrift draag ik een (klein) steentje bij aan dit onderzoek. Ik heb on-
derzoek gedaan naar de werking van corticosteroїden en enkele synthetische ana-
logen. Hierbij heb ik mij met name gericht op de processen die zich afspelen in de
cel. De effecten van corticosteroïden op celniveau bepalen uiteindelijk ook wat het
effect zal zijn op het weefsel, orgaan en het hele organisme.
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Corticosteroïden in de cel
Corticosteroïden kunnen binden aan twee verschillende receptoreiwitten: de Mine-
ralocorticoïd Receptor (MR) en de Glucocorticoïd Receptor (GR). Bijna alle cellen in
ons lichaam bezitten de GR, terwijl de MR alleen in specifieke weefsels voorkomt.
De twee receptoren hebben ook twee verschillende werkingsmechanismes in de
cel (geïllustreerd in Figuur 1). De meeste receptoren bevinden zich in het cytoplas-
ma van de cel en zodra het hormoon bindt, verplaatst de geactiveerde receptor zich
naar de kern. In de kern kunnen de receptoren direct binden aan het DNA. Bin-
ding van de receptoren zorgt ervoor dat nieuwe genen worden afgeschreven. Hier-
door worden nieuwe eiwitten geproduceerd, die uiteindelijk zorgen voor verdere
effecten. Deze route geeft de genomische effecten. Deze effecten zijn pas met een
vertraging zichtbaar, maar houden wel erg lang aan.
Een kleiner gedeelte van de receptoren bevindt zich op het membraan. Ook
deze membraangebonden MR en GR worden geactiveerd door binding van cortico-
steroïden, wanneer ze geactiveerd zijn kunnen ze al bestaande eiwitten activeren.
Dit geeft de niet-genomische effecten. Niet-genomische effecten zijn al binnen
enkele minuten zichtbaar, maar houden korter aan.
Doel van dit proefschrift
In dit proefschrift heb ik zowel de genomische als de niet-genomische effecten van
corticosteroïden onderzocht, ik had hierbij 3 specifieke doelen.
I Het evalueren van de verschillende niet-genomische effecten van corticoste-
roïden in de hersenen. Tevens om te beschrijven hoe deze passen binnen de
stress reactie.
II Het opzetten van in vitromodellen die gebruikt kunnen worden om de mem-
braangebonden fractie van de MR te laten zien en te karakteriseren.
III Het onderzoeken van de dynamiek van DNA-binding door zowel de GR als de
MR. Tevens om te bepalen hoe deze dynamiek wordt beïnvloed door mutaties
in de receptoren en door binding van verschillende liganden.
Deze specifieke doelen heb ik verder uitgewerkt in hoofdstukken 2 tot en met 6. In
hoofdstuk 7 heb ik de belangrijkste bevindingen verder bediscussieerd.
Fluorescentie-microscopie en single-molecule microscopie
Voordat ik de belangrijkste bevindingen uit dit proefschrift beschrijf eerst een korte
uitweiding over de gebruikte technieken. Inmijn onderzoek heb ik gebruik gemaakt
van verschillende moleculaire technieken, maar voor het belangrijkste deel heb ik
gebruik gemaakt van geavanceerde fluorescentie-microscopie. Hieronder leg ik een





























Figuur 1: De dynamiek van corticosteroïd receptoren in de cel
In dit proefschrift heb ik de functie en de dynamiek van de twee corticosteroïd receptortypen, de MR en
de GR, onderzocht. De beweging, of dynamiek, van de MR en GR hangt samen met hun verschillende
functies binnen de cel. Een aantal belangrijke bevindingen van mijn proefschrift zijn hier geïllustreerd.
In afwezigheid van hormoon bevinden de meeste MR en GR moleculen zich in het cytoplasma van de
cel. Ze zijn hier gebonden door hulpeiwitten (cofactoren) en ze bewegen grotendeels vrijelijk. Binding
van het hormoon, bijvoorbeeld cortisol, leidt ertoe dat de receptoren zich naar de kern verplaatsen. In de
kern bewegen de receptoren ook vrijelijk, maar gaan ze tevens korte bindingen aan met het DNA. DNA
binding leidt tot immobilisatie van de eiwitten. In hoofdstukken 5 en 6 laten wij zien dat deze binding
altijd kortdurend is, maar wel in verschillende vormen kan voorkomen. Aspecifieke bindingen met het
DNA zijn zeer kort (millisecondes tot een halve seconde) terwijl langere bindingen (meerdere secondes)
waarschijnlijk wijzen op specifieke binding van de receptor. Specifieke binding leidt tot gentranscrip-
tie en tot de genomische effecten van corticosteroïden. Een kleiner gedeelte van de receptorpopulatie
bevindt zich aan het celmembraan. Cofactoren helpen met de membraanbinding. In hoofdstuk 4 laten
wij zien dat de membraangebonden MR langzamer beweegt dan in het cytoplasma of de kern. Corti-
sol binding aan de membraangebonden receptoren leidt tot snelle modificaties van eiwitten en tot de
niet-genomische effecten van corticosteroïden. Welke verder staan beschreven in hoofdstukken 2 en 3.
Fluorescentie-microscopie gaat uit van fluorescerende moleculen. Dit zijn mo-
leculen die de energie van een lichtbron (bijvoorbeeld een laser of een lamp van een
specifieke golflengte) kunnen absorberen en als reactie zelf ook licht gaan uitstra-
len. Het bekendste fluorescerende eiwit is GFP (green fluorescent protein), dit eiwit
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absorbeert blauw licht en straalt hierop zelf groen licht uit. Er zijn vele varianten
op GFP ontwikkeld met andere kleuren. In dit proefschrift maak ik voornamelijk
gebruik van YFP (yellow fluorescent protein) een eiwit dat geel licht uitzendt. Om
de functie van de twee corticosteroïd receptoren —de MR en GR— te onderzoe-
ken heb ik deze receptoren gefuseerd aan YFP. Het resulterende eiwit —YFP-MR
of YFP-GR— gedraagt zich als de MR of GR, maar dan zit er een fluorescerend deel
aan vast.
Voor de experimenten in dit proefschrift heb ik veelvuldig gebruik gemaakt van
een variatie op fluorescentie-microscopie: single-moleculemicroscopie. Hierbij wor-
den individuele fluorescerende moleculen gevolgd over de tijd waardoor de bewe-
ging (dynamiek) vanmoleculen bestudeerd kan worden (geïllustreerd in Figuur 2 ).
Wij gebruikten hiervoor cellen die YFP-MR of YFP-GR bezitten. In elke cel zitten
dan vele duizenden YFP-MR of YFP-GR moleculen. Om individuele moleculen van
elkaar te onderscheidenmoet eerst het overgrote gedeelte van demoleculenworden
uitgedoofd. Dit wordt gedaan door de cel langdurig met de lichtbron te beschijnen.
De meeste YFP moleculen doven dan uit. Zodra de dichtheid van de nog fluoresce-
rende moleculen laag genoeg is kan met een zeer gevoelige camera de fluorescentie
van deze individuele moleculen zichtbaar worden gemaakt. Wij maakten hiervan
filmpjes met om elke 6 millisecondes een nieuwe foto. Een individueel molecuul
kan dan op opeenvolgende foto’s worden gevolgd en als het tijdens deze periode be-
weegt zien we het steeds op een andere plek terug. Met een pakket aan analysesoft-
ware kunnen we de bewegingen van vele individuele moleculen samen analyseren
en dit geeft ons een beeld van hoe deze moleculen bewegen.
Een tweede methode om de dynamiek van fluorescerende moleculen te onder-
zoeken is FRAP (fluorescence recovery after photobleaching). Hierbij wordt een ster-
ke laser gebruikt die fluorescerende moleculen uitdooft (photobleaching). Deze la-
ser wordt maar op een deel van de cel gezet, dus alleen in dit stukje cel wordt de
fluorescentie gedoofd en dit stukje wordt dan een tijdlang gevolgd. Omdat eiwitten
bewegen zullen fluorescerende eiwitten uit andere delen van de cel zich verplaat-
sen naar het uitgedoofde gebied en zal er dus langzaam herstel van de fluorescentie
gezien worden. Hoe sneller een eiwit beweegt, des te sneller zal het gebied weer
opnieuw opgevuld worden met fluorescentie (zie Figuur 2 ).
Een laatste variatie op fluorescentie-microscopie die wij hebben gebruikt is TIRF
(total internal reflection fluorescence) microscopie. Bij TIRF-microscopie wordt de
activatie laser in een scherpe hoek geplaatst waardoor het licht op het glas wordt ge-
reflecteerd. Als reactie hierop wordt een dun energieveld gevormd. Dit energieveld
reikt maar tot maximaal 100 nanometer diep en activeert dus alleen fluoresceren-
de moleculen die zich in dit dunne veld bevinden. Wij hebben TIRF-microscopie
gebruikt op cellen die bovenop het glas waren geplaatst. Cellen zijn meerdere mi-
crometers dik en met TIRF-microscopie wordt dus alleen het onderste laagje van
de cel belicht. Aangezien het membraan het laagste deel van de cel is worden met





































Figuur 2: Geavanceerde fluorescentie microscopie
(A) Single moleculemicroscopie. Een fluorescerend eiwit (bijvoorbeeld YFP-GR) bevindt zich in de kern
van een cel. Het fluorescentiesignaal van vele moleculen samen geeft een beeld van een volledige cel-
kern (meest links). Voor singlemoleculemicroscopie wordt de cel eerst langdurigmet een laser bestraald
zodat de meeste fluorescentie uitdooft: slechts enkele nog fluorescerende moleculen blijven over. Met
een zeer gevoelige camera wordt de fluorescentie van deze individuele moleculen zichtbaar gemaakt
en gevolgd (figuur midden). Meest rechts zijn twee individuele YFP-GR moleculen afgebeeld: één zit
gedurende 6 millisecondes op 1 plaats (en is daarna niet meer zichtbaar), de andere beweegt geduren-
de 18 millisecondes door de kern heen. (B) FRAP. Bij FRAP wordt een klein gedeelte van de celkern met
een sterke laser beschenen zodat alle fluorescerendemoleculen hier uitdoven. Daarna vindt vermenging
plaats van nog fluorescerende moleculen uit andere gedeelten van de kern en de uitgedoofde moleculen
waardoor er nieuwe fluorescentie in het bestraalde gebied terugkeert. Hoe sneller een eiwit beweegt,
hoe sneller dit herstel zal zijn. Rechts staat een voorbeeld van FRAP op YFP-GR. (C) TIRF-microscopie.
TIRF-microscopie is een techniek om fluorescerende eiwitten bij het membraan te bekijken. Bij TIRF-
microscopie komt de laser met een sterke hoek binnen, waardoor vrijwel alle energie van de laser terug-
kaatst het objectief in. Een klein deel van de energie komt aan het oppervlak vrij, slechts een tiende van
een micrometer diep. Rechts ziet u voorbeelden van de fluorescentie van een membraangebonden eiwit
eerst bekeken met ‘normale’ fluorescentie microscopie waarbij veel en diffuse fluorescentie te zien is en




licht samen met een klein stukje van het bovenliggende cytoplasma. Hierdoor krij-
gen we met TIRF-microscopie een grote verrijking van fluorescerende moleculen in
het membraan ten opzichte van het cytoplasma (zie Figuur 2 ).
Belangrijkste bevindingen van dit proefschrift
Gedurende de laatste 20 jaar is er veel nieuw onderzoek gedaan naar de niet-
genomische effecten van corticosteroïden. Voor het eerst werd gevonden dat deze
snelle effecten ook via deMRenGR lopen en dat deze receptoren aan hetmembraan
voor komen. In hoofdstuk 2 evalueer ik de huidige kennis over de niet-genomische
corticosteroïd effecten in de hersenen. Voorts beschrijf ik de relevantie van deze
effecten voor de stressreactie. Een belangrijke bevinding hierbij is dat deze niet-
genomische effecten conditioneel zijn en werken als een neuromodulator. Dat wil
zeggen dat ze zelf geen neurale activiteit veroorzaken maar wel de afgifte van een
transmitter kunnen beïnvloeden of de gevoeligheid van neuronen voor activatie ver-
anderen.
Hetmechanisme dat ten grondslag ligt aan de niet-genomische werking van cor-
ticosteroïden is slechts in beperkte mate onderzocht. In hoofdstuk 3 hebben wij
een niet-genomisch effect nagebootst in een in vitro cellijn. In hippocampale neuro-
nen geeft een korte behandeling met corticosteron een inhibitie van één specifiek
type kaliumkanaal: het A-type. Wij hebben laten zien dat ook de NS-1 cellijn een
A-type kaliumstroom bevat. Na transfectie met de MR, leidt kortstondige behande-
ling met corticosteron tot een inhibitie van deze A-type kanalen in NS-1 cellen. In
NS-1 cellen zonder MR heeft corticosteron geen effect. Bovendien vonden we dat
corticosteron ook geen effect gaf op een ander type kaliumkanaal (langzaam inac-
tiverend). Samengevat vonden we dat aanwezigheid van de MR voldoende is voor
een niet-genomisch effect van corticosteron en dat dit effect specifiek is voor A-type
kanalen.
In hoofdstuk 4 beschrijf ik verder onderzoek naar de membraangebonden
MR. Het is bekend dat een kleine fractie van alle MR moleculen aan het mem-
braan geankerd zit, maar het is heel moeilijk om deze kleine fractie te onder-
scheiden van de veel grotere populatie MR moleculen die zich in het cytoplas-
ma bevindt. In dit hoofdstuk vergeleken wij de dynamiek van YFP-MR moleculen
tussen conventionele-microscopie (voornamelijk cytoplasma) en TIRF-microscopie
(grote verrijking van membraan fractie). De dynamiek van YFP-MR werd geme-
ten met single-molecule microscopie. Met TIRF-microscopie werd een anderhalf
maal grotere fractie aan zeer langzaam bewegende YFP-MR moleculen gevonden
danmet conventionele-microscopie. Membraangebondenmoleculen bewegen zeer
langzaam, dus deze bevinding wijst erop dat er inderdaad een kleine membraange-
bonden fractie van YFP-MR bestaat (geïllustreerd in Figuur 1).
Zowel de GR en de MR kunnen direct aan het DNA binden. Deze bindingen zijn
niet statisch: de receptoren binden het DNA steeds kort en laten dan weer los om




is zeer lastig. In hoofdstuk 5 gebruikten wij een combinatie van single-molecule
microscopie en FRAP om de bindingsdynamiek van de GR aan het DNA te kwanti-
ficeren. Ten eerste vonden wij dat beide ona ankelijke technieken een zeer verge-
lijkbare kwantificatie van de DNA-bindingen van de GR gaven. In zijn geactiveerde
vorm was op elk moment 50% van de GR moleculen aan het DNA gebonden terwijl
de resterende 50% vrij bewoog. Met FRAP konden wij tevens de duur van de DNA
bindingen kwantificeren en vonden bindingstijden rond de halve seconde (30%)
en tussen de 2 en 3 secondes (20%). Niet-geactiveerde GR liet minder frequente en
kortere DNA-binding zien en tevens een snellere diffusie. Deze laatste bevinding
suggereert dat er in de bewegende fractie nog een derde zeer korte DNA-binding
verstopt zit: bindingen van minder dan 6 millisecondes. Alles samen genomen kun-
nen we concluderen dat de GR binnen de kern veel korte—aspecifieke— bindingen
met het DNA laat zien en slechts sporadisch voor langere tijd aan zijn specifieke
bindingsplaatsen zit gebonden (geïllustreerd in Figuur 1).
In hoofdstuk 6 hebben wij dezelfde combinatie van single-molecule microsco-
pie en FRAP gebruikt om de bindingsdynamiek van de MR aan het DNA te bestude-
ren. Ook voor de MR vonden wij dat de geactiveerde receptor voor 50% van de tijd
aan het DNA gebonden zat. De frequentie en duur van deze DNA-bindingen was
veel lager als de receptor met een antagonist was gebonden. De natuurlijke corti-
costeroïden —cortisol en corticosteron— hebben een hogere affiniteit voor de MR
dan voor de GR. Dit leidt tot een verschil in bindingsdynamiek tussen de MR en de
GR. Wanneer beide gebonden zijn door hun natuurlijke ligand laat de MR meer en
langere DNA-binding zien dan de GR.
Conclusie
In dit proefschrift heb ik onderzoek naar de cellulaire effecten van corticosteroïden
beschreven. Ik heb hiervoor verschillende geavanceerde fluorescentie microscopie
methodes gebruikt. Met TIRF en single-molecule microscopie heb ik sterke indica-
ties gevonden voor het bestaan van een membraangebonden fractie van de MR. De
combinatie van FRAP en single-molecule microscopie gaf een zeer precieze kwanti-
ficatie van de bindingsdynamiek van zowel de GR als de MR aan het DNA. Hierbij
kon ik onderscheid maken tussen frequente aspecifieke bindingen en minder fre-
quente specifieke bindingen. Ook de bevinding dat verschillende hormonen een
heel ander DNA-bindingsdynamiek van de MR en de GR aan het DNA laten zien is
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